id	sid	tid	token	lemma	pos
aji-17	1	1	_	_	PUNCT
aji-17	2	1	_	_	PUNCT
aji-17	3	1	_	_	PUNCT
aji-17	4	1	_	_	PUNCT
aji-17	5	1	_	_	PUNCT
aji-17	6	1	_	_	PUNCT
aji-17	7	1	_	_	PUNCT
aji-17	8	1	_	_	PUNCT
aji-17	9	1	_	_	PUNCT
aji-17	10	1	_	_	PUNCT
aji-17	11	1	_	_	PUNCT
aji-17	12	1	_	_	PUNCT
aji-17	13	1	_	_	PUNCT
aji-17	14	1	_	_	PUNCT
aji-17	15	1	_	_	PUNCT
aji-17	16	1	_	_	PUNCT
aji-17	17	1	_	_	PUNCT
aji-17	18	1	_	_	PUNCT
aji-17	19	1	_	_	PUNCT
aji-17	20	1	_	_	PUNCT
aji-17	21	1	_	_	PUNCT
aji-17	22	1	_	_	PUNCT
aji-17	23	1	_	_	PUNCT
aji-17	24	1	_	_	PUNCT
aji-17	25	1	_	_	PUNCT
aji-17	26	1	_	_	PUNCT
aji-17	27	1	_	_	PUNCT
aji-17	28	1	_	_	PUNCT
aji-17	29	1	_	_	PUNCT
aji-17	30	1	_	_	PUNCT
aji-17	31	1	_	_	PUNCT
aji-17	32	1	_	_	PUNCT
aji-17	33	1	_	_	PUNCT
aji-17	34	1	_	_	PUNCT
aji-17	35	1	_	_	PUNCT
aji-17	36	1	_	_	PUNCT
aji-17	37	1	_	_	PUNCT
aji-17	38	1	_	_	PUNCT
aji-17	39	1	_	_	PUNCT
aji-17	40	1	_	_	PUNCT
aji-17	41	1	_	_	PUNCT
aji-17	42	1	_	_	PUNCT
aji-17	43	1	_	_	PUNCT
aji-17	44	1	_	_	PUNCT
aji-17	45	1	_	_	PUNCT
aji-17	46	1	_	_	PUNCT
aji-17	47	1	_	_	PUNCT
aji-17	48	1	_	_	PUNCT
aji-17	49	1	_	_	PUNCT
aji-17	50	1	_	_	PUNCT
aji-17	51	1	_	_	PUNCT
aji-17	52	1	_	_	PUNCT
aji-17	53	1	_	_	PUNCT
aji-17	54	1	_	_	PUNCT
aji-17	55	1	_	_	PUNCT
aji-17	56	1	_	_	PUNCT
aji-17	57	1	_	_	PUNCT
aji-17	58	1	_	_	PUNCT
aji-17	59	1	_	_	PUNCT
aji-17	60	1	_	_	PUNCT
aji-17	61	1	_	_	PUNCT
aji-17	62	1	_	_	PUNCT
aji-17	63	1	_	_	PUNCT
aji-17	64	1	_	_	PUNCT
aji-17	65	1	_	_	PUNCT
aji-17	66	1	_	_	PUNCT
aji-17	67	1	_	_	PUNCT
aji-17	68	1	_	_	PUNCT
aji-17	69	1	_	_	PUNCT
aji-17	70	1	_	_	PUNCT
aji-17	71	1	_	_	PUNCT
aji-17	72	1	_	_	PUNCT
aji-17	73	1	_	_	PUNCT
aji-17	74	1	_	_	PUNCT
aji-17	75	1	_	_	PUNCT
aji-17	76	1	_	_	PUNCT
aji-17	77	1	_	_	PUNCT
aji-17	78	1	_	_	PUNCT
aji-17	79	1	_	_	PUNCT
aji-17	80	1	_	_	PUNCT
aji-17	81	1	_	_	PUNCT
aji-17	82	1	_	_	PUNCT
aji-17	83	1	_	_	PUNCT
aji-17	84	1	_	_	PUNCT
aji-17	85	1	_	_	PUNCT
aji-17	86	1	_	_	PUNCT
aji-17	87	1	_	_	PUNCT
aji-17	88	1	_	_	PUNCT
aji-17	89	1	_	_	PUNCT
aji-17	90	1	_	_	PUNCT
aji-17	91	1	_	_	PUNCT
aji-17	92	1	_	_	PUNCT
aji-17	93	1	_	_	PUNCT
aji-17	94	1	_	_	PUNCT
aji-17	95	1	_	_	PUNCT
aji-17	96	1	_	_	PUNCT
aji-17	97	1	_	_	PUNCT
aji-17	98	1	_	_	PUNCT
aji-17	99	1	_	_	PUNCT
aji-17	100	1	_	_	PUNCT
aji-17	101	1	_	_	PUNCT
aji-17	102	1	*	*	PUNCT
aji-17	102	2	corresponding	correspond	VERB
aji-17	102	3	author	author	NOUN
aji-17	102	4	:	:	PUNCT
aji-17	102	5	e	e	NOUN
aji-17	102	6	-	-	NOUN
aji-17	102	7	mail	mail	NOUN
aji-17	102	8	:	:	PUNCT
aji-17	102	9	drasv@ymail.com	drasv@ymail.com	PROPN
aji-17	102	10	;	;	PUNCT
aji-17	102	11	asian	asian	ADJ
aji-17	102	12	journal	journal	NOUN
aji-17	102	13	of	of	ADP
aji-17	102	14	immunology	immunology	NOUN
aji-17	102	15	3(1	3(1	NUM
aji-17	102	16	):	):	PUNCT
aji-17	102	17	61	61	NUM
aji-17	102	18	-	-	SYM
aji-17	102	19	70	70	NUM
aji-17	102	20	,	,	PUNCT
aji-17	102	21	2020	2020	NUM
aji-17	102	22	;	;	PUNCT
aji-17	102	23	article	article	NOUN
aji-17	102	24	no.aji.55881	no.aji.55881	ADP
aji-17	102	25	local	local	ADJ
aji-17	102	26	immunity	immunity	NOUN
aji-17	102	27	concept	concept	NOUN
aji-17	102	28	in	in	ADP
aji-17	102	29	the	the	DET
aji-17	102	30	context	context	NOUN
aji-17	102	31	of	of	ADP
aji-17	102	32	the	the	DET
aji-17	102	33	novel	novel	ADJ
aji-17	102	34	corona	corona	NOUN
aji-17	102	35	viral	viral	ADJ
aji-17	102	36	infection	infection	NOUN
aji-17	102	37	:	:	PUNCT
aji-17	102	38	a	a	DET
aji-17	102	39	consideration	consideration	NOUN
aji-17	102	40	a.	a.	NOUN
aji-17	102	41	s.	s.	PROPN
aji-17	103	1	v.	v.	ADP
aji-17	103	2	prasad1	prasad1	PROPN
aji-17	103	3	*	*	PROPN
aji-17	103	4	1	1	NUM
aji-17	103	5	department	department	NOUN
aji-17	103	6	of	of	ADP
aji-17	103	7	internal	internal	ADJ
aji-17	103	8	medicine	medicine	NOUN
aji-17	103	9	,	,	PUNCT
aji-17	103	10	gandhi	gandhi	PROPN
aji-17	103	11	institute	institute	PROPN
aji-17	103	12	of	of	ADP
aji-17	103	13	technology	technology	PROPN
aji-17	103	14	and	and	CCONJ
aji-17	103	15	management	management	NOUN
aji-17	103	16	,	,	PUNCT
aji-17	103	17	rishikonda	rishikonda	PROPN
aji-17	103	18	,	,	PUNCT
aji-17	103	19	visakhapatnam	visakhapatnam	PROPN
aji-17	103	20	,	,	PUNCT
aji-17	103	21	india	india	PROPN
aji-17	103	22	.	.	PUNCT
aji-17	104	1	author	author	PROPN
aji-17	104	2	’s	’s	PART
aji-17	104	3	contribution	contribution	NOUN
aji-17	104	4	the	the	DET
aji-17	104	5	sole	sole	ADJ
aji-17	104	6	author	author	NOUN
aji-17	104	7	designed	design	VERB
aji-17	104	8	,	,	PUNCT
aji-17	104	9	analysed	analyse	VERB
aji-17	104	10	,	,	PUNCT
aji-17	104	11	interpreted	interpret	VERB
aji-17	104	12	and	and	CCONJ
aji-17	104	13	prepared	prepare	VERB
aji-17	104	14	the	the	DET
aji-17	104	15	manuscript	manuscript	NOUN
aji-17	104	16	.	.	PUNCT
aji-17	105	1	article	article	NOUN
aji-17	105	2	information	information	PROPN
aji-17	105	3	editor(s	editor(s	PROPN
aji-17	105	4	):	):	PUNCT
aji-17	105	5	(	(	PUNCT
aji-17	105	6	1	1	X
aji-17	105	7	)	)	PUNCT
aji-17	105	8	darko	darko	PROPN
aji-17	105	9	nozic	nozic	PROPN
aji-17	105	10	,	,	PUNCT
aji-17	105	11	university	university	PROPN
aji-17	105	12	of	of	ADP
aji-17	105	13	belgrade	belgrade	PROPN
aji-17	105	14	,	,	PUNCT
aji-17	105	15	serbia	serbia	PROPN
aji-17	105	16	.	.	PUNCT
aji-17	106	1	reviewers	reviewer	NOUN
aji-17	106	2	:	:	PUNCT
aji-17	106	3	(	(	PUNCT
aji-17	106	4	1	1	X
aji-17	106	5	)	)	PUNCT
aji-17	106	6	wuyi	wuyi	PROPN
aji-17	106	7	liu	liu	PROPN
aji-17	106	8	,	,	PUNCT
aji-17	106	9	fuyang	fuyang	PROPN
aji-17	106	10	normal	normal	ADJ
aji-17	106	11	university	university	PROPN
aji-17	106	12	,	,	PUNCT
aji-17	106	13	china	china	PROPN
aji-17	106	14	.	.	PUNCT
aji-17	107	1	(	(	PUNCT
aji-17	107	2	2	2	X
aji-17	107	3	)	)	PUNCT
aji-17	107	4	vijaya	vijaya	PROPN
aji-17	107	5	krishnan	krishnan	PROPN
aji-17	107	6	,	,	PUNCT
aji-17	107	7	mgm	mgm	PROPN
aji-17	107	8	college	college	PROPN
aji-17	107	9	of	of	ADP
aji-17	107	10	physiotherapy	physiotherapy	NOUN
aji-17	107	11	,	,	PUNCT
aji-17	107	12	india	india	PROPN
aji-17	107	13	.	.	PUNCT
aji-17	108	1	(	(	PUNCT
aji-17	108	2	3	3	X
aji-17	108	3	)	)	PUNCT
aji-17	108	4	m.	m.	NOUN
aji-17	108	5	zamri	zamri	PROPN
aji-17	108	6	saad	saad	PROPN
aji-17	108	7	,	,	PUNCT
aji-17	108	8	universiti	universiti	PROPN
aji-17	108	9	putra	putra	PROPN
aji-17	108	10	malaysia	malaysia	PROPN
aji-17	108	11	,	,	PUNCT
aji-17	108	12	malaysia	malaysia	PROPN
aji-17	108	13	.	.	PUNCT
aji-17	109	1	complete	complete	ADJ
aji-17	109	2	peer	peer	NOUN
aji-17	109	3	review	review	NOUN
aji-17	109	4	history	history	NOUN
aji-17	109	5	:	:	PUNCT
aji-17	109	6	http://www.sdiarticle4.com/review-history/55881	http://www.sdiarticle4.com/review-history/55881	PRON
aji-17	109	7	received	receive	VERB
aji-17	109	8	20	20	NUM
aji-17	109	9	march	march	NOUN
aji-17	109	10	2020	2020	NUM
aji-17	109	11	accepted	accept	VERB
aji-17	109	12	30	30	NUM
aji-17	109	13	march	march	NOUN
aji-17	109	14	2020	2020	NUM
aji-17	109	15	published	publish	VERB
aji-17	110	1	01	01	NUM
aji-17	110	2	april	april	PROPN
aji-17	110	3	2020	2020	NUM
aji-17	110	4	abstract	abstract	ADJ
aji-17	110	5	the	the	DET
aji-17	110	6	pandemic	pandemic	NOUN
aji-17	110	7	of	of	ADP
aji-17	110	8	novel	novel	ADJ
aji-17	110	9	corona	corona	NOUN
aji-17	110	10	virus	virus	NOUN
aji-17	110	11	disease	disease	NOUN
aji-17	110	12	(	(	PUNCT
aji-17	110	13	covid	covid	PROPN
aji-17	110	14	19	19	NUM
aji-17	110	15	)	)	PUNCT
aji-17	110	16	,	,	PUNCT
aji-17	110	17	is	be	AUX
aji-17	110	18	presently	presently	ADV
aji-17	110	19	sweeping	sweep	VERB
aji-17	110	20	the	the	DET
aji-17	110	21	world	world	NOUN
aji-17	110	22	over	over	ADP
aji-17	110	23	.	.	PUNCT
aji-17	111	1	the	the	DET
aji-17	111	2	causative	causative	ADJ
aji-17	111	3	virus	virus	NOUN
aji-17	111	4	is	be	AUX
aji-17	111	5	named	name	VERB
aji-17	111	6	,	,	PUNCT
aji-17	111	7	sars	sar	NOUN
aji-17	111	8	-	-	PUNCT
aji-17	111	9	cov-2	cov-2	NOUN
aji-17	111	10	.	.	PUNCT
aji-17	112	1	the	the	DET
aji-17	112	2	rapidity	rapidity	NOUN
aji-17	112	3	with	with	ADP
aji-17	112	4	which	which	PRON
aji-17	112	5	the	the	DET
aji-17	112	6	pandemic	pandemic	NOUN
aji-17	112	7	is	be	AUX
aji-17	112	8	advancing	advance	VERB
aji-17	112	9	is	be	AUX
aji-17	112	10	catastrophic	catastrophic	ADJ
aji-17	112	11	.	.	PUNCT
aji-17	113	1	that	that	SCONJ
aji-17	113	2	there	there	PRON
aji-17	113	3	is	be	VERB
aji-17	113	4	no	no	DET
aji-17	113	5	known	known	ADJ
aji-17	113	6	treatment	treatment	NOUN
aji-17	113	7	for	for	ADP
aji-17	113	8	this	this	DET
aji-17	113	9	killer	killer	NOUN
aji-17	113	10	disease	disease	NOUN
aji-17	113	11	is	be	AUX
aji-17	113	12	throwing	throw	VERB
aji-17	113	13	public	public	ADJ
aji-17	113	14	at	at	ADP
aji-17	113	15	large	large	ADJ
aji-17	113	16	into	into	ADP
aji-17	113	17	a	a	DET
aji-17	113	18	state	state	NOUN
aji-17	113	19	of	of	ADP
aji-17	113	20	fear	fear	NOUN
aji-17	113	21	psychosis	psychosis	NOUN
aji-17	113	22	.	.	PUNCT
aji-17	114	1	the	the	DET
aji-17	114	2	urgent	urgent	ADJ
aji-17	114	3	need	need	NOUN
aji-17	114	4	for	for	ADP
aji-17	114	5	preventive	preventive	ADJ
aji-17	114	6	vaccine	vaccine	NOUN
aji-17	114	7	is	be	AUX
aji-17	114	8	felt	feel	VERB
aji-17	114	9	now	now	ADV
aji-17	114	10	,	,	PUNCT
aji-17	114	11	more	more	ADJ
aji-17	114	12	than	than	ADP
aji-17	114	13	ever	ever	ADV
aji-17	114	14	before	before	ADV
aji-17	114	15	though	though	SCONJ
aji-17	114	16	promising	promising	ADJ
aji-17	114	17	research	research	NOUN
aji-17	114	18	is	be	AUX
aji-17	114	19	going	go	VERB
aji-17	114	20	on	on	ADP
aji-17	114	21	,	,	PUNCT
aji-17	114	22	the	the	DET
aji-17	114	23	goal	goal	NOUN
aji-17	114	24	to	to	PART
aji-17	114	25	achieve	achieve	VERB
aji-17	114	26	a	a	DET
aji-17	114	27	breakthrough	breakthrough	NOUN
aji-17	114	28	vaccine	vaccine	NOUN
aji-17	114	29	is	be	AUX
aji-17	114	30	still	still	ADV
aji-17	114	31	a	a	DET
aji-17	114	32	long	long	ADJ
aji-17	114	33	way	way	NOUN
aji-17	114	34	to	to	PART
aji-17	114	35	go	go	VERB
aji-17	114	36	.	.	PUNCT
aji-17	115	1	since	since	SCONJ
aji-17	115	2	sars	sar	NOUN
aji-17	115	3	-	-	PUNCT
aji-17	115	4	cov-2	cov-2	PART
aji-17	115	5	is	be	AUX
aji-17	115	6	an	an	DET
aji-17	115	7	infection	infection	NOUN
aji-17	115	8	restricted	restrict	VERB
aji-17	115	9	to	to	ADP
aji-17	115	10	respiratory	respiratory	ADJ
aji-17	115	11	system	system	NOUN
aji-17	115	12	of	of	ADP
aji-17	115	13	the	the	DET
aji-17	115	14	affected	affected	ADJ
aji-17	115	15	,	,	PUNCT
aji-17	115	16	vaccines	vaccine	NOUN
aji-17	115	17	aimed	aim	VERB
aji-17	115	18	at	at	ADP
aji-17	115	19	inducing	induce	VERB
aji-17	115	20	local	local	ADJ
aji-17	115	21	(	(	PUNCT
aji-17	115	22	mucosal	mucosal	NOUN
aji-17	115	23	)	)	PUNCT
aji-17	115	24	immunity	immunity	NOUN
aji-17	115	25	may	may	AUX
aji-17	115	26	offer	offer	VERB
aji-17	115	27	better	well	ADJ
aji-17	115	28	chance	chance	NOUN
aji-17	115	29	of	of	ADP
aji-17	115	30	preventing	prevent	VERB
aji-17	115	31	the	the	DET
aji-17	115	32	acquisition	acquisition	NOUN
aji-17	115	33	and	and	CCONJ
aji-17	115	34	spread	spread	VERB
aji-17	115	35	of	of	ADP
aji-17	115	36	the	the	DET
aji-17	115	37	disease	disease	NOUN
aji-17	115	38	to	to	ADP
aji-17	115	39	others	other	NOUN
aji-17	115	40	,	,	PUNCT
aji-17	115	41	than	than	ADP
aji-17	115	42	induction	induction	NOUN
aji-17	115	43	of	of	ADP
aji-17	115	44	systemic	systemic	ADJ
aji-17	115	45	immunity	immunity	NOUN
aji-17	115	46	.	.	PUNCT
aji-17	116	1	with	with	ADP
aji-17	116	2	this	this	DET
aji-17	116	3	background	background	NOUN
aji-17	116	4	theme	theme	NOUN
aji-17	116	5	,	,	PUNCT
aji-17	116	6	this	this	DET
aji-17	116	7	article	article	NOUN
aji-17	116	8	briefly	briefly	ADV
aji-17	116	9	reviewed	review	VERB
aji-17	116	10	the	the	DET
aji-17	116	11	epidemiology	epidemiology	NOUN
aji-17	116	12	,	,	PUNCT
aji-17	116	13	the	the	DET
aji-17	116	14	vaccine	vaccine	NOUN
aji-17	116	15	trials	trial	NOUN
aji-17	116	16	of	of	ADP
aji-17	116	17	the	the	DET
aji-17	116	18	covid	covid	PROPN
aji-17	116	19	19	19	NUM
aji-17	116	20	as	as	ADV
aji-17	116	21	well	well	ADV
aji-17	116	22	as	as	ADP
aji-17	116	23	the	the	DET
aji-17	116	24	immune	immune	ADJ
aji-17	116	25	responses	response	NOUN
aji-17	116	26	to	to	ADP
aji-17	116	27	viral	viral	ADJ
aji-17	116	28	infection	infection	NOUN
aji-17	116	29	in	in	ADP
aji-17	116	30	general	general	ADJ
aji-17	116	31	and	and	CCONJ
aji-17	116	32	with	with	ADP
aji-17	116	33	a	a	DET
aji-17	116	34	special	special	ADJ
aji-17	116	35	focus	focus	NOUN
aji-17	116	36	on	on	ADP
aji-17	116	37	the	the	DET
aji-17	116	38	concept	concept	NOUN
aji-17	116	39	of	of	ADP
aji-17	116	40	local	local	ADJ
aji-17	116	41	immunity	immunity	NOUN
aji-17	116	42	advanced	advance	VERB
aji-17	116	43	by	by	ADP
aji-17	116	44	prof	prof	NOUN
aji-17	116	45	besredka	besredka	NOUN
aji-17	116	46	(	(	PUNCT
aji-17	116	47	1924	1924	NUM
aji-17	116	48	)	)	PUNCT
aji-17	116	49	.	.	PUNCT
aji-17	117	1	the	the	DET
aji-17	117	2	historical	historical	ADJ
aji-17	117	3	perspective	perspective	NOUN
aji-17	117	4	of	of	ADP
aji-17	117	5	the	the	DET
aji-17	117	6	local	local	ADJ
aji-17	117	7	immunity	immunity	NOUN
aji-17	117	8	concept	concept	NOUN
aji-17	117	9	is	be	AUX
aji-17	117	10	recapitulated	recapitulate	VERB
aji-17	117	11	and	and	CCONJ
aji-17	117	12	the	the	DET
aji-17	117	13	diseases	disease	NOUN
aji-17	117	14	,	,	PUNCT
aji-17	117	15	both	both	PRON
aji-17	117	16	viral	viral	ADJ
aji-17	117	17	and	and	CCONJ
aji-17	117	18	bacterial	bacterial	ADJ
aji-17	117	19	,	,	PUNCT
aji-17	117	20	to	to	PART
aji-17	117	21	which	which	PRON
aji-17	117	22	vaccines	vaccine	NOUN
aji-17	117	23	are	be	AUX
aji-17	117	24	developed	develop	VERB
aji-17	117	25	in	in	ADP
aji-17	117	26	the	the	DET
aji-17	117	27	past	past	NOUN
aji-17	117	28	basing	base	VERB
aji-17	117	29	on	on	ADP
aji-17	117	30	this	this	DET
aji-17	117	31	concept	concept	NOUN
aji-17	117	32	are	be	AUX
aji-17	117	33	reviewed	review	VERB
aji-17	117	34	.	.	PUNCT
aji-17	118	1	a	a	DET
aji-17	118	2	case	case	NOUN
aji-17	118	3	is	be	AUX
aji-17	118	4	made	make	VERB
aji-17	118	5	out	out	ADP
aji-17	118	6	for	for	ADP
aji-17	118	7	applying	apply	VERB
aji-17	118	8	this	this	DET
aji-17	118	9	concept	concept	NOUN
aji-17	118	10	for	for	ADP
aji-17	118	11	the	the	DET
aji-17	118	12	prevention	prevention	NOUN
aji-17	118	13	of	of	ADP
aji-17	118	14	covid	covid	PROPN
aji-17	118	15	19	19	NUM
aji-17	118	16	.	.	PUNCT
aji-17	119	1	it	it	PRON
aji-17	119	2	is	be	AUX
aji-17	119	3	suggested	suggest	VERB
aji-17	119	4	that	that	SCONJ
aji-17	119	5	an	an	DET
aji-17	119	6	approach	approach	NOUN
aji-17	119	7	to	to	PART
aji-17	119	8	boost	boost	VERB
aji-17	119	9	local	local	ADJ
aji-17	119	10	immunity	immunity	NOUN
aji-17	119	11	,	,	PUNCT
aji-17	119	12	than	than	ADP
aji-17	119	13	systemic	systemic	ADJ
aji-17	119	14	immunity	immunity	NOUN
aji-17	119	15	,	,	PUNCT
aji-17	119	16	might	might	AUX
aji-17	119	17	be	be	AUX
aji-17	119	18	a	a	DET
aji-17	119	19	better	well	ADJ
aji-17	119	20	strategy	strategy	NOUN
aji-17	119	21	of	of	ADP
aji-17	119	22	prevention	prevention	NOUN
aji-17	119	23	of	of	ADP
aji-17	119	24	covid	covid	PROPN
aji-17	119	25	19	19	NUM
aji-17	119	26	.	.	PUNCT
aji-17	120	1	opinion	opinion	NOUN
aji-17	120	2	article	article	NOUN
aji-17	120	3	prasad	prasad	PROPN
aji-17	120	4	;	;	PUNCT
aji-17	120	5	aji	aji	NOUN
aji-17	120	6	,	,	PUNCT
aji-17	120	7	3(1	3(1	NUM
aji-17	120	8	):	):	PUNCT
aji-17	120	9	61	61	NUM
aji-17	120	10	-	-	SYM
aji-17	120	11	70	70	NUM
aji-17	120	12	,	,	PUNCT
aji-17	120	13	2020	2020	NUM
aji-17	120	14	;	;	PUNCT
aji-17	120	15	article	article	NOUN
aji-17	120	16	no.aji.55881	no.aji.55881	ADP
aji-17	120	17	62	62	NUM
aji-17	120	18	keywords	keyword	NOUN
aji-17	120	19	:	:	PUNCT
aji-17	120	20	covid	covid	PROPN
aji-17	120	21	19	19	NUM
aji-17	120	22	;	;	PUNCT
aji-17	120	23	local	local	ADJ
aji-17	120	24	immunity	immunity	NOUN
aji-17	120	25	;	;	PUNCT
aji-17	120	26	viral	viral	ADJ
aji-17	120	27	immunity	immunity	NOUN
aji-17	120	28	;	;	PUNCT
aji-17	120	29	sars	sar	NOUN
aji-17	120	30	-	-	PUNCT
aji-17	120	31	cov-2(severe	cov-2(severe	VERB
aji-17	120	32	acute	acute	ADJ
aji-17	120	33	respiratory	respiratory	ADJ
aji-17	120	34	syndrome	syndrome	PROPN
aji-17	120	35	corona	corona	PROPN
aji-17	120	36	virus	virus	NOUN
aji-17	120	37	2	2	NUM
aji-17	120	38	)	)	PUNCT
aji-17	120	39	;	;	PUNCT
aji-17	120	40	mers	mer	NOUN
aji-17	120	41	-	-	PUNCT
aji-17	120	42	cov(middle	cov(middle	NUM
aji-17	120	43	east	east	PROPN
aji-17	120	44	respiratory	respiratory	ADJ
aji-17	120	45	syndrome	syndrome	NOUN
aji-17	120	46	coronavirus	coronavirus	NOUN
aji-17	120	47	)	)	PUNCT
aji-17	120	48	.	.	PUNCT
aji-17	121	1	1	1	X
aji-17	121	2	.	.	X
aji-17	121	3	introduction	introduction	NOUN
aji-17	121	4	1.1	1.1	NUM
aji-17	121	5	epidemiological	epidemiological	ADJ
aji-17	121	6	considerations	consideration	NOUN
aji-17	121	7	of	of	ADP
aji-17	121	8	covid	covid	PROPN
aji-17	121	9	19	19	NUM
aji-17	121	10			NOUN
aji-17	121	11	the	the	DET
aji-17	121	12	massive	massive	ADJ
aji-17	121	13	awareness	awareness	NOUN
aji-17	121	14	programme	programme	NOUN
aji-17	121	15	against	against	ADP
aji-17	121	16	the	the	DET
aji-17	121	17	covid	covid	PROPN
aji-17	121	18	19	19	NUM
aji-17	121	19	world	world	NOUN
aji-17	121	20	over	over	ADV
aji-17	121	21	,	,	PUNCT
aji-17	121	22	made	make	VERB
aji-17	121	23	any	any	DET
aji-17	121	24	introduction	introduction	NOUN
aji-17	121	25	to	to	ADP
aji-17	121	26	this	this	DET
aji-17	121	27	disease	disease	NOUN
aji-17	121	28	superfluous	superfluous	ADJ
aji-17	121	29	.	.	PUNCT
aji-17	122	1	similarly	similarly	ADV
aji-17	122	2	the	the	DET
aji-17	122	3	rapid	rapid	ADJ
aji-17	122	4	changes	change	NOUN
aji-17	122	5	from	from	ADP
aji-17	122	6	day	day	NOUN
aji-17	122	7	to	to	ADP
aji-17	122	8	day	day	NOUN
aji-17	122	9	of	of	ADP
aji-17	122	10	statistical	statistical	ADJ
aji-17	122	11	data	datum	NOUN
aji-17	122	12	made	make	VERB
aji-17	122	13	any	any	DET
aji-17	122	14	cited	cite	VERB
aji-17	122	15	data	datum	NOUN
aji-17	122	16	meaningless	meaningless	ADJ
aji-17	122	17	,	,	PUNCT
aji-17	122	18	in	in	ADP
aji-17	122	19	no	no	DET
aji-17	122	20	time	time	NOUN
aji-17	122	21	.	.	PUNCT
aji-17	123	1	nevertheless	nevertheless	ADV
aji-17	123	2	,	,	PUNCT
aji-17	123	3	convention	convention	NOUN
aji-17	123	4	demands	demand	VERB
aji-17	123	5	brief	brief	ADJ
aji-17	123	6	introduction	introduction	NOUN
aji-17	123	7	to	to	ADP
aji-17	123	8	the	the	DET
aji-17	123	9	disease	disease	NOUN
aji-17	123	10	.	.	PUNCT
aji-17	124	1	a	a	DET
aji-17	124	2	pneumonia	pneumonia	NOUN
aji-17	124	3	of	of	ADP
aji-17	124	4	unknown	unknown	ADJ
aji-17	124	5	cause	cause	NOUN
aji-17	124	6	detected	detect	VERB
aji-17	124	7	in	in	ADP
aji-17	124	8	wuhan	wuhan	PROPN
aji-17	124	9	,	,	PUNCT
aji-17	124	10	china	china	PROPN
aji-17	124	11	was	be	AUX
aji-17	124	12	first	first	ADV
aji-17	124	13	reported	report	VERB
aji-17	124	14	to	to	ADP
aji-17	124	15	the	the	DET
aji-17	124	16	who	who	PRON
aji-17	124	17	country	country	NOUN
aji-17	124	18	office	office	NOUN
aji-17	124	19	in	in	ADP
aji-17	124	20	china	china	PROPN
aji-17	124	21	on	on	ADP
aji-17	124	22	31	31	NUM
aji-17	124	23	december	december	PROPN
aji-17	124	24	2019.the	2019.the	DET
aji-17	124	25	outbreak	outbreak	NOUN
aji-17	124	26	was	be	AUX
aji-17	124	27	declared	declare	VERB
aji-17	124	28	a	a	DET
aji-17	124	29	public	public	ADJ
aji-17	124	30	health	health	NOUN
aji-17	124	31	emergency	emergency	NOUN
aji-17	124	32	of	of	ADP
aji-17	124	33	international	international	ADJ
aji-17	124	34	concern	concern	NOUN
aji-17	124	35	on	on	ADP
aji-17	124	36	30	30	NUM
aji-17	124	37	january	january	NOUN
aji-17	124	38	2020	2020	NUM
aji-17	124	39	.	.	PUNCT
aji-17	125	1	on	on	ADP
aji-17	125	2	11	11	NUM
aji-17	125	3	february	february	NOUN
aji-17	125	4	2020	2020	NUM
aji-17	125	5	,	,	PUNCT
aji-17	125	6	who	who	PRON
aji-17	125	7	announced	announce	VERB
aji-17	125	8	a	a	DET
aji-17	125	9	name	name	NOUN
aji-17	125	10	for	for	ADP
aji-17	125	11	the	the	DET
aji-17	125	12	new	new	ADJ
aji-17	125	13	coronavirus	coronavirus	NOUN
aji-17	125	14	disease	disease	NOUN
aji-17	125	15	.	.	PUNCT
aji-17	126	1	the	the	DET
aji-17	126	2	strain	strain	NOUN
aji-17	126	3	involved	involve	VERB
aji-17	126	4	is	be	AUX
aji-17	126	5	considered	consider	VERB
aji-17	126	6	novel	novel	ADJ
aji-17	126	7	as	as	SCONJ
aji-17	126	8	it	it	PRON
aji-17	126	9	is	be	AUX
aji-17	126	10	different	different	ADJ
aji-17	126	11	from	from	ADP
aji-17	126	12	corona	corona	NOUN
aji-17	126	13	virus	virus	NOUN
aji-17	126	14	strains	strain	NOUN
aji-17	126	15	that	that	PRON
aji-17	126	16	are	be	AUX
aji-17	126	17	known	know	VERB
aji-17	126	18	before	before	ADP
aji-17	126	19	and	and	CCONJ
aji-17	126	20	hence	hence	ADV
aji-17	126	21	.	.	PUNCT
aji-17	127	1			X
aji-17	128	1	the	the	DET
aji-17	128	2	name	name	NOUN
aji-17	128	3	covid	covid	NOUN
aji-17	128	4	19	19	NUM
aji-17	128	5	.	.	PUNCT
aji-17	129	1	sars	sar	NOUN
aji-17	129	2	-	-	PUNCT
aji-17	129	3	cov-2	cov-2	PART
aji-17	129	4	belongs	belong	VERB
aji-17	129	5	to	to	ADP
aji-17	129	6	the	the	DET
aji-17	129	7	beta	beta	ADJ
aji-17	129	8	coronavirus	coronavirus	NOUN
aji-17	129	9	genus	genus	NOUN
aji-17	129	10	,	,	PUNCT
aji-17	129	11	which	which	PRON
aji-17	129	12	also	also	ADV
aji-17	129	13	includes	include	VERB
aji-17	129	14	sars	sars	PROPN
aji-17	129	15	cov	cov	PROPN
aji-17	129	16	(	(	PUNCT
aji-17	129	17	2003	2003	NUM
aji-17	129	18	)	)	PUNCT
aji-17	129	19	and	and	CCONJ
aji-17	129	20	mers	mers	PROPN
aji-17	129	21	cov	cov	PROPN
aji-17	129	22	(	(	PUNCT
aji-17	129	23	2012	2012	NUM
aji-17	129	24	)	)	PUNCT
aji-17	129	25	.	.	PUNCT
aji-17	130	1	sars	sars	PROPN
aji-17	130	2	-	-	PUNCT
aji-17	130	3	cov	cov	PROPN
aji-17	130	4	first	first	ADV
aji-17	130	5	emerged	emerge	VERB
aji-17	130	6	in	in	ADP
aji-17	130	7	2002	2002	NUM
aji-17	130	8	-	-	SYM
aji-17	130	9	2003	2003	NUM
aji-17	130	10	in	in	ADP
aji-17	130	11	guangdong	guangdong	PROPN
aji-17	130	12	,	,	PUNCT
aji-17	130	13	china	china	PROPN
aji-17	130	14	as	as	ADP
aji-17	130	15	an	an	DET
aji-17	130	16	unusual	unusual	ADJ
aji-17	130	17	pneumonia	pneumonia	NOUN
aji-17	130	18	,	,	PUNCT
aji-17	130	19	that	that	PRON
aji-17	130	20	caused	cause	VERB
aji-17	130	21	lifethreatening	lifethreatene	VERB
aji-17	130	22	respiratory	respiratory	ADJ
aji-17	130	23	failure	failure	NOUN
aji-17	130	24	in	in	ADP
aji-17	130	25	certain	certain	ADJ
aji-17	130	26	cases	case	NOUN
aji-17	130	27	.	.	PUNCT
aji-17	131	1	it	it	PRON
aji-17	131	2	quickly	quickly	ADV
aji-17	131	3	became	become	VERB
aji-17	131	4	pandemic	pandemic	ADJ
aji-17	131	5	.	.	PUNCT
aji-17	132	1	mers	mer	NOUN
aji-17	132	2	-	-	PUNCT
aji-17	132	3	cov	cov	NOUN
aji-17	132	4	epidemic	epidemic	NOUN
aji-17	132	5	appeared	appear	VERB
aji-17	132	6	in	in	ADP
aji-17	132	7	saudi	saudi	PROPN
aji-17	132	8	arabia	arabia	PROPN
aji-17	132	9	in	in	ADP
aji-17	132	10	2012	2012	NUM
aji-17	132	11	,	,	PUNCT
aji-17	132	12	with	with	ADP
aji-17	132	13	people	people	NOUN
aji-17	132	14	experiencing	experience	VERB
aji-17	132	15	similar	similar	ADJ
aji-17	132	16	symptoms	symptom	NOUN
aji-17	132	17	to	to	ADP
aji-17	132	18	sars	sar	NOUN
aji-17	132	19	-	-	PUNCT
aji-17	132	20	cov	cov	PROPN
aji-17	132	21	but	but	CCONJ
aji-17	132	22	dying	die	VERB
aji-17	132	23	at	at	ADP
aji-17	132	24	a	a	DET
aji-17	132	25	much	much	ADV
aji-17	132	26	higher	high	ADJ
aji-17	132	27	rate	rate	NOUN
aji-17	132	28	of	of	ADP
aji-17	132	29	34	34	NUM
aji-17	132	30	per	per	ADP
aji-17	132	31	cent	cent	NOUN
aji-17	132	32	.	.	PUNCT
aji-17	133	1	unlike	unlike	ADP
aji-17	133	2	sars	sars	PROPN
aji-17	133	3	-	-	PUNCT
aji-17	133	4	cov	cov	NOUN
aji-17	133	5	,	,	PUNCT
aji-17	133	6	which	which	PRON
aji-17	133	7	spread	spread	VERB
aji-17	133	8	quickly	quickly	ADV
aji-17	133	9	and	and	CCONJ
aji-17	133	10	widely	widely	ADV
aji-17	133	11	,	,	PUNCT
aji-17	133	12	mers	mer	NOUN
aji-17	133	13	-	-	PUNCT
aji-17	133	14	cov	cov	NOUN
aji-17	133	15	has	have	AUX
aji-17	133	16	been	be	AUX
aji-17	133	17	mainly	mainly	ADV
aji-17	133	18	limited	limit	VERB
aji-17	133	19	to	to	ADP
aji-17	133	20	the	the	DET
aji-17	133	21	middle	middle	PROPN
aji-17	133	22	east	east	PROPN
aji-17	133	23	.	.	PUNCT
aji-17	134	1	on	on	ADP
aji-17	134	2	11	11	NUM
aji-17	134	3	february	february	NOUN
aji-17	134	4	,	,	PUNCT
aji-17	134	5	the	the	DET
aji-17	134	6	novel	novel	ADJ
aji-17	134	7	coronavirus	coronavirus	NOUN
aji-17	134	8	that	that	PRON
aji-17	134	9	had	have	AUX
aji-17	134	10	provisionally	provisionally	ADV
aji-17	134	11	been	be	AUX
aji-17	134	12	known	know	VERB
aji-17	134	13	as	as	ADP
aji-17	134	14	2019	2019	NUM
aji-17	134	15	-	-	PUNCT
aji-17	134	16	ncov	ncov	ADV
aji-17	134	17	,	,	PUNCT
aji-17	134	18	was	be	AUX
aji-17	134	19	given	give	VERB
aji-17	134	20	a	a	DET
aji-17	134	21	new	new	ADJ
aji-17	134	22	name	name	NOUN
aji-17	134	23	,	,	PUNCT
aji-17	134	24	sars	sar	NOUN
aji-17	134	25	-	-	PUNCT
aji-17	134	26	cov-2	cov-2	NOUN
aji-17	134	27	.	.	PUNCT
aji-17	135	1	the	the	DET
aji-17	135	2	acronym	acronym	NOUN
aji-17	135	3	sars	sar	NOUN
aji-17	135	4	stands	stand	VERB
aji-17	135	5	for	for	ADP
aji-17	135	6	severe	severe	ADJ
aji-17	135	7	acute	acute	ADJ
aji-17	135	8	respiratory	respiratory	ADJ
aji-17	135	9	syndrome	syndrome	NOUN
aji-17	135	10	.	.	PUNCT
aji-17	136	1	cov2	cov2	PROPN
aji-17	136	2	stands	stand	VERB
aji-17	136	3	for	for	ADP
aji-17	136	4	corona	corona	NOUN
aji-17	136	5	virus	virus	NOUN
aji-17	136	6	2	2	NUM
aji-17	136	7	.	.	PUNCT
aji-17	137	1	the	the	DET
aji-17	137	2	name	name	NOUN
aji-17	137	3	denotes	denote	VERB
aji-17	137	4	its	its	PRON
aji-17	137	5	close	close	ADJ
aji-17	137	6	relationship	relationship	NOUN
aji-17	137	7	to	to	ADP
aji-17	137	8	the	the	DET
aji-17	137	9	sars	sars	PROPN
aji-17	137	10	virus	virus	PROPN
aji-17	137	11	.	.	PUNCT
aji-17	138	1	according	accord	VERB
aji-17	138	2	to	to	ADP
aji-17	138	3	who	who	PRON
aji-17	138	4	report	report	VERB
aji-17	138	5	as	as	ADP
aji-17	138	6	on	on	ADP
aji-17	138	7	18	18	NUM
aji-17	138	8	th	th	NUM
aji-17	138	9	march	march	NOUN
aji-17	138	10	2020	2020	NUM
aji-17	138	11	,	,	PUNCT
aji-17	138	12	the	the	DET
aji-17	138	13	total	total	NOUN
aji-17	138	14	globally	globally	ADV
aji-17	138	15	confirmed	confirm	VERB
aji-17	138	16	cases	case	NOUN
aji-17	138	17	are	be	AUX
aji-17	138	18	1,90,415	1,90,415	NUM
aji-17	138	19	and	and	CCONJ
aji-17	138	20	total	total	ADJ
aji-17	138	21	confirmed	confirm	VERB
aji-17	138	22	deaths	death	NOUN
aji-17	138	23	are	be	AUX
aji-17	138	24	7	7	NUM
aji-17	138	25	,	,	PUNCT
aji-17	138	26	800	800	NUM
aji-17	138	27	.	.	PUNCT
aji-17	139	1	as	as	ADP
aji-17	139	2	on	on	ADP
aji-17	139	3	march	march	PROPN
aji-17	139	4	23,2020	23,2020	PROPN
aji-17	139	5	the	the	DET
aji-17	139	6	total	total	ADJ
aji-17	139	7	number	number	NOUN
aji-17	139	8	of	of	ADP
aji-17	139	9	cases	case	NOUN
aji-17	139	10	and	and	CCONJ
aji-17	139	11	total	total	ADJ
aji-17	139	12	deaths	death	NOUN
aji-17	139	13	globally	globally	ADV
aji-17	139	14	are	be	AUX
aji-17	139	15	respectively	respectively	ADV
aji-17	139	16	,	,	PUNCT
aji-17	139	17	292142	292142	NUM
aji-17	139	18	and	and	CCONJ
aji-17	139	19	12784	12784	NUM
aji-17	139	20	who	who	PRON
aji-17	139	21	,	,	PUNCT
aji-17	139	22	data	datum	NOUN
aji-17	139	23	as	as	ADP
aji-17	139	24	on	on	ADP
aji-17	139	25	24	24	NUM
aji-17	139	26	march	march	NOUN
aji-17	139	27	2020	2020	NUM
aji-17	139	28	is	be	AUX
aji-17	139	29	total	total	ADJ
aji-17	139	30	number	number	NOUN
aji-17	139	31	of	of	ADP
aji-17	139	32	cases-372757	cases-372757	NOUN
aji-17	139	33	,	,	PUNCT
aji-17	139	34	deaths	death	NOUN
aji-17	139	35	16,231	16,231	NUM
aji-17	139	36	and	and	CCONJ
aji-17	139	37	countries	country	NOUN
aji-17	139	38	infected	infect	VERB
aji-17	139	39	are	be	AUX
aji-17	139	40	195	195	NUM
aji-17	139	41	.	.	PUNCT
aji-17	140	1	as	as	SCONJ
aji-17	140	2	on	on	ADP
aji-17	140	3	30	30	NUM
aji-17	140	4	march	march	NOUN
aji-17	140	5	2020	2020	NUM
aji-17	140	6	,	,	PUNCT
aji-17	140	7	715	715	NUM
aji-17	140	8	660	660	NUM
aji-17	140	9	cases	case	NOUN
aji-17	140	10	have	have	AUX
aji-17	140	11	been	be	AUX
aji-17	140	12	reported	report	VERB
aji-17	140	13	.	.	PUNCT
aji-17	141	1			NOUN
aji-17	141	2	including	include	VERB
aji-17	141	3	33	33	NUM
aji-17	141	4	579	579	NUM
aji-17	141	5	deaths	death	NOUN
aji-17	141	6	.	.	PUNCT
aji-17	142	1	the	the	DET
aji-17	142	2	speed	speed	NOUN
aji-17	142	3	with	with	ADP
aji-17	142	4	which	which	PRON
aji-17	142	5	the	the	DET
aji-17	142	6	disease	disease	NOUN
aji-17	142	7	is	be	AUX
aji-17	142	8	spreading	spread	VERB
aji-17	142	9	can	can	AUX
aji-17	142	10	be	be	AUX
aji-17	142	11	inferred	infer	VERB
aji-17	142	12	from	from	ADP
aji-17	142	13	the	the	DET
aji-17	142	14	above	above	ADJ
aji-17	142	15	figures	figure	NOUN
aji-17	142	16	.	.	PUNCT
aji-17	143	1	the	the	DET
aji-17	143	2	mortality	mortality	NOUN
aji-17	143	3	rate	rate	NOUN
aji-17	143	4	is	be	AUX
aji-17	143	5	between	between	ADP
aji-17	143	6	,	,	PUNCT
aji-17	143	7	1	1	NUM
aji-17	143	8	t0	t0	NUM
aji-17	143	9	3	3	NUM
aji-17	143	10	%	%	NOUN
aji-17	143	11	the	the	DET
aji-17	143	12	economic	economic	ADJ
aji-17	143	13	loss	loss	NOUN
aji-17	143	14	due	due	ADP
aji-17	143	15	to	to	PART
aji-17	143	16	covid	covid	VERB
aji-17	143	17	19	19	NUM
aji-17	143	18	as	as	SCONJ
aji-17	143	19	estimated	estimate	VERB
aji-17	143	20	in	in	ADP
aji-17	143	21	the	the	DET
aji-17	143	22	beginning	beginning	NOUN
aji-17	143	23	of	of	ADP
aji-17	143	24	march	march	PROPN
aji-17	143	25	2020	2020	NUM
aji-17	143	26	is	be	AUX
aji-17	143	27	about	about	ADV
aji-17	143	28	1	1	NUM
aji-17	143	29	to	to	PART
aji-17	143	30	3	3	NUM
aji-17	143	31	trillion	trillion	NUM
aji-17	143	32	dollar	dollar	NOUN
aji-17	143	33	.	.	PUNCT
aji-17	144	1	trade	trade	NOUN
aji-17	144	2	and	and	CCONJ
aji-17	144	3	tourism	tourism	NOUN
aji-17	144	4	,	,	PUNCT
aji-17	144	5	world	world	NOUN
aji-17	144	6	over	over	ADP
aji-17	144	7	are	be	AUX
aji-17	144	8	worst	worst	ADV
aji-17	144	9	effected	effect	VERB
aji-17	144	10	.	.	PUNCT
aji-17	145	1	it	it	PRON
aji-17	145	2	is	be	AUX
aji-17	145	3	considered	consider	VERB
aji-17	145	4	as	as	ADP
aji-17	145	5	a	a	DET
aji-17	145	6	zoonotic	zoonotic	ADJ
aji-17	145	7	infection	infection	NOUN
aji-17	145	8	,	,	PUNCT
aji-17	145	9	reservoirs	reservoir	NOUN
aji-17	145	10	being	be	AUX
aji-17	145	11	the	the	DET
aji-17	145	12	wild	wild	ADJ
aji-17	145	13	bats	bat	NOUN
aji-17	145	14	and	and	CCONJ
aji-17	145	15	certain	certain	ADJ
aji-17	145	16	snakes	snake	NOUN
aji-17	145	17	.	.	PUNCT
aji-17	146	1	the	the	DET
aji-17	146	2	infection	infection	NOUN
aji-17	146	3	starts	start	VERB
aji-17	146	4	like	like	ADP
aji-17	146	5	flu	flu	NOUN
aji-17	146	6	with	with	ADP
aji-17	146	7	cold	cold	ADJ
aji-17	146	8	and	and	CCONJ
aji-17	146	9	dry	dry	ADJ
aji-17	146	10	cough	cough	NOUN
aji-17	146	11	and	and	CCONJ
aji-17	146	12	fever	fever	NOUN
aji-17	146	13	.	.	PUNCT
aji-17	147	1	soon	soon	ADV
aji-17	147	2	shortness	shortness	NOUN
aji-17	147	3	of	of	ADP
aji-17	147	4	breath	breath	NOUN
aji-17	147	5	occurs	occur	VERB
aji-17	147	6	with	with	ADP
aji-17	147	7	developing	develop	VERB
aji-17	147	8	pneumonia	pneumonia	NOUN
aji-17	147	9	and	and	CCONJ
aji-17	147	10	the	the	DET
aji-17	147	11	patient	patient	NOUN
aji-17	147	12	may	may	AUX
aji-17	147	13	require	require	VERB
aji-17	147	14	ventilator	ventilator	NOUN
aji-17	147	15	support	support	NOUN
aji-17	147	16	.	.	PUNCT
aji-17	148	1	while	while	SCONJ
aji-17	148	2	cold	cold	ADJ
aji-17	148	3	and	and	CCONJ
aji-17	148	4	flu	flu	NOUN
aji-17	148	5	viruses	virus	NOUN
aji-17	148	6	take	take	VERB
aji-17	148	7	2	2	NUM
aji-17	148	8	-	-	SYM
aji-17	148	9	3	3	NUM
aji-17	148	10	days	day	NOUN
aji-17	148	11	to	to	PART
aji-17	148	12	develop	develop	VERB
aji-17	148	13	once	once	SCONJ
aji-17	148	14	you	you	PRON
aji-17	148	15	contract	contract	VERB
aji-17	148	16	the	the	DET
aji-17	148	17	virus	virus	NOUN
aji-17	148	18	,	,	PUNCT
aji-17	148	19	coronavirus	coronavirus	NOUN
aji-17	148	20	symptoms	symptom	NOUN
aji-17	148	21	take	take	VERB
aji-17	148	22	anywhere	anywhere	ADV
aji-17	148	23	from	from	ADP
aji-17	148	24	2	2	NUM
aji-17	148	25	-	-	SYM
aji-17	148	26	14	14	NUM
aji-17	148	27	days	day	NOUN
aji-17	148	28	after	after	ADP
aji-17	148	29	being	be	AUX
aji-17	148	30	exposed	expose	VERB
aji-17	148	31	to	to	ADP
aji-17	148	32	the	the	DET
aji-17	148	33	virus	virus	NOUN
aji-17	148	34	,	,	PUNCT
aji-17	148	35	as	as	ADP
aji-17	148	36	per	per	ADP
aji-17	148	37	the	the	DET
aji-17	148	38	centres	centre	NOUN
aji-17	148	39	of	of	ADP
aji-17	148	40	disease	disease	NOUN
aji-17	148	41	control	control	NOUN
aji-17	148	42	and	and	CCONJ
aji-17	148	43	prevention	prevention	NOUN
aji-17	148	44	(	(	PUNCT
aji-17	148	45	cdc	cdc	PROPN
aji-17	148	46	)	)	PUNCT
aji-17	148	47	.	.	PUNCT
aji-17	149	1	according	accord	VERB
aji-17	149	2	to	to	ADP
aji-17	149	3	a	a	DET
aji-17	149	4	study	study	NOUN
aji-17	149	5	(	(	PUNCT
aji-17	149	6	march	march	PROPN
aji-17	149	7	10	10	NUM
aji-17	149	8	,	,	PUNCT
aji-17	149	9	2020	2020	NUM
aji-17	149	10	)	)	PUNCT
aji-17	149	11	.	.	PUNCT
aji-17	150	1	the	the	DET
aji-17	150	2	transmission	transmission	NOUN
aji-17	150	3	from	from	ADP
aji-17	150	4	man	man	NOUN
aji-17	150	5	to	to	ADP
aji-17	150	6	man	man	NOUN
aji-17	150	7	is	be	AUX
aji-17	150	8	through	through	ADP
aji-17	150	9	direct	direct	ADJ
aji-17	150	10	spread	spread	NOUN
aji-17	150	11	by	by	ADP
aji-17	150	12	droplet	droplet	ADJ
aji-17	150	13	infection	infection	NOUN
aji-17	150	14	and	and	CCONJ
aji-17	150	15	indirectly	indirectly	ADV
aji-17	150	16	by	by	ADP
aji-17	150	17	coming	come	VERB
aji-17	150	18	into	into	ADP
aji-17	150	19	contact	contact	NOUN
aji-17	150	20	with	with	ADP
aji-17	150	21	objects	object	NOUN
aji-17	150	22	on	on	ADP
aji-17	150	23	which	which	PRON
aji-17	150	24	the	the	DET
aji-17	150	25	virus	virus	NOUN
aji-17	150	26	containing	contain	VERB
aji-17	150	27	infective	infective	ADJ
aji-17	150	28	material	material	NOUN
aji-17	150	29	is	be	AUX
aji-17	150	30	deposited	deposit	VERB
aji-17	150	31	.	.	PUNCT
aji-17	151	1	the	the	DET
aji-17	151	2	survival	survival	NOUN
aji-17	151	3	of	of	ADP
aji-17	151	4	the	the	DET
aji-17	151	5	virus	virus	NOUN
aji-17	151	6	outside	outside	ADP
aji-17	151	7	the	the	DET
aji-17	151	8	human	human	ADJ
aji-17	151	9	host	host	NOUN
aji-17	151	10	is	be	AUX
aji-17	151	11	variable	variable	ADJ
aji-17	151	12	,	,	PUNCT
aji-17	151	13	depending	depend	VERB
aji-17	151	14	on	on	ADP
aji-17	151	15	the	the	DET
aji-17	151	16	material	material	NOUN
aji-17	151	17	concerned	concern	VERB
aji-17	151	18	ranges	range	VERB
aji-17	151	19	from	from	ADP
aji-17	151	20	1	1	NUM
aji-17	151	21	to	to	PART
aji-17	151	22	5	5	NUM
aji-17	151	23	days	day	NOUN
aji-17	151	24	.	.	PUNCT
aji-17	152	1	the	the	DET
aji-17	152	2	estimated	estimate	VERB
aji-17	152	3	median	median	NOUN
aji-17	152	4	of	of	ADP
aji-17	152	5	ip	ip	PROPN
aji-17	152	6	is	be	AUX
aji-17	152	7	5.1	5.1	NUM
aji-17	152	8	days	day	NOUN
aji-17	152	9	.	.	PUNCT
aji-17	153	1	comorbid	comorbid	NOUN
aji-17	153	2	conditions	condition	NOUN
aji-17	153	3	in	in	ADP
aji-17	153	4	general	general	ADJ
aji-17	153	5	and	and	CCONJ
aji-17	153	6	respiratory	respiratory	ADJ
aji-17	153	7	diseases	disease	NOUN
aji-17	153	8	like	like	ADP
aji-17	153	9	asthma/	asthma/	NUM
aji-17	153	10	copd	copd	NOUN
aji-17	153	11	as	as	ADV
aji-17	153	12	well	well	ADV
aji-17	153	13	as	as	ADP
aji-17	153	14	old	old	ADJ
aji-17	153	15	age	age	NOUN
aji-17	153	16	appear	appear	VERB
aji-17	153	17	to	to	PART
aji-17	153	18	be	be	AUX
aji-17	153	19	the	the	DET
aji-17	153	20	risk	risk	NOUN
aji-17	153	21	factors	factor	NOUN
aji-17	153	22	at	at	ADP
aji-17	153	23	the	the	DET
aji-17	153	24	individual	individual	ADJ
aji-17	153	25	level	level	NOUN
aji-17	153	26	.	.	PUNCT
aji-17	154	1	women	woman	NOUN
aji-17	154	2	and	and	CCONJ
aji-17	154	3	children	child	NOUN
aji-17	154	4	are	be	AUX
aji-17	154	5	mostly	mostly	ADV
aji-17	154	6	spared	spare	VERB
aji-17	154	7	,	,	PUNCT
aji-17	154	8	but	but	CCONJ
aji-17	154	9	not	not	PART
aji-17	154	10	completely	completely	ADV
aji-17	154	11	.	.	PUNCT
aji-17	155	1	presently	presently	ADV
aji-17	155	2	thereisno	thereisno	VERB
aji-17	155	3	specific	specific	ADJ
aji-17	155	4	drug	drug	NOUN
aji-17	155	5	against	against	ADP
aji-17	155	6	the	the	DET
aji-17	155	7	virus	virus	NOUN
aji-17	155	8	is	be	AUX
aji-17	155	9	available	available	ADJ
aji-17	155	10	,	,	PUNCT
aji-17	155	11	so	so	ADV
aji-17	155	12	,	,	PUNCT
aji-17	155	13	the	the	DET
aji-17	155	14	present	present	ADJ
aji-17	155	15	emphasis	emphasis	NOUN
aji-17	155	16	is	be	AUX
aji-17	155	17	on	on	ADP
aji-17	155	18	prevention	prevention	NOUN
aji-17	155	19	of	of	ADP
aji-17	155	20	the	the	DET
aji-17	155	21	spread	spread	NOUN
aji-17	155	22	of	of	ADP
aji-17	155	23	the	the	DET
aji-17	155	24	infection	infection	NOUN
aji-17	155	25	.	.	PUNCT
aji-17	156	1	home	home	NOUN
aji-17	156	2	isolation	isolation	NOUN
aji-17	156	3	of	of	ADP
aji-17	156	4	the	the	DET
aji-17	156	5	suspected	suspect	VERB
aji-17	156	6	cases	case	NOUN
aji-17	156	7	,	,	PUNCT
aji-17	156	8	qwarentaining	qwarentaine	VERB
aji-17	156	9	the	the	DET
aji-17	156	10	positive	positive	ADJ
aji-17	156	11	cases	case	NOUN
aji-17	156	12	,	,	PUNCT
aji-17	156	13	social	social	ADJ
aji-17	156	14	isolation	isolation	NOUN
aji-17	156	15	and	and	CCONJ
aji-17	156	16	self	self	NOUN
aji-17	156	17	imposed	impose	VERB
aji-17	156	18	curfew	curfew	NOUN
aji-17	156	19	are	be	AUX
aji-17	156	20	some	some	PRON
aji-17	156	21	of	of	ADP
aji-17	156	22	the	the	DET
aji-17	156	23	strategies	strategy	NOUN
aji-17	156	24	adopted	adopt	VERB
aji-17	156	25	,	,	PUNCT
aji-17	156	26	which	which	PRON
aji-17	156	27	are	be	AUX
aji-17	156	28	showing	show	VERB
aji-17	156	29	promising	promising	ADJ
aji-17	156	30	results	result	NOUN
aji-17	156	31	.	.	PUNCT
aji-17	157	1	some	some	DET
aji-17	157	2	retrovial	retrovial	ADJ
aji-17	157	3	drugs	drug	NOUN
aji-17	157	4	and	and	CCONJ
aji-17	157	5	hydroxy	hydroxy	PROPN
aji-17	157	6	chloroquin	chloroquin	PROPN
aji-17	157	7	t	t	PROPN
aji-17	157	8	-	-	PUNCT
aji-17	157	9	azithromycine	azithromycine	NOUN
aji-17	157	10	combination	combination	NOUN
aji-17	157	11	are	be	AUX
aji-17	157	12	used	use	VERB
aji-17	157	13	emparically	emparically	ADV
aji-17	157	14	.	.	PUNCT
aji-17	158	1	there	there	PRON
aji-17	158	2	is	be	VERB
aji-17	158	3	intense	intense	ADJ
aji-17	158	4	research	research	NOUN
aji-17	158	5	going	go	VERB
aji-17	158	6	on	on	ADP
aji-17	158	7	to	to	PART
aji-17	158	8	find	find	VERB
aji-17	158	9	a	a	DET
aji-17	158	10	vaccine	vaccine	NOUN
aji-17	158	11	against	against	ADP
aji-17	158	12	the	the	DET
aji-17	158	13	disease	disease	NOUN
aji-17	158	14	.	.	PUNCT
aji-17	159	1	prasad	prasad	PROPN
aji-17	159	2	;	;	PUNCT
aji-17	159	3	aji	aji	NOUN
aji-17	159	4	,	,	PUNCT
aji-17	159	5	3(1	3(1	NUM
aji-17	159	6	):	):	PUNCT
aji-17	159	7	61	61	NUM
aji-17	159	8	-	-	SYM
aji-17	159	9	70	70	NUM
aji-17	159	10	,	,	PUNCT
aji-17	159	11	2020	2020	NUM
aji-17	159	12	;	;	PUNCT
aji-17	159	13	article	article	NOUN
aji-17	159	14	no.aji.55881	no.aji.55881	ADP
aji-17	159	15	63	63	NUM
aji-17	159	16	1.2	1.2	NUM
aji-17	159	17	can	can	AUX
aji-17	159	18	covid	covid	VERB
aji-17	159	19	19	19	NUM
aji-17	159	20	be	be	AUX
aji-17	159	21	transmitted	transmit	VERB
aji-17	159	22	by	by	ADP
aji-17	159	23	asymptomatic	asymptomatic	ADJ
aji-17	159	24	carriers	carrier	NOUN
aji-17	159	25	?	?	PUNCT
aji-17	160	1	zhang	zhang	PROPN
aji-17	160	2	et	et	PROPN
aji-17	160	3	al	al	PROPN
aji-17	160	4	.	.	PUNCT
aji-17	161	1	[	[	X
aji-17	161	2	1	1	X
aji-17	161	3	]	]	PUNCT
aji-17	161	4	have	have	AUX
aji-17	161	5	reported	report	VERB
aji-17	161	6	a	a	DET
aji-17	161	7	familial	familial	ADJ
aji-17	161	8	cluster	cluster	NOUN
aji-17	161	9	of	of	ADP
aji-17	161	10	covid-19	covid-19	PROPN
aji-17	161	11	indicating	indicate	VERB
aji-17	161	12	virus	virus	NOUN
aji-17	161	13	can	can	AUX
aji-17	161	14	be	be	AUX
aji-17	161	15	transmitted	transmit	VERB
aji-17	161	16	by	by	ADP
aji-17	161	17	asymptomatic	asymptomatic	ADJ
aji-17	161	18	carriers	carrier	NOUN
aji-17	161	19	.	.	PUNCT
aji-17	162	1	anbai	anbai	PROPN
aji-17	162	2	’s	’s	PART
aji-17	162	3	study	study	NOUN
aji-17	162	4	presumed	presume	VERB
aji-17	162	5	that	that	PRON
aji-17	162	6	asymptomatic	asymptomatic	ADJ
aji-17	162	7	2019	2019	NUM
aji-17	162	8	ncov	ncov	NOUN
aji-17	162	9	carrier	carrier	NOUN
aji-17	162	10	could	could	AUX
aji-17	162	11	be	be	AUX
aji-17	162	12	a	a	DET
aji-17	162	13	transmitter	transmitter	NOUN
aji-17	162	14	.	.	PUNCT
aji-17	163	1	[	[	X
aji-17	163	2	2	2	X
aji-17	163	3	]	]	PUNCT
aji-17	163	4	a	a	DET
aji-17	163	5	couple	couple	NOUN
aji-17	163	6	with	with	ADP
aji-17	163	7	covid-19	covid-19	PROPN
aji-17	163	8	were	be	AUX
aji-17	163	9	transmitted	transmit	VERB
aji-17	163	10	infection	infection	NOUN
aji-17	163	11	by	by	ADP
aji-17	163	12	their	their	PRON
aji-17	163	13	asymptomatic	asymptomatic	ADJ
aji-17	163	14	daughter	daughter	NOUN
aji-17	163	15	who	who	PRON
aji-17	163	16	had	have	AUX
aji-17	163	17	travelled	travel	VERB
aji-17	163	18	from	from	ADP
aji-17	163	19	the	the	DET
aji-17	163	20	epidemic	epidemic	NOUN
aji-17	163	21	center	center	NOUN
aji-17	163	22	of	of	ADP
aji-17	163	23	wuhan	wuhan	PROPN
aji-17	163	24	.	.	PUNCT
aji-17	164	1	the	the	DET
aji-17	164	2	sequence	sequence	NOUN
aji-17	164	3	suggests	suggest	VERB
aji-17	164	4	that	that	SCONJ
aji-17	164	5	the	the	DET
aji-17	164	6	coronavirus	coronavirus	NOUN
aji-17	164	7	can	can	AUX
aji-17	164	8	be	be	AUX
aji-17	164	9	transmitted	transmit	VERB
aji-17	164	10	by	by	ADP
aji-17	164	11	asymptomatic	asymptomatic	ADJ
aji-17	164	12	carriers	carrier	NOUN
aji-17	164	13	in	in	ADP
aji-17	164	14	their	their	PRON
aji-17	164	15	early	early	ADJ
aji-17	164	16	and	and	CCONJ
aji-17	164	17	middle	middle	ADJ
aji-17	164	18	latent	latent	NOUN
aji-17	164	19	period	period	NOUN
aji-17	164	20	.	.	PUNCT
aji-17	165	1	asymptomatic	asymptomatic	ADJ
aji-17	165	2	virus	virus	NOUN
aji-17	165	3	carriers	carrier	NOUN
aji-17	165	4	should	should	AUX
aji-17	165	5	be	be	AUX
aji-17	165	6	monitored	monitor	VERB
aji-17	165	7	and	and	CCONJ
aji-17	165	8	isolated	isolate	VERB
aji-17	165	9	as	as	ADV
aji-17	165	10	early	early	ADV
aji-17	165	11	as	as	ADP
aji-17	165	12	possible	possible	ADJ
aji-17	165	13	to	to	PART
aji-17	165	14	facilitate	facilitate	VERB
aji-17	165	15	the	the	DET
aji-17	165	16	control	control	NOUN
aji-17	165	17	of	of	ADP
aji-17	165	18	the	the	DET
aji-17	165	19	epidemic	epidemic	NOUN
aji-17	165	20	.	.	PUNCT
aji-17	166	1	a	a	DET
aji-17	166	2	paper	paper	NOUN
aji-17	166	3	published	publish	VERB
aji-17	166	4	on	on	ADP
aji-17	166	5	nejm	nejm	PROPN
aji-17	166	6	about	about	ADP
aji-17	166	7	the	the	DET
aji-17	166	8	first	first	ADJ
aji-17	166	9	four	four	NUM
aji-17	166	10	people	people	NOUN
aji-17	166	11	in	in	ADP
aji-17	166	12	germany	germany	PROPN
aji-17	166	13	infected	infect	VERB
aji-17	166	14	with	with	ADP
aji-17	166	15	2019	2019	NUM
aji-17	166	16	ncov	ncov	ADV
aji-17	166	17	found	find	VERB
aji-17	166	18	asymptomatic	asymptomatic	ADJ
aji-17	166	19	persons	person	NOUN
aji-17	166	20	can	can	AUX
aji-17	166	21	still	still	ADV
aji-17	166	22	transmit	transmit	VERB
aji-17	166	23	the	the	DET
aji-17	166	24	virus	virus	NOUN
aji-17	166	25	to	to	ADP
aji-17	166	26	others	other	NOUN
aji-17	166	27	[	[	X
aji-17	166	28	3	3	NUM
aji-17	166	29	]	]	PUNCT
aji-17	166	30	but	but	CCONJ
aji-17	166	31	soon	soon	ADV
aji-17	166	32	the	the	DET
aji-17	166	33	german	german	ADJ
aji-17	166	34	government	government	NOUN
aji-17	166	35	’s	’s	PART
aji-17	166	36	public	public	ADJ
aji-17	166	37	health	health	NOUN
aji-17	166	38	agency	agency	NOUN
aji-17	166	39	announced	announce	VERB
aji-17	166	40	that	that	SCONJ
aji-17	166	41	the	the	DET
aji-17	166	42	information	information	NOUN
aji-17	166	43	was	be	AUX
aji-17	166	44	wrong	wrong	ADJ
aji-17	166	45	.	.	PUNCT
aji-17	167	1	the	the	DET
aji-17	167	2	“	"	PUNCT
aji-17	167	3	asymptomatic	asymptomatic	ADJ
aji-17	167	4	”	"	PUNCT
aji-17	167	5	patient	patient	NOUN
aji-17	167	6	actually	actually	ADV
aji-17	167	7	had	have	VERB
aji-17	167	8	some	some	DET
aji-17	167	9	symptoms	symptom	NOUN
aji-17	167	10	,	,	PUNCT
aji-17	167	11	it	it	PRON
aji-17	167	12	was	be	AUX
aji-17	167	13	found	find	VERB
aji-17	167	14	later	later	ADV
aji-17	167	15	[	[	X
aji-17	167	16	4	4	NUM
aji-17	167	17	]	]	PUNCT
aji-17	167	18	.	.	PUNCT
aji-17	168	1	1.3	1.3	NUM
aji-17	168	2	are	be	AUX
aji-17	168	3	there	there	PRON
aji-17	168	4	two	two	NUM
aji-17	168	5	strains	strain	NOUN
aji-17	168	6	of	of	ADP
aji-17	168	7	the	the	DET
aji-17	168	8	novel	novel	ADJ
aji-17	168	9	corona	corona	NOUN
aji-17	168	10	virus	virus	NOUN
aji-17	168	11	?	?	PUNCT
aji-17	169	1	at	at	ADP
aji-17	169	2	the	the	DET
aji-17	169	3	outset	outset	NOUN
aji-17	169	4	it	it	PRON
aji-17	169	5	is	be	AUX
aji-17	169	6	made	make	VERB
aji-17	169	7	clear	clear	ADJ
aji-17	169	8	that	that	SCONJ
aji-17	169	9	the	the	PRON
aji-17	169	10	who	who	PRON
aji-17	169	11	has	have	AUX
aji-17	169	12	not	not	PART
aji-17	169	13	at	at	ADP
aji-17	169	14	accepted	accept	VERB
aji-17	169	15	the	the	DET
aji-17	169	16	2	2	NUM
aji-17	169	17	strains	strain	NOUN
aji-17	169	18	concept	concept	NOUN
aji-17	169	19	as	as	ADP
aji-17	169	20	on	on	ADP
aji-17	169	21	now	now	ADV
aji-17	169	22	.	.	PUNCT
aji-17	170	1	since	since	SCONJ
aji-17	170	2	some	some	DET
aji-17	170	3	investigators	investigator	NOUN
aji-17	170	4	found	find	VERB
aji-17	170	5	two	two	NUM
aji-17	170	6	types	type	NOUN
aji-17	170	7	of	of	ADP
aji-17	170	8	mutations	mutation	NOUN
aji-17	170	9	in	in	ADP
aji-17	170	10	the	the	DET
aji-17	170	11	genome	genome	NOUN
aji-17	170	12	of	of	ADP
aji-17	170	13	the	the	DET
aji-17	170	14	covid	covid	PROPN
aji-17	170	15	virus	virus	NOUN
aji-17	170	16	(	(	PUNCT
aji-17	170	17	see	see	VERB
aji-17	170	18	below	below	ADV
aji-17	170	19	)	)	PUNCT
aji-17	170	20	and	and	CCONJ
aji-17	170	21	few	few	ADJ
aji-17	170	22	investigators	investigator	NOUN
aji-17	170	23	tried	try	VERB
aji-17	170	24	to	to	PART
aji-17	170	25	see	see	VERB
aji-17	170	26	difference	difference	NOUN
aji-17	170	27	in	in	ADP
aji-17	170	28	virulence	virulence	NOUN
aji-17	170	29	patterns	pattern	NOUN
aji-17	170	30	of	of	ADP
aji-17	170	31	the	the	DET
aji-17	170	32	same	same	ADJ
aji-17	170	33	virus	virus	NOUN
aji-17	170	34	at	at	ADP
aji-17	170	35	different	different	ADJ
aji-17	170	36	geographical	geographical	ADJ
aji-17	170	37	places	place	NOUN
aji-17	170	38	,	,	PUNCT
aji-17	170	39	(	(	PUNCT
aji-17	170	40	for	for	ADP
aji-17	170	41	instance	instance	NOUN
aji-17	170	42	the	the	DET
aji-17	170	43	infection	infection	NOUN
aji-17	170	44	is	be	AUX
aji-17	170	45	catastrophic	catastrophic	ADJ
aji-17	170	46	in	in	ADP
aji-17	170	47	italy	italy	PROPN
aji-17	170	48	,	,	PUNCT
aji-17	170	49	but	but	CCONJ
aji-17	170	50	so	so	ADV
aji-17	170	51	far	far	ADV
aji-17	170	52	appears	appear	VERB
aji-17	170	53	to	to	PART
aji-17	170	54	be	be	AUX
aji-17	170	55	comparatively	comparatively	ADV
aji-17	170	56	,	,	PUNCT
aji-17	170	57	mild	mild	ADJ
aji-17	170	58	in	in	ADP
aji-17	170	59	india	india	PROPN
aji-17	170	60	)	)	PUNCT
aji-17	170	61	hazard	hazard	NOUN
aji-17	170	62	a	a	DET
aji-17	170	63	guess	guess	NOUN
aji-17	170	64	about	about	ADP
aji-17	170	65	the	the	DET
aji-17	170	66	existence	existence	NOUN
aji-17	170	67	of	of	ADP
aji-17	170	68	more	more	ADJ
aji-17	170	69	virulent	virulent	ADJ
aji-17	170	70	and	and	CCONJ
aji-17	170	71	less	less	ADV
aji-17	170	72	virulent	virulent	ADJ
aji-17	170	73	strains	strain	NOUN
aji-17	170	74	of	of	ADP
aji-17	170	75	the	the	DET
aji-17	170	76	covid	covid	PROPN
aji-17	170	77	19	19	NUM
aji-17	170	78	virus	virus	NOUN
aji-17	170	79	.	.	PUNCT
aji-17	171	1	it	it	PRON
aji-17	171	2	is	be	AUX
aji-17	171	3	probable	probable	ADJ
aji-17	171	4	that	that	SCONJ
aji-17	171	5	the	the	DET
aji-17	171	6	deficiency	deficiency	NOUN
aji-17	171	7	of	of	ADP
aji-17	171	8	timely	timely	ADJ
aji-17	171	9	interventional	interventional	ADJ
aji-17	171	10	measures	measure	NOUN
aji-17	171	11	might	might	AUX
aji-17	171	12	be	be	AUX
aji-17	171	13	the	the	DET
aji-17	171	14	cause	cause	NOUN
aji-17	171	15	,	,	PUNCT
aji-17	171	16	as	as	SCONJ
aji-17	171	17	felt	feel	VERB
aji-17	171	18	in	in	ADP
aji-17	171	19	case	case	NOUN
aji-17	171	20	of	of	ADP
aji-17	171	21	italy	italy	PROPN
aji-17	171	22	.	.	PUNCT
aji-17	172	1	xiaolu	xiaolu	PROPN
aji-17	172	2	tang	tang	PROPN
aji-17	172	3	et	et	PROPN
aji-17	172	4	al	al	PROPN
aji-17	172	5	,	,	PUNCT
aji-17	172	6	at	at	ADP
aji-17	172	7	peking	peking	PROPN
aji-17	172	8	university	university	PROPN
aji-17	172	9	in	in	ADP
aji-17	172	10	beijing	beijing	PROPN
aji-17	172	11	and	and	CCONJ
aji-17	172	12	his	his	PRON
aji-17	172	13	colleagues	colleague	NOUN
aji-17	172	14	studied	study	VERB
aji-17	172	15	the	the	DET
aji-17	172	16	viral	viral	ADJ
aji-17	172	17	genome	genome	NOUN
aji-17	172	18	taken	take	VERB
aji-17	172	19	from	from	ADP
aji-17	172	20	103	103	NUM
aji-17	172	21	cases	case	NOUN
aji-17	172	22	.	.	PUNCT
aji-17	173	1	they	they	PRON
aji-17	173	2	found	find	VERB
aji-17	173	3	common	common	ADJ
aji-17	173	4	mutations	mutation	NOUN
aji-17	173	5	at	at	ADP
aji-17	173	6	two	two	NUM
aji-17	173	7	locations	location	NOUN
aji-17	173	8	on	on	ADP
aji-17	173	9	the	the	DET
aji-17	173	10	genome	genome	NOUN
aji-17	173	11	.	.	PUNCT
aji-17	174	1	the	the	DET
aji-17	174	2	team	team	NOUN
aji-17	174	3	identified	identify	VERB
aji-17	174	4	two	two	NUM
aji-17	174	5	types	type	NOUN
aji-17	174	6	of	of	ADP
aji-17	174	7	the	the	DET
aji-17	174	8	virus	virus	NOUN
aji-17	174	9	based	base	VERB
aji-17	174	10	on	on	ADP
aji-17	174	11	differences	difference	NOUN
aji-17	174	12	in	in	ADP
aji-17	174	13	the	the	DET
aji-17	174	14	genome	genome	NOUN
aji-17	174	15	at	at	ADP
aji-17	174	16	these	these	DET
aji-17	174	17	two	two	NUM
aji-17	174	18	regions	region	NOUN
aji-17	174	19	.	.	PUNCT
aji-17	175	1	mutation	mutation	NOUN
aji-17	175	2	at	at	ADP
aji-17	175	3	region	region	NOUN
aji-17	175	4	72	72	NUM
aji-17	175	5	are	be	AUX
aji-17	175	6	considered	consider	VERB
aji-17	175	7	to	to	PART
aji-17	175	8	be	be	AUX
aji-17	175	9	the	the	DET
aji-17	175	10	“	"	PUNCT
aji-17	175	11	l	l	NOUN
aji-17	175	12	-	-	NOUN
aji-17	175	13	type	type	NOUN
aji-17	175	14	”	"	PUNCT
aji-17	175	15	and	and	CCONJ
aji-17	175	16	29	29	NUM
aji-17	175	17	were	be	AUX
aji-17	175	18	classed	class	VERB
aji-17	175	19	“	"	PUNCT
aji-17	175	20	s	s	NOUN
aji-17	175	21	-	-	PUNCT
aji-17	175	22	type	type	NOUN
aji-17	175	23	”	"	PUNCT
aji-17	175	24	.	.	PUNCT
aji-17	176	1	s	s	PART
aji-17	176	2	type	type	NOUN
aji-17	176	3	is	be	AUX
aji-17	176	4	believed	believe	VERB
aji-17	176	5	to	to	PART
aji-17	176	6	be	be	AUX
aji-17	176	7	the	the	DET
aji-17	176	8	ancestral	ancestral	ADJ
aji-17	176	9	strain	strain	NOUN
aji-17	176	10	descended	descend	VERB
aji-17	176	11	from	from	ADP
aji-17	176	12	the	the	DET
aji-17	176	13	animal	animal	NOUN
aji-17	176	14	and	and	CCONJ
aji-17	176	15	s	s	NOUN
aji-17	176	16	type	type	NOUN
aji-17	176	17	its	its	PRON
aji-17	176	18	human	human	ADJ
aji-17	176	19	variant	variant	NOUN
aji-17	176	20	that	that	PRON
aji-17	176	21	developed	develop	VERB
aji-17	176	22	later	later	ADV
aji-17	176	23	.	.	PUNCT
aji-17	177	1	s	s	PART
aji-17	177	2	is	be	AUX
aji-17	177	3	wide	wide	ADV
aji-17	177	4	spread	spread	VERB
aji-17	177	5	in	in	ADP
aji-17	177	6	distribution	distribution	NOUN
aji-17	177	7	source:(https://www.newscientist.com	source:(https://www.newscientist.com	NOUN
aji-17	177	8	/	/	SYM
aji-17	177	9	article/223	article/223	ADJ
aji-17	177	10	6544	6544	NUM
aji-17	177	11	-	-	PUNCT
aji-17	177	12	coronavirus	coronavirus	NOUN
aji-17	177	13	-	-	PUNCT
aji-17	177	14	are	be	AUX
aji-17	177	15	-	-	PUNCT
aji-17	177	16	there	there	ADV
aji-17	177	17	-	-	PUNCT
aji-17	177	18	two	two	NUM
aji-17	177	19	-	-	PUNCT
aji-17	177	20	strains	strain	NOUN
aji-17	177	21	-	-	PUNCT
aji-17	177	22	and	and	CCONJ
aji-17	177	23	-	-	PUNCT
aji-17	177	24	isone	isone	NOUN
aji-17	177	25	-	-	PUNCT
aji-17	177	26	more	more	ADJ
aji-17	177	27	-	-	PUNCT
aji-17	177	28	deadly/#ixzz6hohp3wf7	deadly/#ixzz6hohp3wf7	NOUN
aji-17	177	29	)	)	PUNCT
aji-17	177	30	1.4	1.4	NUM
aji-17	177	31	recovery	recovery	NOUN
aji-17	177	32	of	of	ADP
aji-17	177	33	the	the	DET
aji-17	177	34	novel	novel	NOUN
aji-17	177	35	,	,	PUNCT
aji-17	177	36	corona	corona	NOUN
aji-17	177	37	virus	virus	NOUN
aji-17	177	38	from	from	ADP
aji-17	177	39	the	the	DET
aji-17	177	40	feces	fece	NOUN
aji-17	177	41	some	some	DET
aji-17	177	42	researchers	researcher	NOUN
aji-17	177	43	have	have	AUX
aji-17	177	44	reported	report	VERB
aji-17	177	45	the	the	DET
aji-17	177	46	recovery	recovery	NOUN
aji-17	177	47	of	of	ADP
aji-17	177	48	the	the	DET
aji-17	177	49	virus	virus	NOUN
aji-17	177	50	from	from	ADP
aji-17	177	51	the	the	DET
aji-17	177	52	feces	fece	NOUN
aji-17	177	53	,	,	PUNCT
aji-17	177	54	but	but	CCONJ
aji-17	177	55	its	its	PRON
aji-17	177	56	significance	significance	NOUN
aji-17	177	57	at	at	ADP
aji-17	177	58	present	present	NOUN
aji-17	177	59	is	be	AUX
aji-17	177	60	not	not	PART
aji-17	177	61	known	know	VERB
aji-17	177	62	.	.	PUNCT
aji-17	178	1	there	there	PRON
aji-17	178	2	is	be	VERB
aji-17	178	3	no	no	DET
aji-17	178	4	evidence	evidence	NOUN
aji-17	178	5	of	of	ADP
aji-17	178	6	feco	feco	ADJ
aji-17	178	7	-	-	PUNCT
aji-17	178	8	oral	oral	ADJ
aji-17	178	9	transmission	transmission	NOUN
aji-17	178	10	.	.	PUNCT
aji-17	179	1	1.5	1.5	NUM
aji-17	179	2	reinfection	reinfection	NOUN
aji-17	179	3	the	the	PRON
aji-17	179	4	who	who	PRON
aji-17	179	5	has	have	AUX
aji-17	179	6	not	not	PART
aji-17	179	7	yet	yet	ADV
aji-17	179	8	confirmed	confirm	VERB
aji-17	179	9	any	any	DET
aji-17	179	10	possibility	possibility	NOUN
aji-17	179	11	of	of	ADP
aji-17	179	12	reinfection	reinfection	NOUN
aji-17	179	13	.	.	PUNCT
aji-17	180	1	1.6	1.6	NUM
aji-17	180	2	approaches	approach	NOUN
aji-17	180	3	to	to	ADP
aji-17	180	4	corona	corona	NOUN
aji-17	180	5	virus	virus	NOUN
aji-17	180	6	vaccine	vaccine	NOUN
aji-17	180	7	production	production	NOUN
aji-17	180	8	1.6.1	1.6.1	NUM
aji-17	180	9	structure	structure	NOUN
aji-17	180	10	and	and	CCONJ
aji-17	180	11	antigens	antigen	NOUN
aji-17	180	12	of	of	ADP
aji-17	180	13	corona	corona	NOUN
aji-17	180	14	virus	virus	NOUN
aji-17	180	15	the	the	DET
aji-17	180	16	novel	novel	ADJ
aji-17	180	17	corona	corona	NOUN
aji-17	180	18	virus	virus	NOUN
aji-17	180	19	is	be	AUX
aji-17	180	20	an	an	DET
aji-17	180	21	enveloped	envelop	VERB
aji-17	180	22	virus	virus	NOUN
aji-17	180	23	containing	contain	VERB
aji-17	180	24	a	a	DET
aji-17	180	25	single	single	ADJ
aji-17	180	26	stranded	strand	VERB
aji-17	180	27	m	m	PROPN
aji-17	180	28	rna	rna	NOUN
aji-17	180	29	and	and	CCONJ
aji-17	180	30	a	a	DET
aji-17	180	31	protein	protein	NOUN
aji-17	180	32	inside	inside	ADV
aji-17	180	33	and	and	CCONJ
aji-17	180	34	spoke	speak	VERB
aji-17	180	35	like	like	ADP
aji-17	180	36	projections	projection	NOUN
aji-17	180	37	of	of	ADP
aji-17	180	38	glycoprotein	glycoprotein	NOUN
aji-17	180	39	on	on	ADP
aji-17	180	40	the	the	DET
aji-17	180	41	surface	surface	NOUN
aji-17	180	42	.	.	PUNCT
aji-17	181	1	the	the	DET
aji-17	181	2	later	later	ADV
aji-17	181	3	earned	earn	VERB
aji-17	181	4	the	the	DET
aji-17	181	5	virus	virus	NOUN
aji-17	181	6	the	the	DET
aji-17	181	7	name	name	NOUN
aji-17	181	8	corona	corona	PROPN
aji-17	181	9	,	,	PUNCT
aji-17	181	10	which	which	PRON
aji-17	181	11	means	mean	VERB
aji-17	181	12	a	a	DET
aji-17	181	13	crown	crown	NOUN
aji-17	181	14	.	.	PUNCT
aji-17	182	1	genome	genome	NOUN
aji-17	182	2	of	of	ADP
aji-17	182	3	sars	sar	NOUN
aji-17	182	4	-	-	PUNCT
aji-17	182	5	cov-2	cov-2	PART
aji-17	182	6	(	(	PUNCT
aji-17	182	7	2019	2019	NUM
aji-17	182	8	-	-	PUNCT
aji-17	182	9	ncov	ncov	NOUN
aji-17	182	10	)	)	PUNCT
aji-17	182	11	encodes	encode	VERB
aji-17	182	12	the	the	DET
aji-17	182	13	spike	spike	ADJ
aji-17	182	14	protein	protein	NOUN
aji-17	182	15	,	,	PUNCT
aji-17	182	16	the	the	DET
aji-17	182	17	envelope	envelope	NOUN
aji-17	182	18	protein	protein	NOUN
aji-17	182	19	,	,	PUNCT
aji-17	182	20	the	the	DET
aji-17	182	21	membrane	membrane	NOUN
aji-17	182	22	protein	protein	NOUN
aji-17	182	23	and	and	CCONJ
aji-17	182	24	the	the	DET
aji-17	182	25	nucleocapsid	nucleocapsid	ADJ
aji-17	182	26	protein	protein	NOUN
aji-17	182	27	.	.	PUNCT
aji-17	183	1	the	the	DET
aji-17	183	2	spike	spike	ADJ
aji-17	183	3	protein	protein	NOUN
aji-17	183	4	(	(	PUNCT
aji-17	183	5	s	s	NOUN
aji-17	183	6	-	-	NOUN
aji-17	183	7	protein	protein	NOUN
aji-17	183	8	)	)	PUNCT
aji-17	183	9	mediates	mediate	VERB
aji-17	183	10	receptor	receptor	NOUN
aji-17	183	11	binding	bind	VERB
aji-17	183	12	and	and	CCONJ
aji-17	183	13	membrane	membrane	NOUN
aji-17	183	14	fusion	fusion	NOUN
aji-17	183	15	.	.	PUNCT
aji-17	184	1	spike	spike	ADJ
aji-17	184	2	protein	protein	NOUN
aji-17	184	3	contains	contain	VERB
aji-17	184	4	two	two	NUM
aji-17	184	5	subunits	subunit	NOUN
aji-17	184	6	,	,	PUNCT
aji-17	184	7	s1	s1	NOUN
aji-17	184	8	and	and	CCONJ
aji-17	184	9	s2	s2	PROPN
aji-17	184	10	.	.	PUNCT
aji-17	185	1	s1	s1	NOUN
aji-17	185	2	contains	contain	VERB
aji-17	185	3	a	a	DET
aji-17	185	4	receptor	receptor	NOUN
aji-17	185	5	binding	bind	VERB
aji-17	185	6	domain	domain	NOUN
aji-17	185	7	(	(	PUNCT
aji-17	185	8	rbd	rbd	NOUN
aji-17	185	9	)	)	PUNCT
aji-17	185	10	,	,	PUNCT
aji-17	185	11	which	which	PRON
aji-17	185	12	is	be	AUX
aji-17	185	13	responsible	responsible	ADJ
aji-17	185	14	for	for	ADP
aji-17	185	15	recognizing	recognize	VERB
aji-17	185	16	and	and	CCONJ
aji-17	185	17	binding	bind	VERB
aji-17	185	18	with	with	ADP
aji-17	185	19	the	the	DET
aji-17	185	20	cell	cell	NOUN
aji-17	185	21	surface	surface	NOUN
aji-17	185	22	receptor	receptor	NOUN
aji-17	185	23	.	.	PUNCT
aji-17	186	1	s2	s2	NOUN
aji-17	186	2	subunit	subunit	NOUN
aji-17	186	3	is	be	AUX
aji-17	186	4	the	the	DET
aji-17	186	5	"	"	PUNCT
aji-17	186	6	stem	stem	NOUN
aji-17	186	7	"	"	PUNCT
aji-17	186	8	of	of	ADP
aji-17	186	9	the	the	DET
aji-17	186	10	structure	structure	NOUN
aji-17	186	11	,	,	PUNCT
aji-17	186	12	which	which	PRON
aji-17	186	13	contains	contain	VERB
aji-17	186	14	other	other	ADJ
aji-17	186	15	basic	basic	ADJ
aji-17	186	16	elements	element	NOUN
aji-17	186	17	needed	need	VERB
aji-17	186	18	for	for	ADP
aji-17	186	19	the	the	DET
aji-17	186	20	membrane	membrane	NOUN
aji-17	186	21	fusion	fusion	NOUN
aji-17	186	22	.	.	PUNCT
aji-17	187	1	the	the	DET
aji-17	187	2	spike	spike	ADJ
aji-17	187	3	protein	protein	NOUN
aji-17	187	4	is	be	AUX
aji-17	187	5	the	the	DET
aji-17	187	6	common	common	ADJ
aji-17	187	7	target	target	NOUN
aji-17	187	8	for	for	ADP
aji-17	187	9	neutralizing	neutralize	VERB
aji-17	187	10	antibodies	antibody	NOUN
aji-17	187	11	and	and	CCONJ
aji-17	187	12	vaccines.euis	vaccines.euis	ADV
aji-17	187	13	been	be	AUX
aji-17	187	14	reported	report	VERB
aji-17	187	15	that	that	SCONJ
aji-17	187	16	sars	sar	NOUN
aji-17	187	17	-	-	PUNCT
aji-17	187	18	cov-2	cov-2	PART
aji-17	187	19	(	(	PUNCT
aji-17	187	20	2019	2019	NUM
aji-17	187	21	-	-	PUNCT
aji-17	187	22	ncov	ncov	ADV
aji-17	187	23	can	can	AUX
aji-17	187	24	infect	infect	VERB
aji-17	187	25	the	the	DET
aji-17	187	26	human	human	ADJ
aji-17	187	27	respiratory	respiratory	ADJ
aji-17	187	28	epithelial	epithelial	ADJ
aji-17	187	29	cells	cell	NOUN
aji-17	187	30	through	through	ADP
aji-17	187	31	interaction	interaction	NOUN
aji-17	187	32	with	with	ADP
aji-17	187	33	the	the	DET
aji-17	187	34	human	human	ADJ
aji-17	187	35	ace2	ace2	NOUN
aji-17	187	36	receptor	receptor	NOUN
aji-17	187	37	.	.	PUNCT
aji-17	188	1	indeed	indeed	ADV
aji-17	188	2	,	,	PUNCT
aji-17	188	3	the	the	DET
aji-17	188	4	recombinant	recombinant	ADJ
aji-17	188	5	spike	spike	ADJ
aji-17	188	6	protein	protein	NOUN
aji-17	188	7	can	can	AUX
aji-17	188	8	bind	bind	VERB
aji-17	188	9	with	with	ADP
aji-17	188	10	recombinant	recombinant	ADJ
aji-17	188	11	ace2	ace2	NOUN
aji-17	188	12	protein	protein	NOUN
aji-17	188	13	.	.	PUNCT
aji-17	189	1	it	it	PRON
aji-17	189	2	has	have	AUX
aji-17	189	3	been	be	AUX
aji-17	189	4	reported	report	VERB
aji-17	189	5	that	that	SCONJ
aji-17	189	6	sars	sar	NOUN
aji-17	189	7	-	-	PUNCT
aji-17	189	8	cov-2	cov-2	PART
aji-17	189	9	(	(	PUNCT
aji-17	189	10	2019	2019	NUM
aji-17	189	11	-	-	PUNCT
aji-17	189	12	ncov	ncov	NOUN
aji-17	189	13	)	)	PUNCT
aji-17	189	14	can	can	AUX
aji-17	189	15	infect	infect	VERB
aji-17	189	16	the	the	DET
aji-17	189	17	human	human	ADJ
aji-17	189	18	respiratory	respiratory	ADJ
aji-17	189	19	epithelial	epithelial	ADJ
aji-17	189	20	cells	cell	NOUN
aji-17	189	21	through	through	ADP
aji-17	189	22	interaction	interaction	NOUN
aji-17	189	23	with	with	ADP
aji-17	189	24	the	the	DET
aji-17	189	25	human	human	ADJ
aji-17	189	26	ace2	ace2	NOUN
aji-17	189	27	receptor	receptor	NOUN
aji-17	189	28	.	.	PUNCT
aji-17	190	1	indeed	indeed	ADV
aji-17	190	2	,	,	PUNCT
aji-17	190	3	the	the	DET
aji-17	190	4	recombinant	recombinant	ADJ
aji-17	190	5	spike	spike	ADJ
aji-17	190	6	protein	protein	NOUN
aji-17	190	7	can	can	AUX
aji-17	190	8	bind	bind	VERB
aji-17	190	9	with	with	ADP
aji-17	190	10	recombinant	recombinant	ADJ
aji-17	190	11	ace2	ace2	NOUN
aji-17	190	12	protein	protein	NOUN
aji-17	190	13	.	.	PUNCT
aji-17	191	1	the	the	DET
aji-17	191	2	spike	spike	ADJ
aji-17	191	3	protein	protein	NOUN
aji-17	191	4	(	(	PUNCT
aji-17	191	5	s	s	NOUN
aji-17	191	6	)	)	PUNCT
aji-17	191	7	on	on	ADP
aji-17	191	8	the	the	DET
aji-17	191	9	envelope	envelope	NOUN
aji-17	191	10	of	of	ADP
aji-17	191	11	the	the	DET
aji-17	191	12	virus	virus	NOUN
aji-17	191	13	and	and	CCONJ
aji-17	191	14	m	m	NOUN
aji-17	191	15	-	-	NOUN
aji-17	191	16	rna	rna	NOUN
aji-17	191	17	strand	strand	NOUN
aji-17	191	18	of	of	ADP
aji-17	191	19	the	the	DET
aji-17	191	20	virus	virus	NOUN
aji-17	191	21	within	within	ADP
aji-17	191	22	the	the	DET
aji-17	191	23	capsid	capsid	NOUN
aji-17	191	24	are	be	AUX
aji-17	191	25	two	two	NUM
aji-17	191	26	novel	novel	NOUN
aji-17	191	27	approached	approach	VERB
aji-17	191	28	in	in	ADP
aji-17	191	29	the	the	DET
aji-17	191	30	vaccine	vaccine	NOUN
aji-17	191	31	industry	industry	NOUN
aji-17	191	32	(	(	PUNCT
aji-17	191	33	source	source	NOUN
aji-17	191	34	:	:	PUNCT
aji-17	191	35	sino	sino	ADJ
aji-17	191	36	biological	biological	NOUN
aji-17	191	37	,	,	PUNCT
aji-17	191	38	inc	inc	PROPN
aji-17	191	39	with	with	ADP
aji-17	191	40	headquarters	headquarters	PROPN
aji-17	191	41	in	in	ADP
aji-17	191	42	beijing	beijing	PROPN
aji-17	191	43	,	,	PUNCT
aji-17	191	44	china	china	PROPN
aji-17	191	45	with	with	ADP
aji-17	191	46	branches	branch	NOUN
aji-17	191	47	in	in	ADP
aji-17	191	48	the	the	DET
aji-17	191	49	united	united	PROPN
aji-17	191	50	states	states	PROPN
aji-17	191	51	and	and	CCONJ
aji-17	191	52	europe	europe	PROPN
aji-17	191	53	)	)	PUNCT
aji-17	191	54	.	.	PUNCT
aji-17	192	1	1.6.2	1.6.2	NUM
aji-17	192	2	the	the	DET
aji-17	192	3	vaccine	vaccine	NOUN
aji-17	192	4	trials	trial	NOUN
aji-17	192	5	according	accord	VERB
aji-17	192	6	to	to	ADP
aji-17	192	7	the	the	DET
aji-17	192	8	kaiser	kaiser	PROPN
aji-17	192	9	permanente	permanente	PROPN
aji-17	192	10	report	report	NOUN
aji-17	192	11	“	"	PUNCT
aji-17	192	12	the	the	DET
aji-17	192	13	artificial	artificial	ADJ
aji-17	192	14	mrna	mrna	NOUN
aji-17	192	15	produced	produce	VERB
aji-17	192	16	in	in	ADP
aji-17	192	17	the	the	DET
aji-17	192	18	lab	lab	NOUN
aji-17	192	19	,	,	PUNCT
aji-17	192	20	prompts	prompt	NOUN
aji-17	192	21	host	host	NOUN
aji-17	192	22	prasad	prasad	NOUN
aji-17	192	23	;	;	PUNCT
aji-17	192	24	aji	aji	NOUN
aji-17	192	25	,	,	PUNCT
aji-17	192	26	3(1	3(1	NUM
aji-17	192	27	):	):	PUNCT
aji-17	192	28	61	61	NUM
aji-17	192	29	-	-	SYM
aji-17	192	30	70	70	NUM
aji-17	192	31	,	,	PUNCT
aji-17	192	32	2020	2020	NUM
aji-17	192	33	;	;	PUNCT
aji-17	192	34	article	article	NOUN
aji-17	192	35	no.aji.55881	no.aji.55881	SCONJ
aji-17	192	36	64	64	NUM
aji-17	192	37	cells	cell	NOUN
aji-17	192	38	to	to	PART
aji-17	192	39	build	build	VERB
aji-17	192	40	a	a	DET
aji-17	192	41	protein	protein	NOUN
aji-17	192	42	found	find	VERB
aji-17	192	43	on	on	ADP
aji-17	192	44	the	the	DET
aji-17	192	45	surface	surface	NOUN
aji-17	192	46	of	of	ADP
aji-17	192	47	the	the	DET
aji-17	192	48	virus	virus	NOUN
aji-17	192	49	,	,	PUNCT
aji-17	192	50	.	.	PUNCT
aji-17	193	1	a	a	DET
aji-17	193	2	person	person	NOUN
aji-17	193	3	’s	’s	PART
aji-17	193	4	immune	immune	ADJ
aji-17	193	5	system	system	NOUN
aji-17	193	6	would	would	AUX
aji-17	193	7	react	react	VERB
aji-17	193	8	to	to	ADP
aji-17	193	9	this	this	DET
aji-17	193	10	new	new	ADJ
aji-17	193	11	protein	protein	NOUN
aji-17	193	12	by	by	ADP
aji-17	193	13	building	build	VERB
aji-17	193	14	up	up	ADP
aji-17	193	15	an	an	DET
aji-17	193	16	arsenal	arsenal	NOUN
aji-17	193	17	of	of	ADP
aji-17	193	18	antibodies	antibody	NOUN
aji-17	193	19	that	that	SCONJ
aji-17	193	20	target	target	VERB
aji-17	193	21	and	and	CCONJ
aji-17	193	22	latchonto	latchonto	ADP
aji-17	193	23	this	this	DET
aji-17	193	24	protein	protein	NOUN
aji-17	193	25	,	,	PUNCT
aji-17	193	26	tagging	tag	VERB
aji-17	193	27	the	the	DET
aji-17	193	28	virus	virus	NOUN
aji-17	193	29	for	for	ADP
aji-17	193	30	elimination	elimination	NOUN
aji-17	193	31	.	.	PUNCT
aji-17	194	1	then	then	ADV
aji-17	194	2	,	,	PUNCT
aji-17	194	3	the	the	DET
aji-17	194	4	mrna	mrna	PROPN
aji-17	194	5	should	should	AUX
aji-17	194	6	break	break	VERB
aji-17	194	7	down	down	ADP
aji-17	194	8	and	and	CCONJ
aji-17	194	9	be	be	AUX
aji-17	194	10	eliminated	eliminate	VERB
aji-17	194	11	by	by	ADP
aji-17	194	12	the	the	DET
aji-17	194	13	body	body	NOUN
aji-17	194	14	,	,	PUNCT
aji-17	194	15	leaving	leave	VERB
aji-17	194	16	the	the	DET
aji-17	194	17	vaccinated	vaccinated	ADJ
aji-17	194	18	person	person	NOUN
aji-17	194	19	better	well	ADV
aji-17	194	20	prepared	prepared	ADJ
aji-17	194	21	to	to	PART
aji-17	194	22	fight	fight	VERB
aji-17	194	23	off	off	ADP
aji-17	194	24	sars	sar	NOUN
aji-17	194	25	-	-	PUNCT
aji-17	194	26	cov-2	cov-2	NOUN
aji-17	194	27	,	,	PUNCT
aji-17	194	28	if	if	SCONJ
aji-17	194	29	they	they	PRON
aji-17	194	30	are	be	AUX
aji-17	194	31	infected	infect	VERB
aji-17	194	32	subsequently	subsequently	ADV
aji-17	194	33	.	.	PUNCT
aji-17	195	1	a	a	DET
aji-17	195	2	clinical	clinical	ADJ
aji-17	195	3	trial	trial	NOUN
aji-17	195	4	is	be	AUX
aji-17	195	5	slated	slate	VERB
aji-17	195	6	on	on	ADP
aji-17	195	7	april	april	PROPN
aji-17	195	8	2020	2020	NUM
aji-17	195	9	to	to	PART
aji-17	195	10	conduct	conduct	VERB
aji-17	195	11	a	a	DET
aji-17	195	12	preliminary	preliminary	ADJ
aji-17	195	13	human	human	ADJ
aji-17	195	14	safety	safety	NOUN
aji-17	195	15	clinical	clinical	ADJ
aji-17	195	16	trial	trial	NOUN
aji-17	195	17	of	of	ADP
aji-17	195	18	this	this	DET
aji-17	195	19	vaccine	vaccine	NOUN
aji-17	195	20	a	a	DET
aji-17	195	21	wall	wall	PROPN
aji-17	195	22	street	street	PROPN
aji-17	195	23	journal	journal	PROPN
aji-17	195	24	reports	report	VERB
aji-17	195	25	.	.	PUNCT
aji-17	196	1	in	in	ADP
aji-17	196	2	february	february	PROPN
aji-17	196	3	2020	2020	NUM
aji-17	196	4	,	,	PUNCT
aji-17	196	5	novavax	novavax	NOUN
aji-17	196	6	started	start	VERB
aji-17	196	7	testing	test	VERB
aji-17	196	8	its	its	PRON
aji-17	196	9	recombinant	recombinant	ADJ
aji-17	196	10	nanoparticle	nanoparticle	NOUN
aji-17	196	11	vaccine	vaccine	NOUN
aji-17	196	12	candidate	candidate	NOUN
aji-17	196	13	for	for	ADP
aji-17	196	14	coronavirus	coronavirus	NOUN
aji-17	196	15	in	in	ADP
aji-17	196	16	animal	animal	NOUN
aji-17	196	17	models	model	NOUN
aji-17	196	18	.	.	PUNCT
aji-17	197	1	the	the	DET
aji-17	197	2	candidates	candidate	NOUN
aji-17	197	3	produced	produce	VERB
aji-17	197	4	antigens	antigen	NOUN
aji-17	197	5	derived	derive	VERB
aji-17	197	6	from	from	ADP
aji-17	197	7	the	the	DET
aji-17	197	8	coronavirus	coronavirus	NOUN
aji-17	197	9	spike	spike	NOUN
aji-17	197	10	(	(	PUNCT
aji-17	197	11	s	s	NOUN
aji-17	197	12	)	)	PUNCT
aji-17	197	13	protein	protein	NOUN
aji-17	197	14	.	.	PUNCT
aji-17	198	1	novavax	novavax	PROPN
aji-17	198	2	is	be	AUX
aji-17	198	3	planning	plan	VERB
aji-17	198	4	to	to	PART
aji-17	198	5	use	use	VERB
aji-17	198	6	its	its	PRON
aji-17	198	7	matrix	matrix	NOUN
aji-17	198	8	-	-	PUNCT
aji-17	198	9	m	m	NOUN
aji-17	198	10	adjuvant	adjuvant	ADJ
aji-17	198	11	with	with	ADP
aji-17	198	12	its	its	PRON
aji-17	198	13	covid-19	covid-19	PROPN
aji-17	198	14	vaccine	vaccine	NOUN
aji-17	198	15	candidates	candidate	NOUN
aji-17	198	16	to	to	PART
aji-17	198	17	boost	boost	VERB
aji-17	198	18	immune	immune	ADJ
aji-17	198	19	responses	response	NOUN
aji-17	198	20	.	.	PUNCT
aji-17	199	1	“	"	PUNCT
aji-17	199	2	curevac	curevac	NOUN
aji-17	199	3	has	have	AUX
aji-17	199	4	successfully	successfully	ADV
aji-17	199	5	harnessed	harness	VERB
aji-17	199	6	its	its	PRON
aji-17	199	7	biological	biological	ADJ
aji-17	199	8	insights	insight	NOUN
aji-17	199	9	of	of	ADP
aji-17	199	10	the	the	DET
aji-17	199	11	lifeenabling	lifeenabling	NOUN
aji-17	199	12	molecule	molecule	NOUN
aji-17	199	13	mrna	mrna	NOUN
aji-17	199	14	to	to	PART
aji-17	199	15	move	move	VERB
aji-17	199	16	medicine	medicine	NOUN
aji-17	199	17	into	into	ADP
aji-17	199	18	the	the	DET
aji-17	199	19	future	future	NOUN
aji-17	199	20	.	.	PUNCT
aji-17	200	1	powered	power	VERB
aji-17	200	2	by	by	ADP
aji-17	200	3	our	our	PRON
aji-17	200	4	optimization	optimization	NOUN
aji-17	200	5	technology	technology	NOUN
aji-17	200	6	.	.	PUNCT
aji-17	200	7	”	"	PUNCT
aji-17	201	1	curevac	curevac	PROPN
aji-17	201	2	ag	ag	PROPN
aji-17	201	3	,	,	PUNCT
aji-17	201	4	a	a	DET
aji-17	201	5	clinical	clinical	ADJ
aji-17	201	6	stage	stage	NOUN
aji-17	201	7	biopharmaceutical	biopharmaceutical	NOUN
aji-17	201	8	company	company	NOUN
aji-17	201	9	is	be	AUX
aji-17	201	10	pioneering	pioneer	VERB
aji-17	201	11	mrna	mrna	PROPN
aji-17	201	12	-	-	PUNCT
aji-17	201	13	based	base	VERB
aji-17	201	14	vaccine	vaccine	NOUN
aji-17	201	15	against	against	ADP
aji-17	201	16	the	the	DET
aji-17	201	17	novel	novel	ADJ
aji-17	201	18	corona	corona	NOUN
aji-17	201	19	virus	virus	NOUN
aji-17	201	20	.	.	PUNCT
aji-17	202	1	recently	recently	ADV
aji-17	202	2	the	the	PRON
aji-17	202	3	who	who	PRON
aji-17	202	4	approved	approve	VERB
aji-17	202	5	hydroxy	hydroxy	ADJ
aji-17	202	6	chloroquine	chloroquine	NOUN
aji-17	202	7	vaccine	vaccine	NOUN
aji-17	202	8	for	for	ADP
aji-17	202	9	prophylaxis	prophylaxis	NOUN
aji-17	202	10	against	against	ADP
aji-17	202	11	covid	covid	PROPN
aji-17	202	12	19	19	NUM
aji-17	202	13	.	.	PUNCT
aji-17	202	14	who	who	PRON
aji-17	202	15	has	have	AUX
aji-17	202	16	published	publish	VERB
aji-17	202	17	a	a	DET
aji-17	202	18	long	long	ADJ
aji-17	202	19	list	list	NOUN
aji-17	202	20	of	of	ADP
aji-17	202	21	counties	county	NOUN
aji-17	202	22	working	work	VERB
aji-17	202	23	on	on	ADP
aji-17	202	24	corona	corona	NOUN
aji-17	202	25	virus	virus	NOUN
aji-17	202	26	vaccine	vaccine	NOUN
aji-17	202	27	and	and	CCONJ
aji-17	202	28	their	their	PRON
aji-17	202	29	different	different	ADJ
aji-17	202	30	approaches	approach	NOUN
aji-17	202	31	,	,	PUNCT
aji-17	202	32	in	in	ADP
aji-17	202	33	this	this	DET
aji-17	202	34	regard	regard	NOUN
aji-17	202	35	.	.	PUNCT
aji-17	203	1	interested	interested	ADJ
aji-17	203	2	can	can	AUX
aji-17	203	3	refer	refer	VERB
aji-17	203	4	the	the	DET
aji-17	203	5	same	same	ADJ
aji-17	203	6	as	as	SCONJ
aji-17	203	7	it	it	PRON
aji-17	203	8	is	be	AUX
aji-17	203	9	out	out	ADP
aji-17	203	10	of	of	ADP
aji-17	203	11	the	the	DET
aji-17	203	12	scope	scope	NOUN
aji-17	203	13	of	of	ADP
aji-17	203	14	this	this	DET
aji-17	203	15	article	article	NOUN
aji-17	203	16	.	.	PUNCT
aji-17	204	1	2	2	X
aji-17	204	2	.	.	X
aji-17	204	3	discussion	discussion	NOUN
aji-17	204	4	it	it	PRON
aji-17	204	5	is	be	AUX
aji-17	204	6	proposed	propose	VERB
aji-17	204	7	to	to	PART
aji-17	204	8	briefly	briefly	ADV
aji-17	204	9	review	review	VERB
aji-17	204	10	the	the	DET
aji-17	204	11	broad	broad	ADJ
aji-17	204	12	principles	principle	NOUN
aji-17	204	13	of	of	ADP
aji-17	204	14	immune	immune	ADJ
aji-17	204	15	reaction	reaction	NOUN
aji-17	204	16	s	s	NOUN
aji-17	204	17	to	to	ADP
aji-17	204	18	viral	viral	ADJ
aji-17	204	19	infections	infection	NOUN
aji-17	204	20	in	in	ADP
aji-17	204	21	general	general	ADJ
aji-17	204	22	as	as	SCONJ
aji-17	204	23	the	the	DET
aji-17	204	24	specific	specific	ADJ
aji-17	204	25	immune	immune	ADJ
aji-17	204	26	reaction	reaction	NOUN
aji-17	204	27	of	of	ADP
aji-17	204	28	corona	corona	PROPN
aji-17	204	29	virus	virus	NOUN
aji-17	204	30	19	19	NUM
aji-17	204	31	is	be	AUX
aji-17	204	32	to	to	PART
aji-17	204	33	early	early	ADV
aji-17	204	34	to	to	ADP
aji-17	204	35	decipher	decipher	PROPN
aji-17	204	36	.	.	PUNCT
aji-17	205	1	however	however	ADV
aji-17	205	2	,	,	PUNCT
aji-17	205	3	the	the	DET
aji-17	205	4	intended	intend	VERB
aji-17	205	5	focus	focus	NOUN
aji-17	205	6	is	be	AUX
aji-17	205	7	on	on	ADP
aji-17	205	8	the	the	DET
aji-17	205	9	concept	concept	NOUN
aji-17	205	10	of	of	ADP
aji-17	205	11	local	local	ADJ
aji-17	205	12	immunity	immunity	NOUN
aji-17	205	13	and	and	CCONJ
aji-17	205	14	it	it	PRON
aji-17	205	15	’s	’	VERB
aji-17	205	16	possible	possible	ADJ
aji-17	205	17	role	role	NOUN
aji-17	205	18	in	in	ADP
aji-17	205	19	the	the	DET
aji-17	205	20	interventional	interventional	ADJ
aji-17	205	21	strategy	strategy	NOUN
aji-17	205	22	to	to	PART
aji-17	205	23	contain	contain	VERB
aji-17	205	24	the	the	DET
aji-17	205	25	disease	disease	NOUN
aji-17	205	26	.	.	PUNCT
aji-17	206	1	principles	principle	NOUN
aji-17	206	2	of	of	ADP
aji-17	206	3	immune	immune	ADJ
aji-17	206	4	reactions	reaction	NOUN
aji-17	206	5	against	against	ADP
aji-17	206	6	viral	viral	ADJ
aji-17	206	7	infections	infection	NOUN
aji-17	206	8	in	in	ADP
aji-17	206	9	general	general	ADJ
aji-17	206	10	:	:	PUNCT
aji-17	206	11	there	there	PRON
aji-17	206	12	are	be	VERB
aji-17	206	13	two	two	NUM
aji-17	206	14	types	type	NOUN
aji-17	206	15	of	of	ADP
aji-17	206	16	systemic	systemic	ADJ
aji-17	206	17	immunity	immunity	NOUN
aji-17	206	18	they	they	PRON
aji-17	206	19	are	be	AUX
aji-17	206	20			NOUN
aji-17	206	21	innate	innate	ADJ
aji-17	206	22	immunity	immunity	NOUN
aji-17	206	23			NOUN
aji-17	206	24	adoptive	adoptive	ADJ
aji-17	206	25	immunity	immunity	NOUN
aji-17	206	26	innate	innate	ADJ
aji-17	206	27	and	and	CCONJ
aji-17	206	28	adoptive	adoptive	ADJ
aji-17	206	29	immune	immune	ADJ
aji-17	206	30	mechanisms	mechanism	NOUN
aji-17	206	31	both	both	PRON
aji-17	206	32	operate	operate	VERB
aji-17	206	33	against	against	ADP
aji-17	206	34	the	the	DET
aji-17	206	35	virus	virus	NOUN
aji-17	206	36	or	or	CCONJ
aji-17	206	37	the	the	DET
aji-17	206	38	infected	infected	ADJ
aji-17	206	39	cells	cell	NOUN
aji-17	206	40	of	of	ADP
aji-17	206	41	the	the	DET
aji-17	206	42	host	host	NOUN
aji-17	206	43	.	.	PUNCT
aji-17	207	1	cytotoxic	cytotoxic	ADJ
aji-17	207	2	cells	cell	NOUN
aji-17	207	3	:	:	PUNCT
aji-17	207	4	nk	nk	PROPN
aji-17	207	5	(	(	PUNCT
aji-17	207	6	natural	natural	ADJ
aji-17	207	7	killer	killer	NOUN
aji-17	207	8	)	)	PUNCT
aji-17	207	9	and	and	CCONJ
aji-17	207	10	cd8+cells	cd8+cells	DET
aji-17	207	11	cytotoxic	cytotoxic	ADJ
aji-17	207	12	t	t	NOUN
aji-17	207	13	cell	cell	NOUN
aji-17	207	14	circulate	circulate	VERB
aji-17	207	15	and	and	CCONJ
aji-17	207	16	kills	kill	VERB
aji-17	207	17	cells	cell	NOUN
aji-17	207	18	that	that	PRON
aji-17	207	19	are	be	AUX
aji-17	207	20	infected	infect	VERB
aji-17	207	21	with	with	ADP
aji-17	207	22	viruses	virus	NOUN
aji-17	207	23	with	with	ADP
aji-17	207	24	toxic	toxic	ADJ
aji-17	207	25	mediators	mediator	NOUN
aji-17	207	26	.	.	PUNCT
aji-17	208	1	cytotoxic	cytotoxic	ADJ
aji-17	208	2	t	t	PROPN
aji-17	208	3	cells	cell	NOUN
aji-17	208	4	have	have	VERB
aji-17	208	5	specialised	specialised	ADJ
aji-17	208	6	proteins	protein	NOUN
aji-17	208	7	on	on	ADP
aji-17	208	8	their	their	PRON
aji-17	208	9	surface	surface	NOUN
aji-17	208	10	that	that	PRON
aji-17	208	11	help	help	VERB
aji-17	208	12	them	they	PRON
aji-17	208	13	to	to	PART
aji-17	208	14	recognise	recognise	VERB
aji-17	208	15	virally	virally	ADV
aji-17	208	16	-	-	PUNCT
aji-17	208	17	infected	infect	VERB
aji-17	208	18	cells	cell	NOUN
aji-17	208	19	.	.	PUNCT
aji-17	209	1	these	these	DET
aji-17	209	2	proteins	protein	NOUN
aji-17	209	3	are	be	AUX
aji-17	209	4	called	call	VERB
aji-17	209	5	t	t	NOUN
aji-17	209	6	cell	cell	NOUN
aji-17	209	7	receptors	receptor	NOUN
aji-17	209	8	(	(	PUNCT
aji-17	209	9	tcrs	tcrs	NOUN
aji-17	209	10	)	)	PUNCT
aji-17	209	11	.	.	PUNCT
aji-17	210	1	each	each	DET
aji-17	210	2	cytotoxic	cytotoxic	ADJ
aji-17	210	3	t	t	NOUN
aji-17	210	4	cell	cell	NOUN
aji-17	210	5	has	have	VERB
aji-17	210	6	a	a	DET
aji-17	210	7	tcr	tcr	PROPN
aji-17	210	8	that	that	PRON
aji-17	210	9	can	can	AUX
aji-17	210	10	specifically	specifically	ADV
aji-17	210	11	recognise	recognise	VERB
aji-17	210	12	a	a	DET
aji-17	210	13	particular	particular	ADJ
aji-17	210	14	antigenic	antigenic	ADJ
aji-17	210	15	peptide	peptide	NOUN
aji-17	210	16	bound	bind	VERB
aji-17	210	17	to	to	ADP
aji-17	210	18	an	an	DET
aji-17	210	19	mhc	mhc	PROPN
aji-17	210	20	1	1	NUM
aji-17	210	21	molecule	molecule	NOUN
aji-17	210	22	.	.	PUNCT
aji-17	211	1	the	the	DET
aji-17	211	2	virus	virus	NOUN
aji-17	211	3	have	have	VERB
aji-17	211	4	tcr	tcr	NOUN
aji-17	211	5	receptors	receptor	NOUN
aji-17	211	6	which	which	PRON
aji-17	211	7	express	express	VERB
aji-17	211	8	the	the	DET
aji-17	211	9	viral	viral	ADJ
aji-17	211	10	proteins	protein	NOUN
aji-17	211	11	.	.	PUNCT
aji-17	212	1	the	the	DET
aji-17	212	2	host	host	NOUN
aji-17	212	3	cells	cell	NOUN
aji-17	212	4	have	have	VERB
aji-17	212	5	hla	hla	PROPN
aji-17	212	6	1	1	NUM
aji-17	212	7	antigens	antigen	NOUN
aji-17	212	8	to	to	PART
aji-17	212	9	which	which	PRON
aji-17	212	10	the	the	DET
aji-17	212	11	vral	vral	ADJ
aji-17	212	12	proteins	protein	NOUN
aji-17	212	13	are	be	AUX
aji-17	212	14	bound	bind	VERB
aji-17	212	15	bind	bind	NOUN
aji-17	212	16	.	.	PUNCT
aji-17	213	1	nk	nk	PROPN
aji-17	213	2	cytotoxic	cytotoxic	ADJ
aji-17	213	3	cells	cell	NOUN
aji-17	213	4	are	be	AUX
aji-17	213	5	innate	innate	ADJ
aji-17	213	6	defence	defence	NOUN
aji-17	213	7	mechanisms	mechanism	NOUN
aji-17	213	8	which	which	PRON
aji-17	213	9	have	have	VERB
aji-17	213	10	fewer	few	ADJ
aji-17	213	11	than	than	ADP
aji-17	213	12	normal	normal	ADJ
aji-17	213	13	mhc	mhc	NOUN
aji-17	213	14	1	1	NUM
aji-17	213	15	receptors	receptor	NOUN
aji-17	213	16	on	on	ADP
aji-17	213	17	the	the	DET
aji-17	213	18	surface	surface	NOUN
aji-17	213	19	of	of	ADP
aji-17	213	20	the	the	DET
aji-17	213	21	cells	cell	NOUN
aji-17	213	22	.	.	PUNCT
aji-17	214	1	toxic	toxic	ADJ
aji-17	214	2	mediators	mediator	NOUN
aji-17	214	3	of	of	ADP
aji-17	214	4	t	t	NOUN
aji-17	214	5	cells	cell	NOUN
aji-17	214	6	:	:	PUNCT
aji-17	214	7	preformed	preform	VERB
aji-17	214	8	toxic	toxic	ADJ
aji-17	214	9	mediators	mediator	NOUN
aji-17	214	10	are	be	AUX
aji-17	214	11	stored	store	VERB
aji-17	214	12	called	call	VERB
aji-17	214	13	granules	granule	NOUN
aji-17	214	14	,	,	PUNCT
aji-17	214	15	in	in	ADP
aji-17	214	16	both	both	DET
aji-17	214	17	cytotoxic	cytotoxic	ADJ
aji-17	214	18	t	t	NOUN
aji-17	214	19	cells	cell	NOUN
aji-17	214	20	and	and	CCONJ
aji-17	214	21	nk	nk	PROPN
aji-17	214	22	cells	cell	NOUN
aji-17	214	23	,	,	PUNCT
aji-17	214	24	until	until	SCONJ
aji-17	214	25	contact	contact	NOUN
aji-17	214	26	with	with	ADP
aji-17	214	27	an	an	DET
aji-17	214	28	infected	infected	ADJ
aji-17	214	29	cell	cell	NOUN
aji-17	214	30	triggers	trigger	VERB
aji-17	214	31	their	their	PRON
aji-17	214	32	release	release	NOUN
aji-17	214	33	.	.	PUNCT
aji-17	215	1	one	one	NUM
aji-17	215	2	of	of	ADP
aji-17	215	3	these	these	DET
aji-17	215	4	mediators	mediator	NOUN
aji-17	215	5	is	be	AUX
aji-17	215	6	perforin	perforin	NOUN
aji-17	215	7	,	,	PUNCT
aji-17	215	8	a	a	DET
aji-17	215	9	protein	protein	NOUN
aji-17	215	10	that	that	PRON
aji-17	215	11	can	can	AUX
aji-17	215	12	make	make	VERB
aji-17	215	13	pores	pore	NOUN
aji-17	215	14	in	in	ADP
aji-17	215	15	cell	cell	NOUN
aji-17	215	16	membranes	membrane	NOUN
aji-17	215	17	;	;	PUNCT
aji-17	215	18	these	these	DET
aji-17	215	19	pores	pore	NOUN
aji-17	215	20	allow	allow	VERB
aji-17	215	21	entry	entry	NOUN
aji-17	215	22	of	of	ADP
aji-17	215	23	other	other	ADJ
aji-17	215	24	factors	factor	NOUN
aji-17	215	25	into	into	ADP
aji-17	215	26	a	a	DET
aji-17	215	27	target	target	NOUN
aji-17	215	28	cell	cell	NOUN
aji-17	215	29	to	to	PART
aji-17	215	30	facilitate	facilitate	VERB
aji-17	215	31	destruction	destruction	NOUN
aji-17	215	32	of	of	ADP
aji-17	215	33	the	the	DET
aji-17	215	34	cell	cell	NOUN
aji-17	215	35	.	.	PUNCT
aji-17	216	1	enzymes	enzyme	NOUN
aji-17	216	2	called	call	VERB
aji-17	216	3	granzymes	granzyme	NOUN
aji-17	216	4	are	be	AUX
aji-17	216	5	also	also	ADV
aji-17	216	6	stored	store	VERB
aji-17	216	7	in	in	ADP
aji-17	216	8	,	,	PUNCT
aji-17	216	9	and	and	CCONJ
aji-17	216	10	released	release	VERB
aji-17	216	11	from	from	ADP
aji-17	216	12	,	,	PUNCT
aji-17	216	13	the	the	DET
aji-17	216	14	granules	granule	NOUN
aji-17	216	15	.	.	PUNCT
aji-17	217	1	granzymes	granzyme	NOUN
aji-17	217	2	enter	enter	VERB
aji-17	217	3	target	target	NOUN
aji-17	217	4	cells	cell	NOUN
aji-17	217	5	through	through	ADP
aji-17	217	6	the	the	DET
aji-17	217	7	holes	hole	NOUN
aji-17	217	8	made	make	VERB
aji-17	217	9	by	by	ADP
aji-17	217	10	perforin	perforin	NOUN
aji-17	217	11	.	.	PUNCT
aji-17	218	1	once	once	ADV
aji-17	218	2	inside	inside	ADP
aji-17	218	3	the	the	DET
aji-17	218	4	target	target	NOUN
aji-17	218	5	cell	cell	NOUN
aji-17	218	6	,	,	PUNCT
aji-17	218	7	they	they	PRON
aji-17	218	8	initiate	initiate	VERB
aji-17	218	9	a	a	DET
aji-17	218	10	process	process	NOUN
aji-17	218	11	known	know	VERB
aji-17	218	12	as	as	ADP
aji-17	218	13	programmed	program	VERB
aji-17	218	14	cell	cell	NOUN
aji-17	218	15	death	death	NOUN
aji-17	218	16	or	or	CCONJ
aji-17	218	17	apoptosis	apoptosis	NOUN
aji-17	218	18	,	,	PUNCT
aji-17	218	19	causing	cause	VERB
aji-17	218	20	the	the	DET
aji-17	218	21	target	target	NOUN
aji-17	218	22	cell	cell	NOUN
aji-17	218	23	to	to	PART
aji-17	218	24	die	die	VERB
aji-17	218	25	.	.	PUNCT
aji-17	219	1	another	another	PRON
aji-17	219	2	released	release	VERB
aji-17	219	3	cytotoxic	cytotoxic	ADJ
aji-17	219	4	factor	factor	NOUN
aji-17	219	5	is	be	AUX
aji-17	219	6	granulysin	granulysin	NOUN
aji-17	219	7	,	,	PUNCT
aji-17	219	8	directly	directly	ADV
aji-17	219	9	attacks	attack	VERB
aji-17	219	10	the	the	DET
aji-17	219	11	outer	outer	ADJ
aji-17	219	12	membrane	membrane	NOUN
aji-17	219	13	of	of	ADP
aji-17	219	14	the	the	DET
aji-17	219	15	table	table	NOUN
aji-17	219	16	1	1	NUM
aji-17	219	17	.	.	PUNCT
aji-17	219	18	showing	show	VERB
aji-17	219	19	the	the	DET
aji-17	219	20	various	various	ADJ
aji-17	219	21	viral	viral	ADJ
aji-17	219	22	immune	immune	ADJ
aji-17	219	23	mechanisms	mechanism	NOUN
aji-17	219	24	immune	immune	ADJ
aji-17	219	25	mechanisms	mechanism	NOUN
aji-17	219	26	in	in	ADP
aji-17	219	27	viral	viral	ADJ
aji-17	219	28	infections	infection	NOUN
aji-17	219	29	against	against	ADP
aji-17	219	30	the	the	DET
aji-17	219	31	infected	infect	VERB
aji-17	219	32	cells	cell	NOUN
aji-17	219	33	against	against	ADP
aji-17	219	34	the	the	DET
aji-17	219	35	virus	virus	NOUN
aji-17	219	36	innate	innate	VERB
aji-17	219	37	nk	nk	PROPN
aji-17	219	38	cells	cell	NOUN
aji-17	219	39	interferons	interferon	NOUN
aji-17	219	40	(	(	PUNCT
aji-17	219	41	a	a	PRON
aji-17	219	42	,	,	PUNCT
aji-17	219	43	b	b	NOUN
aji-17	219	44	and	and	CCONJ
aji-17	219	45	g	g	NOUN
aji-17	219	46	)	)	PUNCT
aji-17	219	47	alternative	alternative	ADJ
aji-17	219	48	compliment	compliment	NOUN
aji-17	219	49	pathway	pathway	NOUN
aji-17	219	50	adaptive	adaptive	ADJ
aji-17	219	51	adcc	adcc	NOUN
aji-17	219	52	(	(	PUNCT
aji-17	219	53	antibody	antibody	NOUN
aji-17	219	54	dependant	dependant	ADJ
aji-17	219	55	cell	cell	NOUN
aji-17	219	56	mediated	mediate	VERB
aji-17	219	57	cytotoxicity	cytotoxicity	NOUN
aji-17	219	58	classical	classical	ADJ
aji-17	219	59	complement	complement	NOUN
aji-17	219	60	pathway	pathway	NOUN
aji-17	219	61	cd	cd	PROPN
aji-17	219	62	8	8	NUM
aji-17	219	63	cytotoxic	cytotoxic	ADJ
aji-17	219	64	cells	cell	NOUN
aji-17	219	65	phagocytosis	phagocytosis	VERB
aji-17	219	66	prasad	prasad	NOUN
aji-17	219	67	;	;	PUNCT
aji-17	219	68	aji	aji	NOUN
aji-17	219	69	,	,	PUNCT
aji-17	219	70	3(1	3(1	NUM
aji-17	219	71	):	):	PUNCT
aji-17	219	72	61	61	NUM
aji-17	219	73	-	-	SYM
aji-17	219	74	70	70	NUM
aji-17	219	75	,	,	PUNCT
aji-17	219	76	2020	2020	NUM
aji-17	219	77	;	;	PUNCT
aji-17	219	78	article	article	NOUN
aji-17	219	79	no.aji.55881	no.aji.55881	ADP
aji-17	219	80	65	65	NUM
aji-17	219	81	target	target	NOUN
aji-17	219	82	cell	cell	NOUN
aji-17	219	83	,	,	PUNCT
aji-17	219	84	destroying	destroy	VERB
aji-17	219	85	it	it	PRON
aji-17	219	86	by	by	ADP
aji-17	219	87	lysis	lysis	NOUN
aji-17	219	88	.	.	PUNCT
aji-17	220	1	cytotoxic	cytotoxic	ADJ
aji-17	220	2	cells	cell	NOUN
aji-17	220	3	synthesise	synthesise	VERB
aji-17	220	4	and	and	CCONJ
aji-17	220	5	release	release	VERB
aji-17	220	6	,	,	PUNCT
aji-17	220	7	cytokines	cytokine	NOUN
aji-17	220	8	,	,	PUNCT
aji-17	220	9	after	after	ADP
aji-17	220	10	making	make	VERB
aji-17	220	11	contact	contact	NOUN
aji-17	220	12	with	with	ADP
aji-17	220	13	infected	infected	ADJ
aji-17	220	14	cells	cell	NOUN
aji-17	220	15	.	.	PUNCT
aji-17	221	1	cytokines	cytokine	NOUN
aji-17	221	2	include	include	VERB
aji-17	221	3	interferon	interferon	ADJ
aji-17	221	4	-	-	PUNCT
aji-17	221	5	g	g	NOUN
aji-17	221	6	and	and	CCONJ
aji-17	221	7	tumour	tumour	NOUN
aji-17	221	8	necrosis	necrosis	NOUN
aji-17	221	9	factor	factor	NOUN
aji-17	221	10	-	-	PUNCT
aji-17	221	11	a.	a.	NOUN
aji-17	221	12	interferon	interferon	NOUN
aji-17	221	13	:	:	PUNCT
aji-17	221	14	it	it	PRON
aji-17	221	15	is	be	AUX
aji-17	221	16	one	one	NUM
aji-17	221	17	of	of	ADP
aji-17	221	18	the	the	DET
aji-17	221	19	most	most	ADV
aji-17	221	20	effective	effective	ADJ
aji-17	221	21	innate	innate	ADJ
aji-17	221	22	defence	defence	NOUN
aji-17	221	23	mechanism	mechanism	NOUN
aji-17	221	24	produced	produce	VERB
aji-17	221	25	by	by	ADP
aji-17	221	26	the	the	DET
aji-17	221	27	infected	infect	VERB
aji-17	221	28	.	.	PUNCT
aji-17	222	1	host	host	NOUN
aji-17	222	2	cell	cell	NOUN
aji-17	222	3	.	.	PUNCT
aji-17	223	1	there	there	PRON
aji-17	223	2	are	be	VERB
aji-17	223	3	3	3	NUM
aji-17	223	4	types	type	NOUN
aji-17	223	5	of	of	ADP
aji-17	223	6	interferon	interferon	NOUN
aji-17	223	7	,	,	PUNCT
aji-17	223	8	a	a	DET
aji-17	223	9	,	,	PUNCT
aji-17	223	10	b	b	NOUN
aji-17	223	11	and	and	CCONJ
aji-17	223	12	g	g	ADP
aji-17	223	13	the	the	DET
aji-17	223	14	first	first	ADJ
aji-17	223	15	two	two	NUM
aji-17	223	16	are	be	AUX
aji-17	223	17	mainly	mainly	ADV
aji-17	223	18	produced	produce	VERB
aji-17	223	19	by	by	ADP
aji-17	223	20	monocytes	monocyte	NOUN
aji-17	223	21	-	-	PUNCT
aji-17	223	22	macrophages	macrophage	NOUN
aji-17	223	23	and	and	CCONJ
aji-17	223	24	to	to	ADP
aji-17	223	25	a	a	DET
aji-17	223	26	lesser	less	ADJ
aji-17	223	27	extent	extent	NOUN
aji-17	223	28	by	by	ADP
aji-17	223	29	fibroblasts	fibroblast	NOUN
aji-17	223	30	.	.	PUNCT
aji-17	224	1	but	but	CCONJ
aji-17	224	2	interferon	interferon	ADJ
aji-17	224	3	-	-	PUNCT
aji-17	224	4	g	g	NOUN
aji-17	224	5	is	be	AUX
aji-17	224	6	produced	produce	VERB
aji-17	224	7	by	by	ADP
aji-17	224	8	cd	cd	PROPN
aji-17	224	9	4	4	NUM
aji-17	224	10	and	and	CCONJ
aji-17	224	11	cd	cd	PROPN
aji-17	224	12	8	8	NUM
aji-17	224	13	lymphocytes	lymphocyte	NOUN
aji-17	224	14	and	and	CCONJ
aji-17	224	15	nk	nk	PROPN
aji-17	224	16	cells	cell	NOUN
aji-17	224	17	.	.	PUNCT
aji-17	225	1	mechanisms	mechanism	NOUN
aji-17	225	2	of	of	ADP
aji-17	225	3	interferon	interferon	ADJ
aji-17	225	4	action	action	NOUN
aji-17	225	5	:	:	PUNCT
aji-17	225	6	"	"	PUNCT
aji-17	225	7	transitory	transitory	ADJ
aji-17	225	8	resistance	resistance	NOUN
aji-17	225	9	of	of	ADP
aji-17	225	10	cells	cell	NOUN
aji-17	225	11	;	;	PUNCT
aji-17	225	12	induction	induction	NOUN
aji-17	225	13	of	of	ADP
aji-17	225	14	different	different	ADJ
aji-17	225	15	molecules	molecule	NOUN
aji-17	225	16	with	with	ADP
aji-17	225	17	anti	anti	ADJ
aji-17	225	18	-	-	ADJ
aji-17	225	19	viral	viral	ADJ
aji-17	225	20	activity	activity	NOUN
aji-17	225	21	;	;	PUNCT
aji-17	225	22	activation	activation	NOUN
aji-17	225	23	of	of	ADP
aji-17	225	24	genes	gene	NOUN
aji-17	225	25	expressing	express	VERB
aji-17	225	26	anti	anti	ADJ
aji-17	225	27	-	-	ADJ
aji-17	225	28	viral	viral	ADJ
aji-17	225	29	proteins	protein	NOUN
aji-17	225	30	,	,	PUNCT
aji-17	225	31	and	and	CCONJ
aji-17	225	32	increasing	increase	VERB
aji-17	225	33	the	the	DET
aji-17	225	34	expression	expression	NOUN
aji-17	225	35	of	of	ADP
aji-17	225	36	sla	sla	PROPN
aji-17	225	37	i	i	PROPN
aji-17	225	38	and	and	CCONJ
aji-17	225	39	sla	sla	PROPN
aji-17	225	40	ii	ii	PROPN
aji-17	225	41	“	"	PUNCT
aji-17	225	42	.	.	PUNCT
aji-17	226	1	role	role	NOUN
aji-17	226	2	of	of	ADP
aji-17	226	3	antibodies	antibody	NOUN
aji-17	226	4	(	(	PUNCT
aji-17	226	5	ig	ig	PROPN
aji-17	226	6	g	g	PROPN
aji-17	226	7	,	,	PUNCT
aji-17	226	8	igm	igm	PROPN
aji-17	226	9	,	,	PUNCT
aji-17	226	10	):	):	PUNCT
aji-17	226	11	1	1	NUM
aji-17	226	12	.	.	X
aji-17	226	13	neutralisation	neutralisation	NOUN
aji-17	226	14	of	of	ADP
aji-17	226	15	the	the	DET
aji-17	226	16	virus	virus	NOUN
aji-17	226	17	(	(	PUNCT
aji-17	226	18	both	both	CCONJ
aji-17	226	19	igg	igg	PROPN
aji-17	226	20	and	and	CCONJ
aji-17	226	21	igm	igm	PROPN
aji-17	226	22	)	)	PUNCT
aji-17	226	23	2	2	NUM
aji-17	226	24	.	.	X
aji-17	226	25	agglutination	agglutination	PROPN
aji-17	226	26	(	(	PUNCT
aji-17	226	27	igm	igm	PROPN
aji-17	226	28	)	)	PUNCT
aji-17	226	29	effectiveness	effectiveness	NOUN
aji-17	226	30	of	of	ADP
aji-17	226	31	humoral	humoral	ADJ
aji-17	226	32	vs	vs	ADP
aji-17	226	33	cell	cell	NOUN
aji-17	226	34	mediated	mediate	VERB
aji-17	226	35	immunity	immunity	NOUN
aji-17	226	36	(	(	PUNCT
aji-17	226	37	cmi	cmi	PROPN
aji-17	226	38	):	):	PUNCT
aji-17	226	39	some	some	DET
aji-17	226	40	investigators	investigator	NOUN
aji-17	226	41	have	have	AUX
aji-17	226	42	suggested	suggest	VERB
aji-17	226	43	that	that	SCONJ
aji-17	226	44	serum	serum	NOUN
aji-17	226	45	antibody	antibody	NOUN
aji-17	226	46	is	be	AUX
aji-17	226	47	responsible	responsible	ADJ
aji-17	226	48	for	for	ADP
aji-17	226	49	protection	protection	NOUN
aji-17	226	50	in	in	ADP
aji-17	226	51	the	the	DET
aji-17	226	52	human	human	NOUN
aji-17	226	53	,	,	PUNCT
aji-17	226	54	others	other	NOUN
aji-17	226	55	have	have	AUX
aji-17	226	56	observed	observe	VERB
aji-17	226	57	that	that	SCONJ
aji-17	226	58	influenza	influenza	ADJ
aji-17	226	59	infection	infection	NOUN
aji-17	226	60	is	be	AUX
aji-17	226	61	not	not	PART
aji-17	226	62	prevented	prevent	VERB
aji-17	226	63	by	by	ADP
aji-17	226	64	high	high	ADJ
aji-17	226	65	levels	level	NOUN
aji-17	226	66	of	of	ADP
aji-17	226	67	serum	serum	NOUN
aji-17	226	68	antibody	antibody	NOUN
aji-17	226	69	still	still	ADV
aji-17	226	70	investigators	investigator	NOUN
aji-17	226	71	believe	believe	VERB
aji-17	226	72	that	that	SCONJ
aji-17	226	73	serum	serum	NOUN
aji-17	226	74	antibody	antibody	NOUN
aji-17	226	75	correlates	correlate	VERB
aji-17	226	76	with	with	ADP
aji-17	226	77	,	,	PUNCT
aji-17	226	78	but	but	CCONJ
aji-17	226	79	does	do	AUX
aji-17	226	80	not	not	PART
aji-17	226	81	cause	cause	VERB
aji-17	226	82	,	,	PUNCT
aji-17	226	83	protection	protection	NOUN
aji-17	226	84	.	.	PUNCT
aji-17	227	1	cell	cell	NOUN
aji-17	227	2	-	-	PUNCT
aji-17	227	3	mediated	mediate	VERB
aji-17	227	4	immune	immune	ADJ
aji-17	227	5	responses	response	NOUN
aji-17	227	6	are	be	AUX
aji-17	227	7	not	not	PART
aji-17	227	8	only	only	ADV
aji-17	227	9	effective	effective	ADJ
aji-17	227	10	during	during	ADP
aji-17	227	11	acute	acute	ADJ
aji-17	227	12	phase	phase	NOUN
aji-17	227	13	of	of	ADP
aji-17	227	14	viral	viral	ADJ
aji-17	227	15	infection.when	infection.when	NOUN
aji-17	227	16	infected	infect	VERB
aji-17	227	17	cells	cell	NOUN
aji-17	227	18	with	with	ADP
aji-17	227	19	virus	virus	NOUN
aji-17	227	20	are	be	AUX
aji-17	227	21	targeted	target	VERB
aji-17	227	22	by	by	ADP
aji-17	227	23	the	the	DET
aji-17	227	24	cd	cd	PROPN
aji-17	227	25	8	8	NUM
aji-17	227	26	+	+	NOUN
aji-17	227	27	subset	subset	NOUN
aji-17	227	28	of	of	ADP
aji-17	227	29	t	t	PROPN
aji-17	227	30	cell	cell	NOUN
aji-17	227	31	population	population	NOUN
aji-17	227	32	but	but	CCONJ
aji-17	227	33	also	also	ADV
aji-17	227	34	establish	establish	VERB
aji-17	227	35	long	long	ADV
aji-17	227	36	-	-	PUNCT
aji-17	227	37	lived	live	VERB
aji-17	227	38	immunological	immunological	ADJ
aji-17	227	39	memory	memory	NOUN
aji-17	227	40	by	by	ADP
aji-17	227	41	virtue	virtue	NOUN
aji-17	227	42	of	of	ADP
aji-17	227	43	cd	cd	PROPN
aji-17	227	44	4	4	NUM
aji-17	227	45	+	+	NOUN
aji-17	227	46	t	t	NOUN
aji-17	227	47	cells	cell	NOUN
aji-17	227	48	..	..	PUNCT
aji-17	228	1	these	these	DET
aji-17	228	2	memory	memory	NOUN
aji-17	228	3	t	t	PROPN
aji-17	228	4	cells	cell	NOUN
aji-17	228	5	become	become	VERB
aji-17	228	6	rapidly	rapidly	ADV
aji-17	228	7	activated	activate	VERB
aji-17	228	8	if	if	SCONJ
aji-17	228	9	they	they	PRON
aji-17	228	10	re	re	VERB
aji-17	228	11	-	-	VERB
aji-17	228	12	encounter	encounter	ADJ
aji-17	228	13	virally	virally	ADV
aji-17	228	14	infected	infect	VERB
aji-17	228	15	cells	cell	NOUN
aji-17	228	16	and	and	CCONJ
aji-17	228	17	therefore	therefore	ADV
aji-17	228	18	function	function	VERB
aji-17	228	19	to	to	PART
aji-17	228	20	protect	protect	VERB
aji-17	228	21	against	against	ADP
aji-17	228	22	secondary	secondary	ADJ
aji-17	228	23	exposures	exposure	NOUN
aji-17	228	24	to	to	ADP
aji-17	228	25	the	the	DET
aji-17	228	26	original	original	ADJ
aji-17	228	27	viral	viral	ADJ
aji-17	228	28	pathogens	pathogen	NOUN
aji-17	228	29	.	.	PUNCT
aji-17	229	1	it	it	PRON
aji-17	229	2	can	can	AUX
aji-17	229	3	be	be	AUX
aji-17	229	4	host	host	NOUN
aji-17	229	5	damaging	damaging	ADJ
aji-17	229	6	if	if	SCONJ
aji-17	229	7	hypersensitive	hypersensitive	ADJ
aji-17	229	8	reaction	reaction	NOUN
aji-17	229	9	develops	develop	VERB
aji-17	229	10	as	as	ADP
aji-17	229	11	a	a	DET
aji-17	229	12	part	part	NOUN
aji-17	229	13	of	of	ADP
aji-17	229	14	immune	immune	ADJ
aji-17	229	15	reaction	reaction	NOUN
aji-17	229	16	.	.	PUNCT
aji-17	230	1	it	it	PRON
aji-17	230	2	has	have	AUX
aji-17	230	3	also	also	ADV
aji-17	230	4	been	be	AUX
aji-17	230	5	proposed	propose	VERB
aji-17	230	6	that	that	SCONJ
aji-17	230	7	cell	cell	NOUN
aji-17	230	8	-	-	PUNCT
aji-17	230	9	mediated	mediate	VERB
aji-17	230	10	immunity	immunity	NOUN
aji-17	230	11	might	might	AUX
aji-17	230	12	be	be	AUX
aji-17	230	13	important	important	ADJ
aji-17	230	14	in	in	ADP
aji-17	230	15	protection	protection	NOUN
aji-17	230	16	against	against	ADP
aji-17	230	17	viral	viral	ADJ
aji-17	230	18	infections	infection	NOUN
aji-17	230	19	as	as	SCONJ
aji-17	230	20	exemplified	exemplify	VERB
aji-17	230	21	by	by	ADP
aji-17	230	22	the	the	DET
aji-17	230	23	patients	patient	NOUN
aji-17	230	24	with	with	ADP
aji-17	230	25	hypogammaglobulinemia	hypogammaglobulinemia	NOUN
aji-17	230	26	are	be	AUX
aji-17	230	27	not	not	PART
aji-17	230	28	prone	prone	ADJ
aji-17	230	29	to	to	ADP
aji-17	230	30	more	more	ADV
aji-17	230	31	frequent	frequent	ADJ
aji-17	230	32	or	or	CCONJ
aji-17	230	33	severe	severe	ADJ
aji-17	230	34	viral	viral	ADJ
aji-17	230	35	infections	infection	NOUN
aji-17	230	36	.	.	PUNCT
aji-17	231	1	2.1	2.1	NUM
aji-17	231	2	the	the	DET
aji-17	231	3	concept	concept	NOUN
aji-17	231	4	of	of	ADP
aji-17	231	5	local	local	ADJ
aji-17	231	6	immunity	immunity	NOUN
aji-17	231	7	historical	historical	ADJ
aji-17	231	8	perspective	perspective	NOUN
aji-17	231	9	of	of	ADP
aji-17	231	10	the	the	DET
aji-17	231	11	concept	concept	NOUN
aji-17	231	12	of	of	ADP
aji-17	231	13	local	local	ADJ
aji-17	231	14	immunity	immunity	NOUN
aji-17	231	15	[	[	X
aji-17	231	16	5	5	NUM
aji-17	231	17	]	]	PUNCT
aji-17	231	18	:	:	PUNCT
aji-17	231	19	prof	prof	NOUN
aji-17	231	20	besredka	besredka	NOUN
aji-17	231	21	is	be	AUX
aji-17	231	22	the	the	DET
aji-17	231	23	founder	founder	NOUN
aji-17	231	24	of	of	ADP
aji-17	231	25	this	this	DET
aji-17	231	26	type	type	NOUN
aji-17	231	27	of	of	ADP
aji-17	231	28	immunity	immunity	NOUN
aji-17	231	29	.	.	PUNCT
aji-17	232	1	working	work	VERB
aji-17	232	2	in	in	ADP
aji-17	232	3	pasture	pasture	NOUN
aji-17	232	4	institute	institute	NOUN
aji-17	232	5	in	in	ADP
aji-17	232	6	1924	1924	NUM
aji-17	232	7	,	,	PUNCT
aji-17	232	8	he	he	PRON
aji-17	232	9	developed	develop	VERB
aji-17	232	10	his	his	PRON
aji-17	232	11	concept	concept	NOUN
aji-17	232	12	and	and	CCONJ
aji-17	232	13	tested	test	VERB
aji-17	232	14	on	on	ADP
aji-17	232	15	different	different	ADJ
aji-17	232	16	organisms	organism	NOUN
aji-17	232	17	.	.	PUNCT
aji-17	233	1	he	he	PRON
aji-17	233	2	showed	show	VERB
aji-17	233	3	that	that	SCONJ
aji-17	233	4	b	b	NUM
aji-17	233	5	anthracite	anthracite	NOUN
aji-17	233	6	inoculated	inoculate	VERB
aji-17	233	7	intraperitonially	intraperitonially	ADV
aji-17	233	8	in	in	ADP
aji-17	233	9	guinea	guinea	NOUN
aji-17	233	10	pig	pig	NOUN
aji-17	233	11	neither	neither	CCONJ
aji-17	233	12	produced	produce	VERB
aji-17	233	13	antibodies	antibody	NOUN
aji-17	233	14	in	in	ADP
aji-17	233	15	the	the	DET
aji-17	233	16	blood	blood	NOUN
aji-17	233	17	nor	nor	CCONJ
aji-17	233	18	protected	protect	VERB
aji-17	233	19	the	the	DET
aji-17	233	20	animal	animal	NOUN
aji-17	233	21	from	from	ADP
aji-17	233	22	subsequent	subsequent	ADJ
aji-17	233	23	challenge	challenge	NOUN
aji-17	233	24	with	with	ADP
aji-17	233	25	the	the	DET
aji-17	233	26	live	live	ADJ
aji-17	233	27	virus	virus	NOUN
aji-17	233	28	.	.	PUNCT
aji-17	234	1	age	age	NOUN
aji-17	234	2	also	also	ADV
aji-17	234	3	proved	prove	VERB
aji-17	234	4	that	that	SCONJ
aji-17	234	5	the	the	DET
aji-17	234	6	organism	organism	NOUN
aji-17	234	7	when	when	SCONJ
aji-17	234	8	applied	apply	VERB
aji-17	234	9	to	to	ADP
aji-17	234	10	the	the	DET
aji-17	234	11	skin	skin	NOUN
aji-17	234	12	,	,	PUNCT
aji-17	234	13	though	though	SCONJ
aji-17	234	14	it	it	PRON
aji-17	234	15	did	do	AUX
aji-17	234	16	not	not	PART
aji-17	234	17	also	also	ADV
aji-17	234	18	develop	develop	VERB
aji-17	234	19	any	any	DET
aji-17	234	20	antibodies	antibody	NOUN
aji-17	234	21	,	,	PUNCT
aji-17	234	22	protected	protect	VERB
aji-17	234	23	the	the	DET
aji-17	234	24	animal	animal	NOUN
aji-17	234	25	from	from	ADP
aji-17	234	26	subsequent	subsequent	ADJ
aji-17	234	27	challenge	challenge	NOUN
aji-17	234	28	with	with	ADP
aji-17	234	29	the	the	DET
aji-17	234	30	microorganism	microorganism	NOUN
aji-17	234	31	.	.	PUNCT
aji-17	235	1	this	this	DET
aji-17	235	2	study	study	NOUN
aji-17	235	3	has	have	AUX
aji-17	235	4	driven	drive	VERB
aji-17	235	5	home	home	NOUN
aji-17	235	6	two	two	NUM
aji-17	235	7	truths	truth	NOUN
aji-17	235	8	.	.	PUNCT
aji-17	236	1	one	one	NUM
aji-17	236	2	,	,	PUNCT
aji-17	236	3	that	that	SCONJ
aji-17	236	4	immunity	immunity	NOUN
aji-17	236	5	against	against	ADP
aji-17	236	6	the	the	DET
aji-17	236	7	infection	infection	NOUN
aji-17	236	8	can	can	AUX
aji-17	236	9	be	be	AUX
aji-17	236	10	achieved	achieve	VERB
aji-17	236	11	even	even	ADV
aji-17	236	12	in	in	ADP
aji-17	236	13	the	the	DET
aji-17	236	14	absence	absence	NOUN
aji-17	236	15	of	of	ADP
aji-17	236	16	raising	raise	VERB
aji-17	236	17	antibodies	antibody	NOUN
aji-17	236	18	against	against	ADP
aji-17	236	19	it	it	PRON
aji-17	236	20	.	.	PUNCT
aji-17	237	1	second	second	ADV
aji-17	237	2	,	,	PUNCT
aji-17	237	3	vaccinating	vaccinate	VERB
aji-17	237	4	the	the	DET
aji-17	237	5	site	site	NOUN
aji-17	237	6	which	which	PRON
aji-17	237	7	is	be	AUX
aji-17	237	8	the	the	DET
aji-17	237	9	portal	portal	NOUN
aji-17	237	10	of	of	ADP
aji-17	237	11	entry	entry	NOUN
aji-17	237	12	of	of	ADP
aji-17	237	13	the	the	DET
aji-17	237	14	micro	micro	PROPN
aji-17	237	15	organism	organism	NOUN
aji-17	237	16	conferred	confer	VERB
aji-17	237	17	immunity	immunity	NOUN
aji-17	237	18	,	,	PUNCT
aji-17	237	19	independent	independent	ADJ
aji-17	237	20	of	of	ADP
aji-17	237	21	humoral	humoral	ADJ
aji-17	237	22	immunity	immunity	NOUN
aji-17	237	23	.	.	PUNCT
aji-17	238	1	this	this	DET
aji-17	238	2	type	type	NOUN
aji-17	238	3	of	of	ADP
aji-17	238	4	immunity	immunity	NOUN
aji-17	238	5	,	,	PUNCT
aji-17	238	6	he	he	PRON
aji-17	238	7	called	call	VERB
aji-17	238	8	as	as	ADP
aji-17	238	9	"	"	PUNCT
aji-17	238	10	local	local	ADJ
aji-17	238	11	immunity	immunity	NOUN
aji-17	238	12	"	"	PUNCT
aji-17	238	13	.	.	PUNCT
aji-17	239	1	2.2	2.2	NUM
aji-17	239	2	review	review	NOUN
aji-17	239	3	of	of	ADP
aji-17	239	4	some	some	PRON
aji-17	239	5	of	of	ADP
aji-17	239	6	the	the	DET
aji-17	239	7	diseases	disease	NOUN
aji-17	239	8	to	to	PART
aji-17	239	9	which	which	PRON
aji-17	239	10	the	the	DET
aji-17	239	11	concept	concept	NOUN
aji-17	239	12	of	of	ADP
aji-17	239	13	local	local	ADJ
aji-17	239	14	immunity	immunity	NOUN
aji-17	239	15	is	be	AUX
aji-17	239	16	applied	apply	VERB
aji-17	239	17	and	and	CCONJ
aji-17	239	18	tested	test	VERB
aji-17	239	19	2.2.1	2.2.1	NUM
aji-17	239	20	local	local	ADJ
aji-17	239	21	immunity	immunity	NOUN
aji-17	239	22	in	in	ADP
aji-17	239	23	polio	polio	NOUN
aji-17	239	24	virus	virus	NOUN
aji-17	239	25	infection	infection	NOUN
aji-17	239	26	[	[	X
aji-17	239	27	6	6	NUM
aji-17	239	28	]	]	PUNCT
aji-17	239	29	the	the	DET
aji-17	239	30	salk	salk	NOUN
aji-17	239	31	polio	polio	NOUN
aji-17	239	32	vaccine	vaccine	NOUN
aji-17	239	33	,	,	PUNCT
aji-17	239	34	which	which	PRON
aji-17	239	35	consists	consist	VERB
aji-17	239	36	of	of	ADP
aji-17	239	37	killed	kill	VERB
aji-17	239	38	virus	virus	NOUN
aji-17	239	39	administered	administer	VERB
aji-17	239	40	systemically	systemically	ADV
aji-17	239	41	,	,	PUNCT
aji-17	239	42	elicits	elicit	VERB
aji-17	239	43	serum	serum	NOUN
aji-17	239	44	igg	igg	PROPN
aji-17	239	45	as	as	ADP
aji-17	239	46	the	the	DET
aji-17	239	47	major	major	ADJ
aji-17	239	48	antibody	antibody	NOUN
aji-17	239	49	and	and	CCONJ
aji-17	239	50	induces	induce	VERB
aji-17	239	51	little	little	ADJ
aji-17	239	52	or	or	CCONJ
aji-17	239	53	no	no	PRON
aji-17	239	54	secretory	secretory	ADJ
aji-17	239	55	response	response	NOUN
aji-17	239	56	.	.	PUNCT
aji-17	240	1	as	as	ADP
aji-17	240	2	a	a	DET
aji-17	240	3	result	result	NOUN
aji-17	240	4	,	,	PUNCT
aji-17	240	5	the	the	DET
aji-17	240	6	immunized	immunize	VERB
aji-17	240	7	individual	individual	ADJ
aji-17	240	8	resists	resist	NOUN
aji-17	240	9	systemic	systemic	ADJ
aji-17	240	10	infection	infection	NOUN
aji-17	240	11	,	,	PUNCT
aji-17	240	12	but	but	CCONJ
aji-17	240	13	may	may	AUX
aji-17	240	14	become	become	VERB
aji-17	240	15	a	a	DET
aji-17	240	16	temporary	temporary	ADJ
aji-17	240	17	carrier	carrier	NOUN
aji-17	240	18	,	,	PUNCT
aji-17	240	19	with	with	ADP
aji-17	240	20	virus	virus	NOUN
aji-17	240	21	persisting	persist	VERB
aji-17	240	22	at	at	ADP
aji-17	240	23	the	the	DET
aji-17	240	24	intestinal	intestinal	ADJ
aji-17	240	25	portal	portal	NOUN
aji-17	240	26	of	of	ADP
aji-17	240	27	entry	entry	NOUN
aji-17	240	28	because	because	SCONJ
aji-17	240	29	of	of	ADP
aji-17	240	30	the	the	DET
aji-17	240	31	lack	lack	NOUN
aji-17	240	32	of	of	ADP
aji-17	240	33	secretory	secretory	ADJ
aji-17	240	34	antibody	antibody	NOUN
aji-17	240	35	.	.	PUNCT
aji-17	241	1	the	the	DET
aji-17	241	2	orally	orally	ADV
aji-17	241	3	administered	administer	VERB
aji-17	241	4	,	,	PUNCT
aji-17	241	5	live	live	ADJ
aji-17	241	6	sabin	sabin	NOUN
aji-17	241	7	polio	polio	NOUN
aji-17	241	8	vaccine	vaccine	NOUN
aji-17	241	9	,	,	PUNCT
aji-17	241	10	on	on	ADP
aji-17	241	11	the	the	DET
aji-17	241	12	other	other	ADJ
aji-17	241	13	hand	hand	NOUN
aji-17	241	14	,	,	PUNCT
aji-17	241	15	induces	induce	VERB
aji-17	241	16	secretory	secretory	ADJ
aji-17	241	17	antibody	antibody	NOUN
aji-17	241	18	in	in	ADP
aji-17	241	19	the	the	DET
aji-17	241	20	intestine	intestine	NOUN
aji-17	241	21	and	and	CCONJ
aji-17	241	22	is	be	AUX
aji-17	241	23	effective	effective	ADJ
aji-17	241	24	in	in	ADP
aji-17	241	25	preventing	prevent	VERB
aji-17	241	26	replication	replication	NOUN
aji-17	241	27	and	and	CCONJ
aji-17	241	28	subsequent	subsequent	ADJ
aji-17	241	29	mucosal	mucosal	NOUN
aji-17	241	30	penetration	penetration	NOUN
aji-17	241	31	by	by	ADP
aji-17	241	32	the	the	DET
aji-17	241	33	virus	virus	NOUN
aji-17	241	34	.	.	PUNCT
aji-17	242	1	however	however	ADV
aji-17	242	2	us	we	PRON
aji-17	242	3	stopped	stop	VERB
aji-17	242	4	opv	opv	PROPN
aji-17	242	5	in	in	ADP
aji-17	242	6	favour	favour	NOUN
aji-17	242	7	of	of	ADP
aji-17	242	8	ipv	ipv	PROPN
aji-17	242	9	(	(	PUNCT
aji-17	242	10	inactivated	inactivated	ADJ
aji-17	242	11	polio	polio	NOUN
aji-17	242	12	vaccine	vaccine	NOUN
aji-17	242	13	)	)	PUNCT
aji-17	242	14	to	to	PART
aji-17	242	15	prevent	prevent	VERB
aji-17	242	16	resurgence	resurgence	NOUN
aji-17	242	17	of	of	ADP
aji-17	242	18	type	type	NOUN
aji-17	242	19	2	2	NUM
aji-17	242	20	polio	polio	NOUN
aji-17	242	21	virus	virus	NOUN
aji-17	242	22	.	.	PUNCT
aji-17	243	1	2.2.2	2.2.2	NUM
aji-17	243	2	local	local	ADJ
aji-17	243	3	immunity	immunity	NOUN
aji-17	243	4	in	in	ADP
aji-17	243	5	the	the	DET
aji-17	243	6	influenza	influenza	NOUN
aji-17	243	7	virus	virus	NOUN
aji-17	243	8	infection	infection	NOUN
aji-17	243	9	influenza	influenza	NOUN
aji-17	243	10	infection	infection	NOUN
aji-17	243	11	of	of	ADP
aji-17	243	12	the	the	DET
aji-17	243	13	ferret	ferret	NOUN
aji-17	243	14	resembles	resemble	VERB
aji-17	243	15	the	the	DET
aji-17	243	16	disease	disease	NOUN
aji-17	243	17	in	in	ADP
aji-17	243	18	the	the	DET
aji-17	243	19	human	human	NOUN
aji-17	243	20	,	,	PUNCT
aji-17	243	21	[	[	X
aji-17	243	22	7	7	X
aji-17	243	23	]	]	PUNCT
aji-17	243	24	and	and	CCONJ
aji-17	243	25	has	have	AUX
aji-17	243	26	been	be	AUX
aji-17	243	27	studied	study	VERB
aji-17	243	28	extensively	extensively	ADV
aji-17	243	29	by	by	ADP
aji-17	243	30	henry	henry	PROPN
aji-17	243	31	barber	barber	PROPN
aji-17	243	32	and	and	CCONJ
aji-17	243	33	parker	parker	PROPN
aji-17	243	34	a.	a.	PROPN
aji-17	243	35	small	small	PROPN
aji-17	243	36	,	,	PUNCT
aji-17	243	37	jr	jr	PROPN
aji-17	243	38	,	,	PUNCT
aji-17	243	39	who	who	PRON
aji-17	243	40	showed	show	VERB
aji-17	243	41	that	that	SCONJ
aji-17	243	42	influenza	influenza	ADJ
aji-17	243	43	infection	infection	NOUN
aji-17	243	44	in	in	ADP
aji-17	243	45	the	the	DET
aji-17	243	46	ferret	ferret	NOUN
aji-17	243	47	is	be	AUX
aji-17	243	48	a	a	DET
aji-17	243	49	local	local	ADJ
aji-17	243	50	phenomenon	phenomenon	NOUN
aji-17	243	51	,	,	PUNCT
aji-17	243	52	whereas	whereas	SCONJ
aji-17	243	53	recovery	recovery	NOUN
aji-17	243	54	from	from	ADP
aji-17	243	55	active	active	ADJ
aji-17	243	56	infection	infection	NOUN
aji-17	243	57	is	be	AUX
aji-17	243	58	influenced	influence	VERB
aji-17	243	59	by	by	ADP
aji-17	243	60	systemic	systemic	ADJ
aji-17	243	61	immune	immune	ADJ
aji-17	243	62	mechanism	mechanism	NOUN
aji-17	243	63	"	"	PUNCT
aji-17	243	64	[	[	X
aji-17	243	65	8	8	NUM
aji-17	243	66	]	]	PUNCT
aji-17	243	67	.	.	PUNCT
aji-17	244	1	several	several	ADJ
aji-17	244	2	workers	worker	NOUN
aji-17	244	3	[	[	X
aji-17	244	4	9,10,11	9,10,11	NOUN
aji-17	244	5	]	]	PUNCT
aji-17	244	6	have	have	AUX
aji-17	244	7	shown	show	VERB
aji-17	244	8	that	that	DET
aji-17	244	9	natural	natural	ADJ
aji-17	244	10	infection	infection	NOUN
aji-17	244	11	with	with	ADP
aji-17	244	12	respiratory	respiratory	ADJ
aji-17	244	13	viruses	virus	NOUN
aji-17	244	14	stimulates	stimulate	VERB
aji-17	244	15	the	the	DET
aji-17	244	16	production	production	NOUN
aji-17	244	17	of	of	ADP
aji-17	244	18	immunoglobulin	immunoglobulin	NOUN
aji-17	244	19	a	a	DET
aji-17	244	20	antibodies	antibody	NOUN
aji-17	244	21	in	in	ADP
aji-17	244	22	secretions	secretion	NOUN
aji-17	244	23	and	and	CCONJ
aji-17	244	24	leads	lead	VERB
aji-17	244	25	to	to	ADP
aji-17	244	26	resistance	resistance	NOUN
aji-17	244	27	to	to	ADP
aji-17	244	28	reinfection	reinfection	NOUN
aji-17	244	29	,	,	PUNCT
aji-17	244	30	it	it	PRON
aji-17	244	31	has	have	AUX
aji-17	244	32	been	be	AUX
aji-17	244	33	postulated	postulate	VERB
aji-17	244	34	that	that	SCONJ
aji-17	244	35	a	a	DET
aji-17	244	36	vaccine	vaccine	NOUN
aji-17	244	37	’s	’s	PART
aji-17	244	38	ability	ability	NOUN
aji-17	244	39	to	to	PART
aji-17	244	40	stimulate	stimulate	VERB
aji-17	244	41	nasal	nasal	PROPN
aji-17	244	42	secretary	secretary	NOUN
aji-17	244	43	antibody	antibody	NOUN
aji-17	244	44	is	be	AUX
aji-17	244	45	the	the	DET
aji-17	244	46	deciding	decide	VERB
aji-17	244	47	factor	factor	NOUN
aji-17	244	48	in	in	ADP
aji-17	244	49	protection	protection	NOUN
aji-17	244	50	of	of	ADP
aji-17	244	51	humans	human	NOUN
aji-17	244	52	against	against	ADP
aji-17	244	53	influenza	influenza	NOUN
aji-17	244	54	infection	infection	NOUN
aji-17	244	55	,	,	PUNCT
aji-17	244	56	and	and	CCONJ
aji-17	244	57	some	some	DET
aji-17	244	58	prasad	prasad	NOUN
aji-17	244	59	;	;	PUNCT
aji-17	244	60	aji	aji	NOUN
aji-17	244	61	,	,	PUNCT
aji-17	244	62	3(1	3(1	NUM
aji-17	244	63	):	):	PUNCT
aji-17	244	64	61	61	NUM
aji-17	244	65	-	-	SYM
aji-17	244	66	70	70	NUM
aji-17	244	67	,	,	PUNCT
aji-17	244	68	2020	2020	NUM
aji-17	244	69	;	;	PUNCT
aji-17	244	70	article	article	NOUN
aji-17	244	71	no.aji.55881	no.aji.55881	ADP
aji-17	244	72	66	66	NUM
aji-17	244	73	field	field	NOUN
aji-17	244	74	trials	trial	NOUN
aji-17	244	75	of	of	ADP
aji-17	244	76	local	local	ADJ
aji-17	244	77	immunization	immunization	NOUN
aji-17	244	78	gave	give	VERB
aji-17	244	79	promising	promising	ADJ
aji-17	244	80	results	result	NOUN
aji-17	244	81	.	.	PUNCT
aji-17	245	1	[	[	X
aji-17	245	2	12,13,14,15	12,13,14,15	NUM
aji-17	245	3	]	]	PUNCT
aji-17	245	4	.	.	PUNCT
aji-17	246	1	on	on	ADP
aji-17	246	2	the	the	DET
aji-17	246	3	contrary	contrary	NOUN
aji-17	246	4	,	,	PUNCT
aji-17	246	5	trial	trial	NOUN
aji-17	246	6	of	of	ADP
aji-17	246	7	local	local	ADJ
aji-17	246	8	immunization	immunization	NOUN
aji-17	246	9	[	[	X
aji-17	246	10	16	16	NUM
aji-17	246	11	]	]	PUNCT
aji-17	246	12	as	as	ADV
aji-17	246	13	well	well	ADV
aji-17	246	14	as	as	ADP
aji-17	246	15	attempts	attempt	NOUN
aji-17	246	16	to	to	PART
aji-17	246	17	correlate	correlate	VERB
aji-17	246	18	secretary	secretary	NOUN
aji-17	246	19	immunoglobulin	immunoglobulin	NOUN
aji-17	246	20	a	a	DET
aji-17	246	21	antibody	antibody	NOUN
aji-17	246	22	with	with	ADP
aji-17	246	23	protection	protection	NOUN
aji-17	246	24	[	[	X
aji-17	246	25	17	17	NUM
aji-17	246	26	]	]	PUNCT
aji-17	246	27	was	be	AUX
aji-17	246	28	unsuccessful	unsuccessful	ADJ
aji-17	246	29	.	.	PUNCT
aji-17	247	1	the	the	DET
aji-17	247	2	study	study	NOUN
aji-17	247	3	suggested	suggest	VERB
aji-17	247	4	that	that	SCONJ
aji-17	247	5	srum	srum	ADJ
aji-17	247	6	antibody	antibody	NOUN
aji-17	247	7	was	be	AUX
aji-17	247	8	irrelevant	irrelevant	ADJ
aji-17	247	9	to	to	ADP
aji-17	247	10	prevention	prevention	NOUN
aji-17	247	11	of	of	ADP
aji-17	247	12	influenza	influenza	NOUN
aji-17	247	13	and	and	CCONJ
aji-17	247	14	recovery	recovery	NOUN
aji-17	247	15	from	from	ADP
aji-17	247	16	influenza	influenza	NOUN
aji-17	247	17	in	in	ADP
aji-17	247	18	the	the	DET
aji-17	247	19	ferret	ferret	NOUN
aji-17	248	1	[	[	X
aji-17	248	2	18	18	NUM
aji-17	248	3	]	]	PUNCT
aji-17	248	4	.	.	PUNCT
aji-17	249	1	antibodies	antibody	NOUN
aji-17	249	2	directed	direct	VERB
aji-17	249	3	to	to	ADP
aji-17	249	4	the	the	DET
aji-17	249	5	2	2	NUM
aji-17	249	6	major	major	ADJ
aji-17	249	7	viral	viral	ADJ
aji-17	249	8	surface	surface	NOUN
aji-17	249	9	membrane	membrane	NOUN
aji-17	249	10	proteins	protein	NOUN
aji-17	249	11	,	,	PUNCT
aji-17	249	12	hemagglutinin	hemagglutinin	X
aji-17	249	13	(	(	PUNCT
aji-17	249	14	ha	ha	INTJ
aji-17	249	15	)	)	PUNCT
aji-17	249	16	and	and	CCONJ
aji-17	249	17	neuraminidase	neuraminidase	NOUN
aji-17	249	18	(	(	PUNCT
aji-17	249	19	na	na	NOUN
aji-17	249	20	)	)	PUNCT
aji-17	249	21	,	,	PUNCT
aji-17	249	22	mediate	mediate	VERB
aji-17	249	23	protection	protection	NOUN
aji-17	249	24	against	against	ADP
aji-17	249	25	reinfection	reinfection	NOUN
aji-17	249	26	following	follow	VERB
aji-17	249	27	natural	natural	ADJ
aji-17	249	28	infection	infection	NOUN
aji-17	249	29	or	or	CCONJ
aji-17	249	30	vaccination	vaccination	NOUN
aji-17	249	31	.	.	PUNCT
aji-17	250	1	some	some	DET
aji-17	250	2	investigators	investigator	NOUN
aji-17	250	3	have	have	AUX
aji-17	250	4	suggested	suggest	VERB
aji-17	250	5	that	that	SCONJ
aji-17	250	6	serum	serum	NOUN
aji-17	250	7	antibody	antibody	NOUN
aji-17	250	8	is	be	AUX
aji-17	250	9	responsible	responsible	ADJ
aji-17	250	10	for	for	ADP
aji-17	250	11	protection	protection	NOUN
aji-17	250	12	in	in	ADP
aji-17	250	13	the	the	DET
aji-17	250	14	human	human	NOUN
aji-17	250	15	,	,	PUNCT
aji-17	250	16	[	[	X
aji-17	250	17	19	19	NUM
aji-17	250	18	]	]	X
aji-17	250	19	others	other	NOUN
aji-17	250	20	have	have	AUX
aji-17	250	21	observed	observe	VERB
aji-17	250	22	that	that	SCONJ
aji-17	250	23	influenza	influenza	ADJ
aji-17	250	24	infection	infection	NOUN
aji-17	250	25	is	be	AUX
aji-17	250	26	not	not	PART
aji-17	250	27	prevented	prevent	VERB
aji-17	250	28	by	by	ADP
aji-17	250	29	high	high	ADJ
aji-17	250	30	levels	level	NOUN
aji-17	250	31	of	of	ADP
aji-17	250	32	serum	serum	NOUN
aji-17	250	33	antibody	antibody	NOUN
aji-17	250	34	[	[	X
aji-17	250	35	20	20	NUM
aji-17	250	36	]	]	PUNCT
aji-17	250	37	.	.	PUNCT
aji-17	251	1	several	several	ADJ
aji-17	251	2	investigators	investigator	NOUN
aji-17	251	3	believe	believe	VERB
aji-17	251	4	that	that	SCONJ
aji-17	251	5	serum	serum	NOUN
aji-17	251	6	antibody	antibody	NOUN
aji-17	251	7	correlates	correlate	VERB
aji-17	251	8	with	with	ADP
aji-17	251	9	,	,	PUNCT
aji-17	251	10	but	but	CCONJ
aji-17	251	11	does	do	AUX
aji-17	251	12	not	not	PART
aji-17	251	13	cause	cause	VERB
aji-17	251	14	,	,	PUNCT
aji-17	251	15	protection	protection	NOUN
aji-17	251	16	[	[	X
aji-17	251	17	21	21	NUM
aji-17	251	18	]	]	PUNCT
aji-17	251	19	.	.	PUNCT
aji-17	252	1	the	the	DET
aji-17	252	2	lack	lack	NOUN
aji-17	252	3	of	of	ADP
aji-17	252	4	virus	virus	NOUN
aji-17	252	5	dissemination	dissemination	NOUN
aji-17	252	6	is	be	AUX
aji-17	252	7	consistent	consistent	ADJ
aji-17	252	8	with	with	ADP
aji-17	252	9	the	the	DET
aji-17	252	10	inability	inability	NOUN
aji-17	252	11	to	to	PART
aji-17	252	12	detect	detect	VERB
aji-17	252	13	viremia	viremia	NOUN
aji-17	252	14	during	during	ADP
aji-17	252	15	influenza	influenza	ADJ
aji-17	252	16	infection	infection	NOUN
aji-17	252	17	of	of	ADP
aji-17	252	18	ferrets	ferret	NOUN
aji-17	252	19	and	and	CCONJ
aji-17	252	20	humans	human	NOUN
aji-17	252	21	[	[	X
aji-17	252	22	22	22	NUM
aji-17	252	23	]	]	PUNCT
aji-17	252	24	.	.	PUNCT
aji-17	253	1	mucosal	mucosal	NOUN
aji-17	253	2	immunity	immunity	NOUN
aji-17	253	3	in	in	ADP
aji-17	253	4	shigella	shigella	PROPN
aji-17	253	5	et	et	PROPN
aji-17	253	6	al	al	PROPN
aji-17	253	7	.	.	PUNCT
aji-17	254	1	[	[	X
aji-17	254	2	23	23	NUM
aji-17	254	3	]	]	PUNCT
aji-17	254	4	explored	explore	VERB
aji-17	254	5	the	the	DET
aji-17	254	6	mechanisms	mechanism	NOUN
aji-17	254	7	of	of	ADP
aji-17	254	8	protection	protection	NOUN
aji-17	254	9	mediated	mediate	VERB
aji-17	254	10	by	by	ADP
aji-17	254	11	shigella	shigella	PROPN
aji-17	254	12	lps	lps	PROPN
aji-17	254	13	-	-	PUNCT
aji-17	254	14	specific	specific	ADJ
aji-17	254	15	secretory	secretory	NOUN
aji-17	254	16	iga	iga	PROPN
aji-17	254	17	(	(	PUNCT
aji-17	254	18	siga	siga	PROPN
aji-17	254	19	)	)	PUNCT
aji-17	254	20	,	,	PUNCT
aji-17	254	21	the	the	DET
aji-17	254	22	major	major	ADJ
aji-17	254	23	mucosal	mucosal	NOUN
aji-17	254	24	ab	ab	NOUN
aji-17	254	25	(	(	PUNCT
aji-17	254	26	antibody	antibody	NOUN
aji-17	254	27	)	)	PUNCT
aji-17	254	28	induced	induce	VERB
aji-17	254	29	upon	upon	SCONJ
aji-17	254	30	natural	natural	ADJ
aji-17	254	31	infection	infection	NOUN
aji-17	254	32	.	.	PUNCT
aji-17	255	1	they	they	PRON
aji-17	255	2	found	find	VERB
aji-17	255	3	that	that	SCONJ
aji-17	255	4	anti	anti	ADJ
aji-17	255	5	-	-	ADJ
aji-17	255	6	shigella	shigella	ADJ
aji-17	255	7	lps	lps	PROPN
aji-17	255	8	siga	siga	PROPN
aji-17	255	9	,	,	PUNCT
aji-17	255	10	mainly	mainly	ADV
aji-17	255	11	via	via	ADP
aji-17	255	12	immune	immune	ADJ
aji-17	255	13	exclusion	exclusion	NOUN
aji-17	255	14	,	,	PUNCT
aji-17	255	15	prevented	prevent	VERB
aji-17	255	16	shigella	shigella	ADV
aji-17	255	17	-	-	PUNCT
aji-17	255	18	induced	induce	VERB
aji-17	255	19	inflammation	inflammation	NOUN
aji-17	255	20	responsible	responsible	ADJ
aji-17	255	21	for	for	ADP
aji-17	255	22	the	the	DET
aji-17	255	23	destruction	destruction	NOUN
aji-17	255	24	of	of	ADP
aji-17	255	25	the	the	DET
aji-17	255	26	intestinal	intestinal	ADJ
aji-17	255	27	barrier	barrier	NOUN
aji-17	255	28	.	.	PUNCT
aji-17	256	1	in	in	ADP
aji-17	256	2	the	the	DET
aji-17	256	3	form	form	NOUN
aji-17	256	4	of	of	ADP
aji-17	256	5	immune	immune	ADJ
aji-17	256	6	complexes	complex	NOUN
aji-17	256	7	,	,	PUNCT
aji-17	256	8	siga	siga	PROPN
aji-17	256	9	guarantees	guarantee	VERB
aji-17	256	10	both	both	DET
aji-17	256	11	immune	immune	ADJ
aji-17	256	12	exclusion	exclusion	NOUN
aji-17	256	13	and	and	CCONJ
aji-17	256	14	neutralization	neutralization	NOUN
aji-17	256	15	of	of	ADP
aji-17	256	16	translocated	translocated	ADJ
aji-17	256	17	bacteria	bacteria	NOUN
aji-17	256	18	,	,	PUNCT
aji-17	256	19	thus	thus	ADV
aji-17	256	20	preserving	preserve	VERB
aji-17	256	21	the	the	DET
aji-17	256	22	intestinal	intestinal	ADJ
aji-17	256	23	barrier	barrier	NOUN
aji-17	256	24	integrity	integrity	NOUN
aji-17	256	25	by	by	ADP
aji-17	256	26	preventing	prevent	VERB
aji-17	256	27	bacterial	bacterial	ADJ
aji-17	256	28	-	-	PUNCT
aji-17	256	29	induced	induced	ADJ
aji-17	256	30	inflammation	inflammation	NOUN
aji-17	256	31	.	.	PUNCT
aji-17	257	1	these	these	DET
aji-17	257	2	findings	finding	NOUN
aji-17	257	3	add	add	VERB
aji-17	257	4	to	to	ADP
aji-17	257	5	the	the	DET
aji-17	257	6	multiple	multiple	ADJ
aji-17	257	7	facets	facet	NOUN
aji-17	257	8	of	of	ADP
aji-17	257	9	the	the	DET
aji-17	257	10	non	non	ADJ
aji-17	257	11	inflammatory	inflammatory	ADJ
aji-17	257	12	properties	property	NOUN
aji-17	257	13	of	of	ADP
aji-17	257	14	siga	siga	PROPN
aji-17	257	15	.	.	PUNCT
aji-17	258	1	2.2.3	2.2.3	NUM
aji-17	258	2	mucosal	mucosal	NOUN
aji-17	258	3	immunity	immunity	NOUN
aji-17	258	4	in	in	ADP
aji-17	258	5	infection	infection	NOUN
aji-17	258	6	by	by	ADP
aji-17	258	7	v.	v.	ADP
aji-17	258	8	cholerae	cholerae	PROPN
aji-17	259	1	[	[	X
aji-17	259	2	24	24	NUM
aji-17	259	3	]	]	PUNCT
aji-17	259	4	bloom	bloom	NOUN
aji-17	259	5	pd	pd	PROPN
aji-17	259	6	,	,	PUNCT
aji-17	259	7	et	et	PROPN
aji-17	259	8	al	al	PROPN
aji-17	259	9	.	.	PUNCT
aji-17	259	10	reviewing	review	VERB
aji-17	259	11	the	the	DET
aji-17	259	12	mucosal	mucosal	NOUN
aji-17	259	13	immunity	immunity	NOUN
aji-17	259	14	against	against	ADP
aji-17	259	15	enteric	enteric	ADJ
aji-17	259	16	bacterial	bacterial	ADJ
aji-17	259	17	pathogens	pathogen	NOUN
aji-17	259	18	states	state	VERB
aji-17	259	19	that	that	SCONJ
aji-17	259	20	"	"	PUNCT
aji-17	259	21	v	v	ADP
aji-17	259	22	cholerae	cholerae	NOUN
aji-17	259	23	,	,	PUNCT
aji-17	259	24	secretes	secrete	VERB
aji-17	259	25	cholera	cholera	NOUN
aji-17	259	26	toxin	toxin	NOUN
aji-17	259	27	(	(	PUNCT
aji-17	259	28	ct	ct	PROPN
aji-17	259	29	)	)	PUNCT
aji-17	259	30	,	,	PUNCT
aji-17	259	31	a	a	DET
aji-17	259	32	potent	potent	ADJ
aji-17	259	33	enterotoxin	enterotoxin	NOUN
aji-17	259	34	that	that	PRON
aji-17	259	35	induces	induce	VERB
aji-17	259	36	a	a	DET
aji-17	259	37	voluminous	voluminous	ADJ
aji-17	259	38	diarrhea	diarrhea	NOUN
aji-17	259	39	via	via	ADP
aji-17	259	40	adenylate	adenylate	ADJ
aji-17	259	41	cyclase	cyclase	NOUN
aji-17	259	42	-	-	PUNCT
aji-17	259	43	dependent	dependent	ADJ
aji-17	259	44	chloride	chloride	NOUN
aji-17	259	45	secretion	secretion	NOUN
aji-17	259	46	.	.	PUNCT
aji-17	260	1	protective	protective	ADJ
aji-17	260	2	immunity	immunity	NOUN
aji-17	260	3	is	be	AUX
aji-17	260	4	based	base	VERB
aji-17	260	5	on	on	ADP
aji-17	260	6	secretory	secretory	NOUN
aji-17	260	7	(	(	PUNCT
aji-17	260	8	s	s	NOUN
aji-17	260	9	)	)	PUNCT
aji-17	260	10	immunoglobulin	immunoglobulin	NOUN
aji-17	260	11	a	a	DET
aji-17	260	12	directed	direct	VERB
aji-17	260	13	against	against	ADP
aji-17	260	14	whole	whole	ADJ
aji-17	260	15	-	-	PUNCT
aji-17	260	16	cell	cell	NOUN
aji-17	260	17	components	component	NOUN
aji-17	260	18	that	that	PRON
aji-17	260	19	prevent	prevent	VERB
aji-17	260	20	attachment	attachment	NOUN
aji-17	260	21	to	to	PART
aji-17	260	22	gut	gut	VERB
aji-17	260	23	epithelial	epithelial	ADJ
aji-17	260	24	cells	cell	NOUN
aji-17	260	25	and	and	CCONJ
aji-17	260	26	is	be	AUX
aji-17	260	27	enhanced	enhance	VERB
aji-17	260	28	by	by	ADP
aji-17	260	29	ct	ct	PROPN
aji-17	260	30	,	,	PUNCT
aji-17	260	31	an	an	DET
aji-17	260	32	immunogen	immunogen	NOUN
aji-17	260	33	with	with	ADP
aji-17	260	34	potent	potent	ADJ
aji-17	260	35	adjuvant	adjuvant	ADJ
aji-17	260	36	activity	activity	NOUN
aji-17	260	37	"	"	PUNCT
aji-17	260	38	.	.	PUNCT
aji-17	261	1	mycoplasma	mycoplasma	NOUN
aji-17	261	2	and	and	CCONJ
aji-17	261	3	local	local	ADJ
aji-17	261	4	immunity	immunity	NOUN
aji-17	261	5	:	:	PUNCT
aji-17	261	6	lisa	lisa	PROPN
aji-17	261	7	m.	m.	PROPN
aji-17	261	8	hodge	hodge	PROPN
aji-17	261	9	,	,	PUNCT
aji-17	261	10	jerry	jerry	PROPN
aji-17	261	11	w.	w.	PROPN
aji-17	261	12	simecka	simecka	PROPN
aji-17	261	13	et	et	PROPN
aji-17	261	14	al	al	PROPN
aji-17	261	15	.	.	PUNCT
aji-17	262	1	[	[	X
aji-17	262	2	25	25	NUM
aji-17	262	3	]	]	PUNCT
aji-17	262	4	in	in	ADP
aji-17	262	5	their	their	PRON
aji-17	262	6	study	study	NOUN
aji-17	262	7	concluded	conclude	VERB
aji-17	262	8	that	that	SCONJ
aji-17	262	9	"	"	PUNCT
aji-17	262	10	local	local	ADJ
aji-17	262	11	immunity	immunity	NOUN
aji-17	262	12	along	along	ADP
aji-17	262	13	the	the	DET
aji-17	262	14	respiratory	respiratory	ADJ
aji-17	262	15	tract	tract	NOUN
aji-17	262	16	plays	play	VERB
aji-17	262	17	a	a	DET
aji-17	262	18	major	major	ADJ
aji-17	262	19	role	role	NOUN
aji-17	262	20	in	in	ADP
aji-17	262	21	resisting	resist	VERB
aji-17	262	22	and	and	CCONJ
aji-17	262	23	controlling	control	VERB
aji-17	262	24	mycoplasma	mycoplasma	NOUN
aji-17	262	25	infection	infection	NOUN
aji-17	262	26	and	and	CCONJ
aji-17	262	27	should	should	AUX
aji-17	262	28	be	be	AUX
aji-17	262	29	considered	consider	VERB
aji-17	262	30	in	in	ADP
aji-17	262	31	vaccine	vaccine	NOUN
aji-17	262	32	development	development	NOUN
aji-17	262	33	against	against	ADP
aji-17	262	34	mycoplasma	mycoplasma	NOUN
aji-17	262	35	respiratory	respiratory	ADJ
aji-17	262	36	diseases	disease	NOUN
aji-17	262	37	.	.	PUNCT
aji-17	263	1	generation	generation	NOUN
aji-17	263	2	of	of	ADP
aji-17	263	3	immunity	immunity	NOUN
aji-17	263	4	in	in	ADP
aji-17	263	5	the	the	DET
aji-17	263	6	upper	upper	ADJ
aji-17	263	7	respiratory	respiratory	ADJ
aji-17	263	8	tract	tract	NOUN
aji-17	263	9	appears	appear	VERB
aji-17	263	10	to	to	PART
aji-17	263	11	be	be	AUX
aji-17	263	12	optimal	optimal	ADJ
aji-17	263	13	in	in	ADP
aji-17	263	14	preventing	prevent	VERB
aji-17	263	15	the	the	DET
aji-17	263	16	initial	initial	ADJ
aji-17	263	17	mycoplasma	mycoplasma	NOUN
aji-17	263	18	infection	infection	NOUN
aji-17	263	19	at	at	ADP
aji-17	263	20	this	this	DET
aji-17	263	21	site	site	NOUN
aji-17	263	22	,	,	PUNCT
aji-17	263	23	but	but	CCONJ
aji-17	263	24	adjuvants	adjuvant	NOUN
aji-17	263	25	(	(	PUNCT
aji-17	263	26	like	like	ADP
aji-17	263	27	cholera	cholera	NOUN
aji-17	263	28	toxin	toxin	NOUN
aji-17	263	29	(	(	PUNCT
aji-17	263	30	ct	ct	NOUN
aji-17	263	31	)	)	PUNCT
aji-17	263	32	enhanced	enhance	VERB
aji-17	263	33	these	these	DET
aji-17	263	34	protective	protective	ADJ
aji-17	263	35	responses	response	NOUN
aji-17	263	36	.	.	PUNCT
aji-17	264	1	in	in	ADP
aji-17	264	2	the	the	DET
aji-17	264	3	lower	low	ADJ
aji-17	264	4	respiratory	respiratory	ADJ
aji-17	264	5	tract	tract	NOUN
aji-17	264	6	,	,	PUNCT
aji-17	264	7	pulmonary	pulmonary	ADJ
aji-17	264	8	immune	immune	ADJ
aji-17	264	9	responses	response	NOUN
aji-17	264	10	seem	seem	VERB
aji-17	264	11	to	to	PART
aji-17	264	12	be	be	AUX
aji-17	264	13	more	more	ADV
aji-17	264	14	effective	effective	ADJ
aji-17	264	15	than	than	ADP
aji-17	264	16	serum	serum	NOUN
aji-17	264	17	antibody	antibody	NOUN
aji-17	264	18	responses	response	NOUN
aji-17	264	19	and	and	CCONJ
aji-17	264	20	nasal	nasal	ADJ
aji-17	264	21	immunization	immunization	NOUN
aji-17	264	22	can	can	AUX
aji-17	264	23	confer	confer	VERB
aji-17	264	24	some	some	DET
aji-17	264	25	protection	protection	NOUN
aji-17	264	26	from	from	ADP
aji-17	264	27	pulmonary	pulmonary	ADJ
aji-17	264	28	infection	infection	NOUN
aji-17	264	29	"	"	PUNCT
aji-17	264	30	.	.	PUNCT
aji-17	265	1	role	role	NOUN
aji-17	265	2	of	of	ADP
aji-17	265	3	the	the	DET
aji-17	265	4	secretary	secretary	NOUN
aji-17	265	5	iga	iga	PROPN
aji-17	265	6	in	in	ADP
aji-17	265	7	local	local	ADJ
aji-17	265	8	immunity	immunity	NOUN
aji-17	265	9	[	[	X
aji-17	265	10	26	26	NUM
aji-17	265	11	]	]	SYM
aji-17	265	12	:	:	PUNCT
aji-17	265	13	secretory	secretory	PROPN
aji-17	265	14	iga	iga	PROPN
aji-17	265	15	(	(	PUNCT
aji-17	265	16	siga	siga	PROPN
aji-17	265	17	)	)	PUNCT
aji-17	265	18	is	be	AUX
aji-17	265	19	the	the	DET
aji-17	265	20	principal	principal	ADJ
aji-17	265	21	immunoglobulin	immunoglobulin	NOUN
aji-17	265	22	(	(	PUNCT
aji-17	265	23	ig	ig	PROPN
aji-17	265	24	)	)	PUNCT
aji-17	265	25	on	on	ADP
aji-17	265	26	mucosal	mucosal	ADJ
aji-17	265	27	surfaces	surface	NOUN
aji-17	265	28	of	of	ADP
aji-17	265	29	humans	human	NOUN
aji-17	265	30	the	the	DET
aji-17	265	31	respiratory	respiratory	NOUN
aji-17	265	32	contains	contain	VERB
aji-17	265	33	equivalent	equivalent	ADJ
aji-17	265	34	amounts	amount	NOUN
aji-17	265	35	of	of	ADP
aji-17	265	36	iga	iga	PROPN
aji-17	265	37	and	and	CCONJ
aji-17	265	38	igg	igg	PROPN
aji-17	265	39	in	in	ADP
aji-17	265	40	addition	addition	NOUN
aji-17	265	41	to	to	ADP
aji-17	265	42	some	some	DET
aji-17	265	43	igm	igm	NOUN
aji-17	265	44	(	(	PUNCT
aji-17	265	45	brandtzaeg	brandtzaeg	PROPN
aji-17	265	46	et	et	PROPN
aji-17	265	47	al	al	PROPN
aji-17	265	48	.	.	PROPN
aji-17	265	49	,	,	PUNCT
aji-17	265	50	1999	1999	NUM
aji-17	265	51	)	)	PUNCT
aji-17	265	52	.	.	PUNCT
aji-17	266	1	the	the	DET
aji-17	266	2	main	main	ADJ
aji-17	266	3	function	function	NOUN
aji-17	266	4	of	of	ADP
aji-17	266	5	iga	iga	PROPN
aji-17	266	6	is	be	AUX
aji-17	266	7	the	the	DET
aji-17	266	8	neutralization	neutralization	NOUN
aji-17	266	9	of	of	ADP
aji-17	266	10	pathogens	pathogen	NOUN
aji-17	266	11	and	and	CCONJ
aji-17	266	12	toxins	toxin	NOUN
aji-17	266	13	without	without	ADP
aji-17	266	14	causing	cause	VERB
aji-17	266	15	inflammation	inflammation	NOUN
aji-17	266	16	since	since	SCONJ
aji-17	266	17	it	it	PRON
aji-17	266	18	does	do	AUX
aji-17	266	19	not	not	PART
aji-17	266	20	activate	activate	VERB
aji-17	266	21	complement	complement	NOUN
aji-17	266	22	(	(	PUNCT
aji-17	266	23	cerutti	cerutti	PROPN
aji-17	266	24	,	,	PUNCT
aji-17	266	25	2008	2008	NUM
aji-17	266	26	;	;	PUNCT
aji-17	266	27	macpherson	macpherson	PROPN
aji-17	266	28	&	&	CCONJ
aji-17	266	29	slack	slack	PROPN
aji-17	266	30	,	,	PUNCT
aji-17	266	31	2007	2007	NUM
aji-17	266	32	)	)	PUNCT
aji-17	266	33	.	.	PUNCT
aji-17	267	1	the	the	DET
aji-17	267	2	mucosal	mucosal	ADJ
aji-17	267	3	microbiota	microbiota	NOUN
aji-17	267	4	,	,	PUNCT
aji-17	267	5	epithelial	epithelial	ADJ
aji-17	267	6	cells	cell	NOUN
aji-17	267	7	,	,	PUNCT
aji-17	267	8	and	and	CCONJ
aji-17	267	9	the	the	DET
aji-17	267	10	mucosal	mucosal	ADJ
aji-17	267	11	immune	immune	ADJ
aji-17	267	12	system	system	NOUN
aji-17	267	13	constitute	constitute	VERB
aji-17	267	14	a	a	DET
aji-17	267	15	stable	stable	ADJ
aji-17	267	16	and	and	CCONJ
aji-17	267	17	interdependent	interdependent	ADJ
aji-17	267	18	“	"	PUNCT
aji-17	267	19	tripod	tripod	NOUN
aji-17	267	20	”	"	PUNCT
aji-17	267	21	that	that	PRON
aji-17	267	22	maintains	maintain	VERB
aji-17	267	23	mucosal	mucosal	NOUN
aji-17	267	24	homeostasis	homeostasis	NOUN
aji-17	267	25	by	by	ADP
aji-17	267	26	complex	complex	ADJ
aji-17	267	27	mechanisms	mechanism	NOUN
aji-17	267	28	(	(	PUNCT
aji-17	267	29	corthesy	corthesy	NOUN
aji-17	267	30	,	,	PUNCT
aji-17	267	31	2007	2007	NUM
aji-17	267	32	;	;	PUNCT
aji-17	267	33	hooper	hooper	PROPN
aji-17	267	34	,	,	PUNCT
aji-17	267	35	2004	2004	NUM
aji-17	267	36	)	)	PUNCT
aji-17	267	37	.	.	PUNCT
aji-17	268	1	1	1	X
aji-17	268	2	.	.	X
aji-17	268	3	bacteria	bacteria	NOUN
aji-17	268	4	adhere	adhere	VERB
aji-17	268	5	to	to	ADP
aji-17	268	6	the	the	DET
aji-17	268	7	surface	surface	NOUN
aji-17	268	8	receptors	receptor	NOUN
aji-17	268	9	of	of	ADP
aji-17	268	10	the	the	DET
aji-17	268	11	epithelial	epithelial	ADJ
aji-17	268	12	cells	cell	NOUN
aji-17	268	13	and	and	CCONJ
aji-17	268	14	express	express	VERB
aji-17	268	15	the	the	DET
aji-17	268	16	basolateral	basolateral	ADJ
aji-17	268	17	membrane	membrane	NOUN
aji-17	268	18	receptor	receptor	NOUN
aji-17	268	19	(	(	PUNCT
aji-17	268	20	polymeric	polymeric	ADJ
aji-17	268	21	ig	ig	PROPN
aji-17	268	22	receptor	receptor	NOUN
aji-17	268	23	;	;	PUNCT
aji-17	268	24	pigr	pigr	PROPN
aji-17	268	25	)	)	PUNCT
aji-17	268	26	that	that	PRON
aji-17	268	27	transports	transport	VERB
aji-17	268	28	locally	locally	ADV
aji-17	268	29	produced	produce	VERB
aji-17	268	30	polymeric	polymeric	NOUN
aji-17	268	31	(	(	PUNCT
aji-17	268	32	p)iga	p)iga	PROPN
aji-17	268	33	into	into	ADP
aji-17	268	34	the	the	DET
aji-17	268	35	external	external	ADJ
aji-17	268	36	secretions	secretion	NOUN
aji-17	268	37	(	(	PUNCT
aji-17	268	38	kaetzel	kaetzel	PROPN
aji-17	268	39	&	&	CCONJ
aji-17	268	40	mostov	mostov	PROPN
aji-17	268	41	,	,	PUNCT
aji-17	268	42	2005	2005	NUM
aji-17	268	43	)	)	PUNCT
aji-17	268	44	.	.	PUNCT
aji-17	269	1	2	2	X
aji-17	269	2	.	.	X
aji-17	269	3	endogenous	endogenous	ADJ
aji-17	269	4	bacterial	bacterial	ADJ
aji-17	269	5	of	of	ADP
aji-17	269	6	the	the	DET
aji-17	269	7	intestinal	intestinal	ADJ
aji-17	269	8	tract	tract	NOUN
aji-17	269	9	,	,	PUNCT
aji-17	269	10	and	and	CCONJ
aji-17	269	11	the	the	DET
aji-17	269	12	respiratory	respiratory	ADJ
aji-17	269	13	and	and	CCONJ
aji-17	269	14	genital	genital	ADJ
aji-17	269	15	tracts	tract	NOUN
aji-17	269	16	,	,	PUNCT
aji-17	269	17	are	be	AUX
aji-17	269	18	coated	coat	VERB
aji-17	269	19	in	in	ADP
aji-17	269	20	vivo	vivo	NOUN
aji-17	269	21	with	with	ADP
aji-17	269	22	siga	siga	PROPN
aji-17	269	23	(	(	PUNCT
aji-17	269	24	bos	bos	PROPN
aji-17	269	25	,	,	PUNCT
aji-17	269	26	cebra	cebra	NOUN
aji-17	269	27	,	,	PUNCT
aji-17	269	28	&	&	CCONJ
aji-17	269	29	kroese	kroese	PROPN
aji-17	269	30	,	,	PUNCT
aji-17	269	31	2000	2000	NUM
aji-17	269	32	;	;	PUNCT
aji-17	269	33	van	van	PROPN
aji-17	269	34	der	der	NOUN
aji-17	269	35	waaij	waaij	PROPN
aji-17	269	36	et	et	PROPN
aji-17	269	37	al	al	PROPN
aji-17	269	38	.	.	PROPN
aji-17	269	39	2004	2004	NUM
aji-17	269	40	)	)	PUNCT
aji-17	269	41	that	that	PRON
aji-17	269	42	limits	limit	VERB
aji-17	269	43	their	their	PRON
aji-17	269	44	epithelial	epithelial	ADJ
aji-17	269	45	adherence	adherence	NOUN
aji-17	269	46	and	and	CCONJ
aji-17	269	47	penetration	penetration	NOUN
aji-17	269	48	,	,	PUNCT
aji-17	269	49	thereby	thereby	ADV
aji-17	269	50	confining	confine	VERB
aji-17	269	51	them	they	PRON
aji-17	269	52	to	to	ADP
aji-17	269	53	the	the	DET
aji-17	269	54	mucosal	mucosal	NOUN
aji-17	269	55	surfaces	surface	NOUN
aji-17	269	56	.	.	PUNCT
aji-17	270	1	iga	iga	PROPN
aji-17	270	2	neutralizes	neutralize	VERB
aji-17	270	3	inflammatory	inflammatory	ADJ
aji-17	270	4	microbial	microbial	ADJ
aji-17	270	5	products	product	NOUN
aji-17	270	6	inside	inside	ADP
aji-17	270	7	epithelial	epithelial	ADJ
aji-17	270	8	cells	cell	NOUN
aji-17	270	9	(	(	PUNCT
aji-17	270	10	fernandez	fernandez	PROPN
aji-17	270	11	et	et	PROPN
aji-17	270	12	al	al	PROPN
aji-17	270	13	.	.	PROPN
aji-17	270	14	,	,	PUNCT
aji-17	270	15	2003	2003	NUM
aji-17	270	16	)	)	PUNCT
aji-17	270	17	.	.	PUNCT
aji-17	271	1	finally	finally	ADV
aji-17	271	2	,	,	PUNCT
aji-17	271	3	if	if	SCONJ
aji-17	271	4	bacteria	bacteria	NOUN
aji-17	271	5	trespass	trespass	VERB
aji-17	271	6	the	the	DET
aji-17	271	7	epithelial	epithelial	ADJ
aji-17	271	8	barrier	barrier	NOUN
aji-17	271	9	,	,	PUNCT
aji-17	271	10	iga	iga	PROPN
aji-17	271	11	transports	transport	VERB
aji-17	271	12	these	these	DET
aji-17	271	13	bacteria	bacteria	NOUN
aji-17	271	14	back	back	ADV
aji-17	271	15	into	into	ADP
aji-17	271	16	the	the	DET
aji-17	271	17	lumen	luman	NOUN
aji-17	271	18	via	via	ADP
aji-17	271	19	pigr	pigr	NOUN
aji-17	271	20	or	or	CCONJ
aji-17	271	21	promotes	promote	VERB
aji-17	271	22	their	their	PRON
aji-17	271	23	phagocytosis	phagocytosis	NOUN
aji-17	271	24	through	through	ADP
aji-17	271	25	fc	fc	PROPN
aji-17	271	26	(	(	PUNCT
aji-17	271	27	pasquier	pasquier	NOUN
aji-17	271	28	et	et	PROPN
aji-17	271	29	al	al	PROPN
aji-17	271	30	.	.	PROPN
aji-17	271	31	,	,	PUNCT
aji-17	271	32	2005	2005	NUM
aji-17	271	33	;	;	PUNCT
aji-17	271	34	phalipon	phalipon	PROPN
aji-17	271	35	corthésy	corthésy	PROPN
aji-17	271	36	,	,	PUNCT
aji-17	271	37	2003	2003	NUM
aji-17	271	38	)	)	PUNCT
aji-17	271	39	.	.	PUNCT
aji-17	272	1	killed	kill	VERB
aji-17	272	2	bacteria	bacteria	NOUN
aji-17	272	3	seem	seem	VERB
aji-17	272	4	to	to	PART
aji-17	272	5	be	be	AUX
aji-17	272	6	at	at	ADV
aji-17	272	7	least	least	ADJ
aji-17	272	8	100	100	NUM
aji-17	272	9	-	-	NUM
aji-17	272	10	fold	fold	VERB
aji-17	272	11	less	less	ADV
aji-17	272	12	effective	effective	ADJ
aji-17	272	13	at	at	ADP
aji-17	272	14	inducing	induce	VERB
aji-17	272	15	iga	iga	PROPN
aji-17	272	16	responses	response	NOUN
aji-17	272	17	than	than	ADP
aji-17	272	18	live	live	ADJ
aji-17	272	19	bacteria	bacteria	NOUN
aji-17	272	20	,	,	PUNCT
aji-17	272	21	presumably	presumably	ADV
aji-17	272	22	due	due	ADP
aji-17	272	23	to	to	ADP
aji-17	272	24	their	their	PRON
aji-17	272	25	inactivity	inactivity	NOUN
aji-17	272	26	and	and	CCONJ
aji-17	272	27	the	the	DET
aji-17	272	28	digestion	digestion	NOUN
aji-17	272	29	of	of	ADP
aji-17	272	30	dead	dead	ADJ
aji-17	272	31	bacteria	bacteria	NOUN
aji-17	272	32	during	during	ADP
aji-17	272	33	transit	transit	NOUN
aji-17	272	34	through	through	ADP
aji-17	272	35	the	the	DET
aji-17	272	36	stomach	stomach	NOUN
aji-17	272	37	and	and	CCONJ
aji-17	272	38	intestine	intestine	NOUN
aji-17	272	39	(	(	PUNCT
aji-17	272	40	hapfelmeier	hapfelmeier	NOUN
aji-17	272	41	et	et	PROPN
aji-17	272	42	al	al	PROPN
aji-17	272	43	.	.	PROPN
aji-17	272	44	2010	2010	NUM
aji-17	272	45	;	;	PUNCT
aji-17	272	46	macpherson	macpherson	PROPN
aji-17	272	47	&	&	CCONJ
aji-17	272	48	uhr	uhr	PROPN
aji-17	272	49	,	,	PUNCT
aji-17	272	50	2004	2004	NUM
aji-17	272	51	)	)	PUNCT
aji-17	272	52	.	.	PUNCT
aji-17	273	1	prasad	prasad	PROPN
aji-17	273	2	;	;	PUNCT
aji-17	273	3	aji	aji	NOUN
aji-17	273	4	,	,	PUNCT
aji-17	273	5	3(1	3(1	NUM
aji-17	273	6	):	):	PUNCT
aji-17	273	7	61	61	NUM
aji-17	273	8	-	-	SYM
aji-17	273	9	70	70	NUM
aji-17	273	10	,	,	PUNCT
aji-17	273	11	2020	2020	NUM
aji-17	273	12	;	;	PUNCT
aji-17	273	13	article	article	NOUN
aji-17	273	14	no.aji.55881	no.aji.55881	ADP
aji-17	273	15	67	67	NUM
aji-17	273	16	2.2.4	2.2.4	NUM
aji-17	273	17	concept	concept	NOUN
aji-17	273	18	on	on	ADP
aji-17	273	19	local	local	ADJ
aji-17	273	20	immunity	immunity	NOUN
aji-17	273	21	as	as	SCONJ
aji-17	273	22	applied	apply	VERB
aji-17	273	23	to	to	ADP
aji-17	273	24	in	in	ADP
aji-17	273	25	covid	covid	PROPN
aji-17	273	26	19	19	NUM
aji-17	273	27	immunity	immunity	NOUN
aji-17	273	28	2.2.4.1	2.2.4.1	NUM
aji-17	273	29	recapitulation	recapitulation	NOUN
aji-17	273	30	of	of	ADP
aji-17	273	31	some	some	DET
aji-17	273	32	considerations	consideration	NOUN
aji-17	273	33	1	1	NUM
aji-17	273	34	.	.	PUNCT
aji-17	273	35	belyakov	belyakov	PROPN
aji-17	273	36	et	et	PROPN
aji-17	273	37	al	al	PROPN
aji-17	273	38	.	.	PUNCT
aji-17	274	1	[	[	X
aji-17	274	2	27	27	NUM
aji-17	274	3	]	]	PUNCT
aji-17	274	4	opined	opine	VERB
aji-17	274	5	that	that	SCONJ
aji-17	274	6	:	:	PUNCT
aji-17	274	7	a.	a.	NOUN
aji-17	274	8	"	"	PUNCT
aji-17	274	9	the	the	DET
aji-17	274	10	route	route	NOUN
aji-17	274	11	of	of	ADP
aji-17	274	12	vaccination	vaccination	NOUN
aji-17	274	13	is	be	AUX
aji-17	274	14	important	important	ADJ
aji-17	274	15	in	in	ADP
aji-17	274	16	influencing	influence	VERB
aji-17	274	17	immune	immune	ADJ
aji-17	274	18	responses	response	NOUN
aji-17	274	19	at	at	ADP
aji-17	274	20	the	the	DET
aji-17	274	21	initial	initial	ADJ
aji-17	274	22	site	site	NOUN
aji-17	274	23	of	of	ADP
aji-17	274	24	pathogen	pathogen	NOUN
aji-17	274	25	invasion	invasion	NOUN
aji-17	274	26	where	where	SCONJ
aji-17	274	27	protection	protection	NOUN
aji-17	274	28	is	be	AUX
aji-17	274	29	most	most	ADV
aji-17	274	30	effective	effective	ADJ
aji-17	274	31	.	.	PUNCT
aji-17	275	1	immune	immune	ADJ
aji-17	275	2	responses	response	NOUN
aji-17	275	3	required	require	VERB
aji-17	275	4	for	for	ADP
aji-17	275	5	mucosal	mucosal	NOUN
aji-17	275	6	protection	protection	NOUN
aji-17	275	7	can	can	AUX
aji-17	275	8	differ	differ	VERB
aji-17	275	9	vastly	vastly	ADV
aji-17	275	10	depending	depend	VERB
aji-17	275	11	on	on	ADP
aji-17	275	12	the	the	DET
aji-17	275	13	individual	individual	ADJ
aji-17	275	14	pathogen	pathogen	NOUN
aji-17	275	15	.	.	PUNCT
aji-17	276	1	for	for	ADP
aji-17	276	2	some	some	DET
aji-17	276	3	mucosal	mucosal	ADJ
aji-17	276	4	pathogens	pathogen	NOUN
aji-17	276	5	,	,	PUNCT
aji-17	276	6	high	high	ADJ
aji-17	276	7	-	-	PUNCT
aji-17	276	8	titer	titer	NOUN
aji-17	276	9	neutralizing	neutralize	VERB
aji-17	276	10	antibodies	antibody	NOUN
aji-17	276	11	(	(	PUNCT
aji-17	276	12	abs	ab	NOUN
aji-17	276	13	)	)	PUNCT
aji-17	276	14	that	that	PRON
aji-17	276	15	enter	enter	VERB
aji-17	276	16	tissue	tissue	NOUN
aji-17	276	17	parenchyma	parenchyma	NOUN
aji-17	276	18	or	or	CCONJ
aji-17	276	19	transude	transude	NOUN
aji-17	276	20	into	into	ADP
aji-17	276	21	the	the	DET
aji-17	276	22	mucosal	mucosal	NOUN
aji-17	276	23	lumen	luman	NOUN
aji-17	276	24	are	be	AUX
aji-17	276	25	sufficient	sufficient	ADJ
aji-17	276	26	for	for	ADP
aji-17	276	27	clearing	clear	VERB
aji-17	276	28	cells	cell	NOUN
aji-17	276	29	,	,	PUNCT
aji-17	276	30	free	free	ADJ
aji-17	276	31	of	of	ADP
aji-17	276	32	the	the	DET
aji-17	276	33	virus	virus	NOUN
aji-17	276	34	.	.	PUNCT
aji-17	276	35	"	"	PUNCT
aji-17	277	1	b.	b.	NOUN
aji-17	277	2	induction	induction	NOUN
aji-17	277	3	of	of	ADP
aji-17	277	4	the	the	DET
aji-17	277	5	mucosal	mucosal	NOUN
aji-17	277	6	innate	innate	ADJ
aji-17	277	7	and	and	CCONJ
aji-17	277	8	adaptive	adaptive	ADJ
aji-17	277	9	immune	immune	ADJ
aji-17	277	10	systems	system	NOUN
aji-17	277	11	,	,	PUNCT
aji-17	277	12	including	include	VERB
aji-17	277	13	cd4	cd4	PROPN
aji-17	277	14	+	+	PROPN
aji-17	277	15	t	t	PROPN
aji-17	277	16	helper	helper	NOUN
aji-17	277	17	cells	cell	NOUN
aji-17	277	18	,	,	PUNCT
aji-17	277	19	th17	th17	PROPN
aji-17	277	20	,	,	PUNCT
aji-17	277	21	high	high	ADJ
aji-17	277	22	avidity	avidity	NOUN
aji-17	277	23	cd8	cd8	PROPN
aji-17	277	24	+	+	CCONJ
aji-17	277	25	ctl	ctl	PROPN
aji-17	277	26	and	and	CCONJ
aji-17	277	27	secretory	secretory	PROPN
aji-17	277	28	iga	iga	PROPN
aji-17	277	29	and	and	CCONJ
aji-17	277	30	igg1	igg1	NOUN
aji-17	277	31	neutralizing	neutralize	VERB
aji-17	277	32	abs	ab	NOUN
aji-17	277	33	,	,	PUNCT
aji-17	277	34	at	at	ADP
aji-17	277	35	the	the	DET
aji-17	277	36	site	site	NOUN
aji-17	277	37	of	of	ADP
aji-17	277	38	pathogen	pathogen	NOUN
aji-17	277	39	entry	entry	NOUN
aji-17	277	40	may	may	AUX
aji-17	277	41	be	be	AUX
aji-17	277	42	required	require	VERB
aji-17	277	43	for	for	ADP
aji-17	277	44	effective	effective	ADJ
aji-17	277	45	protection	protection	NOUN
aji-17	277	46	against	against	ADP
aji-17	277	47	highly	highly	ADV
aji-17	277	48	invasive	invasive	ADJ
aji-17	277	49	pathogens	pathogen	NOUN
aji-17	277	50	.	.	PUNCT
aji-17	278	1	2	2	X
aji-17	278	2	.	.	X
aji-17	278	3	the	the	DET
aji-17	278	4	main	main	ADJ
aji-17	278	5	function	function	NOUN
aji-17	278	6	of	of	ADP
aji-17	278	7	the	the	DET
aji-17	278	8	innate	innate	ADJ
aji-17	278	9	mucosal	mucosal	ADJ
aji-17	278	10	immune	immune	ADJ
aji-17	278	11	system	system	NOUN
aji-17	278	12	,	,	PUNCT
aji-17	278	13	to	to	PART
aji-17	278	14	discriminate	discriminate	VERB
aji-17	278	15	between	between	ADP
aji-17	278	16	dangerous	dangerous	ADJ
aji-17	278	17	and	and	CCONJ
aji-17	278	18	innocuous	innocuous	ADJ
aji-17	278	19	organisms	organism	NOUN
aji-17	278	20	,	,	PUNCT
aji-17	278	21	is	be	AUX
aji-17	278	22	determined	determine	VERB
aji-17	278	23	by	by	ADP
aji-17	278	24	the	the	DET
aji-17	278	25	recognition	recognition	NOUN
aji-17	278	26	of	of	ADP
aji-17	278	27	specific	specific	ADJ
aji-17	278	28	pathogen	pathogen	NOUN
aji-17	278	29	-	-	PUNCT
aji-17	278	30	associated	associate	VERB
aji-17	278	31	molecular	molecular	ADJ
aji-17	278	32	patterns	pattern	NOUN
aji-17	278	33	via	via	ADP
aji-17	278	34	activation	activation	NOUN
aji-17	278	35	of	of	ADP
aji-17	278	36	tlrs	tlrs	NOUN
aji-17	278	37	,	,	PUNCT
aji-17	278	38	nod	nod	NOUN
aji-17	278	39	-	-	PUNCT
aji-17	278	40	like	like	ADJ
aji-17	278	41	receptors	receptor	NOUN
aji-17	278	42	,	,	PUNCT
aji-17	278	43	retinoic	retinoic	ADJ
aji-17	278	44	acid	acid	NOUN
aji-17	278	45	(	(	PUNCT
aji-17	278	46	ra)-inducible	ra)-inducible	ADJ
aji-17	278	47	gene	gene	NOUN
aji-17	278	48	i	i	NOUN
aji-17	278	49	-	-	PUNCT
aji-17	278	50	like	like	ADJ
aji-17	278	51	helicases	helicase	NOUN
aji-17	278	52	,	,	PUNCT
aji-17	278	53	and	and	CCONJ
aji-17	278	54	c	c	X
aji-17	278	55	-	-	PUNCT
aji-17	278	56	type	type	NOUN
aji-17	278	57	lectins	lectin	NOUN
aji-17	279	1	[	[	X
aji-17	279	2	28	28	NUM
aji-17	279	3	]	]	PUNCT
aji-17	279	4	.	.	PUNCT
aji-17	280	1	3	3	X
aji-17	280	2	.	.	X
aji-17	280	3	studies	study	NOUN
aji-17	280	4	evaluating	evaluate	VERB
aji-17	280	5	mucosal	mucosal	ADJ
aji-17	280	6	infection	infection	NOUN
aji-17	280	7	and	and	CCONJ
aji-17	280	8	immunization	immunization	NOUN
aji-17	280	9	in	in	ADP
aji-17	280	10	humans	human	NOUN
aji-17	280	11	and	and	CCONJ
aji-17	280	12	animals	animal	NOUN
aji-17	280	13	have	have	AUX
aji-17	280	14	demonstrated	demonstrate	VERB
aji-17	280	15	the	the	DET
aji-17	280	16	existence	existence	NOUN
aji-17	280	17	of	of	ADP
aji-17	280	18	a	a	DET
aji-17	280	19	common	common	ADJ
aji-17	280	20	mucosal	mucosal	ADJ
aji-17	280	21	immune	immune	ADJ
aji-17	280	22	system	system	NOUN
aji-17	280	23	(	(	PUNCT
aji-17	280	24	cmis	cmis	PROPN
aji-17	280	25	)	)	PUNCT
aji-17	280	26	that	that	PRON
aji-17	280	27	consists	consist	VERB
aji-17	280	28	of	of	ADP
aji-17	280	29	gastrointestinal	gastrointestinal	ADJ
aji-17	280	30	,	,	PUNCT
aji-17	280	31	respiratory	respiratory	ADJ
aji-17	280	32	,	,	PUNCT
aji-17	280	33	and	and	CCONJ
aji-17	280	34	genital	genital	ADJ
aji-17	280	35	mucosa	mucosa	NOUN
aji-17	280	36	[	[	X
aji-17	280	37	29	29	NUM
aji-17	280	38	]	]	PUNCT
aji-17	280	39	.	.	PUNCT
aji-17	281	1	4	4	X
aji-17	281	2	.	.	X
aji-17	281	3	the	the	DET
aji-17	281	4	cmis	cmis	NOUN
aji-17	281	5	implies	imply	VERB
aji-17	281	6	the	the	DET
aji-17	281	7	ability	ability	NOUN
aji-17	281	8	of	of	ADP
aji-17	281	9	ag	ag	NOUN
aji-17	281	10	-	-	PUNCT
aji-17	281	11	specific	specific	ADJ
aji-17	281	12	lymphocytes	lymphocyte	NOUN
aji-17	281	13	to	to	ADP
aji-17	281	14	home	home	NOUN
aji-17	281	15	to	to	ADP
aji-17	281	16	mucosal	mucosal	ADJ
aji-17	281	17	effector	effector	NOUN
aji-17	281	18	sites	site	NOUN
aji-17	281	19	in	in	ADP
aji-17	281	20	addition	addition	NOUN
aji-17	281	21	to	to	ADP
aji-17	281	22	the	the	DET
aji-17	281	23	site	site	NOUN
aji-17	281	24	where	where	SCONJ
aji-17	281	25	initial	initial	ADJ
aji-17	281	26	ag	ag	PROPN
aji-17	281	27	exposure	exposure	NOUN
aji-17	281	28	occurred	occur	VERB
aji-17	281	29	[	[	X
aji-17	281	30	30	30	NUM
aji-17	281	31	]	]	PUNCT
aji-17	281	32	compartmentalized	compartmentalize	VERB
aji-17	281	33	mucosal	mucosal	ADJ
aji-17	281	34	immune	immune	ADJ
aji-17	281	35	responses	response	NOUN
aji-17	281	36	(	(	PUNCT
aji-17	281	37	cmirs	cmir	NOUN
aji-17	281	38	)	)	PUNCT
aji-17	281	39	that	that	PRON
aji-17	281	40	consist	consist	VERB
aji-17	281	41	of	of	ADP
aji-17	281	42	innate	innate	ADJ
aji-17	281	43	responses	response	NOUN
aji-17	281	44	,	,	PUNCT
aji-17	281	45	mucosal	mucosal	NOUN
aji-17	281	46	abs	ab	NOUN
aji-17	281	47	(	(	PUNCT
aji-17	281	48	secretory	secretory	NOUN
aji-17	281	49	ig	ig	PROPN
aji-17	281	50	(	(	PUNCT
aji-17	281	51	sig	sig	NOUN
aji-17	281	52	)	)	PUNCT
aji-17	281	53	a	a	PRON
aji-17	281	54	and	and	CCONJ
aji-17	281	55	sigg	sigg	PROPN
aji-17	281	56	)	)	PUNCT
aji-17	281	57	and	and	CCONJ
aji-17	281	58	cd8	cd8	PROPN
aji-17	281	59	+	+	PROPN
aji-17	281	60	ctls	ctls	PROPN
aji-17	281	61	localized	localize	VERB
aji-17	281	62	to	to	ADP
aji-17	281	63	tissues	tissue	NOUN
aji-17	281	64	proximal	proximal	ADJ
aji-17	281	65	to	to	ADP
aji-17	281	66	the	the	DET
aji-17	281	67	mucosal	mucosal	NOUN
aji-17	281	68	site	site	NOUN
aji-17	281	69	of	of	ADP
aji-17	281	70	immunization	immunization	NOUN
aji-17	281	71	are	be	AUX
aji-17	281	72	necessary	necessary	ADJ
aji-17	281	73	for	for	ADP
aji-17	281	74	protection	protection	NOUN
aji-17	281	75	from	from	ADP
aji-17	281	76	mucosal	mucosal	ADJ
aji-17	281	77	pathogens	pathogen	NOUN
aji-17	281	78	(	(	PUNCT
aji-17	281	79	belyakov	belyakov	PROPN
aji-17	281	80	et	et	PROPN
aji-17	281	81	al	al	PROPN
aji-17	281	82	.	.	PROPN
aji-17	281	83	)	)	PUNCT
aji-17	281	84	.	.	PUNCT
aji-17	282	1	5	5	X
aji-17	282	2	.	.	X
aji-17	282	3	protective	protective	ADJ
aji-17	282	4	immunity	immunity	NOUN
aji-17	282	5	against	against	ADP
aji-17	282	6	mucosal	mucosal	NOUN
aji-17	282	7	pathogens	pathogen	NOUN
aji-17	282	8	will	will	AUX
aji-17	282	9	require	require	VERB
aji-17	282	10	novel	novel	ADJ
aji-17	282	11	vaccine	vaccine	NOUN
aji-17	282	12	strategies	strategy	NOUN
aji-17	282	13	to	to	PART
aji-17	282	14	induce	induce	VERB
aji-17	282	15	mucosal	mucosal	ADJ
aji-17	282	16	immune	immune	ADJ
aji-17	282	17	responses	response	NOUN
aji-17	282	18	tailored	tailor	VERB
aji-17	282	19	to	to	ADP
aji-17	282	20	the	the	DET
aji-17	282	21	anatomic	anatomic	ADJ
aji-17	282	22	location	location	NOUN
aji-17	282	23	and	and	CCONJ
aji-17	282	24	the	the	DET
aji-17	282	25	threat	threat	NOUN
aji-17	282	26	of	of	ADP
aji-17	282	27	the	the	DET
aji-17	282	28	invading	invade	VERB
aji-17	282	29	pathogen	pathogen	NOUN
aji-17	282	30	6	6	NUM
aji-17	282	31	.	.	PUNCT
aji-17	283	1	protective	protective	ADJ
aji-17	283	2	immunity	immunity	NOUN
aji-17	283	3	against	against	ADP
aji-17	283	4	mucosal	mucosal	NOUN
aji-17	283	5	pathogens	pathogen	NOUN
aji-17	283	6	will	will	AUX
aji-17	283	7	require	require	VERB
aji-17	283	8	novel	novel	ADJ
aji-17	283	9	vaccine	vaccine	NOUN
aji-17	283	10	strategies	strategy	NOUN
aji-17	283	11	to	to	PART
aji-17	283	12	induce	induce	VERB
aji-17	283	13	mucosal	mucosal	ADJ
aji-17	283	14	immune	immune	ADJ
aji-17	283	15	responses	response	NOUN
aji-17	283	16	tailored	tailor	VERB
aji-17	283	17	to	to	ADP
aji-17	283	18	the	the	DET
aji-17	283	19	anatomic	anatomic	ADJ
aji-17	283	20	location	location	NOUN
aji-17	283	21	and	and	CCONJ
aji-17	283	22	the	the	DET
aji-17	283	23	threat	threat	NOUN
aji-17	283	24	of	of	ADP
aji-17	283	25	the	the	DET
aji-17	283	26	invading	invade	VERB
aji-17	283	27	pathogen	pathogen	NOUN
aji-17	283	28	pathogens	pathogen	NOUN
aji-17	283	29	may	may	AUX
aji-17	283	30	require	require	VERB
aji-17	283	31	mucosal	mucosal	ADJ
aji-17	283	32	vaccine	vaccine	NOUN
aji-17	283	33	strategies	strategy	NOUN
aji-17	283	34	that	that	PRON
aji-17	283	35	activate	activate	VERB
aji-17	283	36	multiple	multiple	ADJ
aji-17	283	37	arms	arm	NOUN
aji-17	283	38	of	of	ADP
aji-17	283	39	the	the	DET
aji-17	283	40	innate	innate	ADJ
aji-17	283	41	and	and	CCONJ
aji-17	283	42	adaptive	adaptive	ADJ
aji-17	283	43	immune	immune	ADJ
aji-17	283	44	systems	system	NOUN
aji-17	284	1	[	[	X
aji-17	284	2	31,32,33,34,35	31,32,33,34,35	NOUN
aji-17	284	3	]	]	X
aji-17	284	4	.	.	PUNCT
aji-17	285	1	7	7	X
aji-17	285	2	.	.	X
aji-17	285	3	optimum	optimum	ADJ
aji-17	285	4	mucosal	mucosal	NOUN
aji-17	285	5	vaccination	vaccination	NOUN
aji-17	285	6	leading	lead	VERB
aji-17	285	7	to	to	ADP
aji-17	285	8	compartmentalized	compartmentalized	ADJ
aji-17	285	9	mucosal	mucosal	ADJ
aji-17	285	10	immune	immune	ADJ
aji-17	285	11	responses	response	NOUN
aji-17	285	12	might	might	AUX
aji-17	285	13	ensure	ensure	VERB
aji-17	285	14	that	that	SCONJ
aji-17	285	15	the	the	DET
aji-17	285	16	appropriate	appropriate	ADJ
aji-17	285	17	cells	cell	NOUN
aji-17	285	18	are	be	AUX
aji-17	285	19	armed	armed	ADJ
aji-17	285	20	and	and	CCONJ
aji-17	285	21	ready	ready	ADJ
aji-17	285	22	to	to	PART
aji-17	285	23	respond	respond	VERB
aji-17	285	24	immediately	immediately	ADV
aji-17	285	25	to	to	ADP
aji-17	285	26	infection	infection	NOUN
aji-17	285	27	and	and	CCONJ
aji-17	285	28	to	to	PART
aji-17	285	29	confer	confer	VERB
aji-17	285	30	protection	protection	NOUN
aji-17	285	31	not	not	PART
aji-17	285	32	achieved	achieve	VERB
aji-17	285	33	following	follow	VERB
aji-17	285	34	natural	natural	ADJ
aji-17	285	35	infection	infection	NOUN
aji-17	285	36	.	.	PUNCT
aji-17	286	1	8	8	X
aji-17	286	2	.	.	X
aji-17	286	3	protective	protective	ADJ
aji-17	286	4	mucosal	mucosal	ADJ
aji-17	286	5	immune	immune	ADJ
aji-17	286	6	responses	response	NOUN
aji-17	286	7	are	be	AUX
aji-17	286	8	most	most	ADV
aji-17	286	9	effectively	effectively	ADV
aji-17	286	10	induced	induce	VERB
aji-17	286	11	by	by	ADP
aji-17	286	12	mucosal	mucosal	ADJ
aji-17	286	13	immunization	immunization	NOUN
aji-17	286	14	through	through	ADP
aji-17	286	15	oral	oral	ADJ
aji-17	286	16	,	,	PUNCT
aji-17	286	17	intranasal	intranasal	NOUN
aji-17	286	18	(	(	PUNCT
aji-17	286	19	i.n	i.n	PROPN
aji-17	286	20	.	.	PROPN
aji-17	286	21	)	)	PUNCT
aji-17	286	22	,	,	PUNCT
aji-17	286	23	intrarectal	intrarectal	ADJ
aji-17	286	24	,	,	PUNCT
aji-17	286	25	or	or	CCONJ
aji-17	286	26	intravaginal	intravaginal	ADJ
aji-17	286	27	routes	route	NOUN
aji-17	286	28	,	,	PUNCT
aji-17	286	29	and	and	CCONJ
aji-17	286	30	an	an	DET
aji-17	286	31	optimized	optimize	VERB
aji-17	286	32	mucosal	mucosal	NOUN
aji-17	286	33	vaccination	vaccination	NOUN
aji-17	286	34	strategy	strategy	NOUN
aji-17	286	35	may	may	AUX
aji-17	286	36	have	have	VERB
aji-17	286	37	a	a	DET
aji-17	286	38	much	much	ADV
aji-17	286	39	greater	great	ADJ
aji-17	286	40	potential	potential	NOUN
aji-17	286	41	for	for	ADP
aji-17	286	42	generating	generate	VERB
aji-17	286	43	local	local	ADJ
aji-17	286	44	protective	protective	ADJ
aji-17	286	45	mucosal	mucosal	ADJ
aji-17	286	46	immune	immune	ADJ
aji-17	286	47	responses	response	NOUN
aji-17	286	48	.	.	PUNCT
aji-17	287	1	9	9	X
aji-17	287	2	.	.	X
aji-17	287	3	mucosal	mucosal	NOUN
aji-17	287	4	immunity	immunity	NOUN
aji-17	287	5	concept	concept	NOUN
aji-17	287	6	has	have	AUX
aji-17	287	7	worked	work	VERB
aji-17	287	8	well	well	ADV
aji-17	287	9	in	in	ADP
aji-17	287	10	case	case	NOUN
aji-17	287	11	of	of	ADP
aji-17	287	12	viral	viral	ADJ
aji-17	287	13	infections	infection	NOUN
aji-17	287	14	like	like	ADP
aji-17	287	15	influenza	influenza	NOUN
aji-17	287	16	,	,	PUNCT
aji-17	287	17	poliomyelitis	poliomyelitis	NOUN
aji-17	287	18	and	and	CCONJ
aji-17	287	19	bacterial	bacterial	ADJ
aji-17	287	20	infections	infection	NOUN
aji-17	287	21	like	like	ADP
aji-17	287	22	salmonella	salmonella	NOUN
aji-17	287	23	and	and	CCONJ
aji-17	287	24	v.	v.	ADP
aji-17	287	25	cholerae	cholerae	PROPN
aji-17	287	26	and	and	CCONJ
aji-17	287	27	mycoplasma	mycoplasma	NOUN
aji-17	287	28	infections	infection	NOUN
aji-17	287	29	,	,	PUNCT
aji-17	287	30	as	as	SCONJ
aji-17	287	31	outlined	outline	VERB
aji-17	287	32	above	above	ADV
aji-17	287	33	.	.	PUNCT
aji-17	288	1	10	10	NUM
aji-17	288	2	.	.	PUNCT
aji-17	289	1	the	the	DET
aji-17	289	2	cdc	cdc	PROPN
aji-17	289	3	has	have	AUX
aji-17	289	4	not	not	PART
aji-17	289	5	made	make	VERB
aji-17	289	6	any	any	DET
aji-17	289	7	comments	comment	NOUN
aji-17	289	8	regarding	regard	VERB
aji-17	289	9	the	the	DET
aji-17	289	10	relative	relative	ADJ
aji-17	289	11	merits	merit	NOUN
aji-17	289	12	of	of	ADP
aji-17	289	13	the	the	DET
aji-17	289	14	inactivated	inactivated	ADJ
aji-17	289	15	and	and	CCONJ
aji-17	289	16	recombinant	recombinant	ADJ
aji-17	289	17	vaccine	vaccine	NOUN
aji-17	289	18	and	and	CCONJ
aji-17	289	19	nasal	nasal	NOUN
aji-17	289	20	spray	spray	NOUN
aji-17	289	21	vaccine	vaccine	NOUN
aji-17	289	22	for	for	ADP
aji-17	289	23	influenza	influenza	NOUN
aji-17	289	24	.	.	PUNCT
aji-17	290	1	the	the	DET
aji-17	290	2	proposed	propose	VERB
aji-17	290	3	hypothesis	hypothesis	NOUN
aji-17	290	4	:	:	PUNCT
aji-17	290	5	covid	covid	PROPN
aji-17	290	6	19	19	NUM
aji-17	290	7	is	be	AUX
aji-17	290	8	different	different	ADJ
aji-17	290	9	from	from	ADP
aji-17	290	10	other	other	ADJ
aji-17	290	11	deadly	deadly	ADJ
aji-17	290	12	viral	viral	ADJ
aji-17	290	13	infections	infection	NOUN
aji-17	290	14	,	,	PUNCT
aji-17	290	15	say	say	VERB
aji-17	290	16	for	for	ADP
aji-17	290	17	instance	instance	NOUN
aji-17	290	18	hiv	hiv	PROPN
aji-17	290	19	.	.	PUNCT
aji-17	291	1	in	in	ADP
aji-17	291	2	the	the	DET
aji-17	291	3	later	later	NOUN
aji-17	291	4	,	,	PUNCT
aji-17	291	5	the	the	DET
aji-17	291	6	virus	virus	NOUN
aji-17	291	7	is	be	AUX
aji-17	291	8	found	find	VERB
aji-17	291	9	in	in	ADP
aji-17	291	10	all	all	DET
aji-17	291	11	body	body	NOUN
aji-17	291	12	secretions	secretion	NOUN
aji-17	291	13	including	include	VERB
aji-17	291	14	semen	semen	NOUN
aji-17	291	15	with	with	ADP
aji-17	291	16	variable	variable	ADJ
aji-17	291	17	infectivity	infectivity	NOUN
aji-17	291	18	of	of	ADP
aji-17	291	19	each	each	DET
aji-17	291	20	body	body	NOUN
aji-17	291	21	fluid	fluid	NOUN
aji-17	291	22	.	.	PUNCT
aji-17	292	1	there	there	PRON
aji-17	292	2	is	be	VERB
aji-17	292	3	no	no	DET
aji-17	292	4	suggestion	suggestion	NOUN
aji-17	292	5	of	of	ADP
aji-17	292	6	any	any	DET
aji-17	292	7	tissue	tissue	NOUN
aji-17	292	8	"	"	PUNCT
aji-17	292	9	tropism	tropism	NOUN
aji-17	292	10	"	"	PUNCT
aji-17	292	11	in	in	ADP
aji-17	292	12	hiv	hiv	PROPN
aji-17	292	13	.	.	PUNCT
aji-17	293	1	as	as	ADP
aji-17	293	2	against	against	ADP
aji-17	293	3	hiv	hiv	PROPN
aji-17	293	4	,	,	PUNCT
aji-17	293	5	the	the	DET
aji-17	293	6	corona	corona	PROPN
aji-17	293	7	virus	virus	NOUN
aji-17	293	8	(	(	PUNCT
aji-17	293	9	cov	cov	NOUN
aji-17	293	10	)	)	PUNCT
aji-17	293	11	enters	enter	VERB
aji-17	293	12	the	the	DET
aji-17	293	13	body	body	NOUN
aji-17	293	14	through	through	ADP
aji-17	293	15	the	the	DET
aji-17	293	16	nose	nose	NOUN
aji-17	293	17	,	,	PUNCT
aji-17	293	18	multiplies	multiplie	NOUN
aji-17	293	19	there	there	ADV
aji-17	293	20	,	,	PUNCT
aji-17	293	21	and	and	CCONJ
aji-17	293	22	excreted	excrete	VERB
aji-17	293	23	through	through	ADP
aji-17	293	24	nasal	nasal	ADJ
aji-17	293	25	secretion	secretion	NOUN
aji-17	293	26	.	.	PUNCT
aji-17	294	1	in	in	ADP
aji-17	294	2	fact	fact	NOUN
aji-17	294	3	,	,	PUNCT
aji-17	294	4	they	they	PRON
aji-17	294	5	are	be	AUX
aji-17	294	6	limited	limit	VERB
aji-17	294	7	almost	almost	ADV
aji-17	294	8	exclusively	exclusively	ADV
aji-17	294	9	in	in	ADP
aji-17	294	10	the	the	DET
aji-17	294	11	upper	upper	ADJ
aji-17	294	12	respiratory	respiratory	ADJ
aji-17	294	13	epithelium	epithelium	NOUN
aji-17	294	14	initially	initially	ADV
aji-17	294	15	and	and	CCONJ
aji-17	294	16	later	later	ADV
aji-17	294	17	if	if	SCONJ
aji-17	294	18	not	not	PART
aji-17	294	19	prevented	prevent	VERB
aji-17	294	20	,	,	PUNCT
aji-17	294	21	spreads	spread	VERB
aji-17	294	22	locally	locally	ADV
aji-17	294	23	to	to	ADP
aji-17	294	24	lower	low	ADJ
aji-17	294	25	respiratory	respiratory	ADJ
aji-17	294	26	epithelium	epithelium	NOUN
aji-17	294	27	,	,	PUNCT
aji-17	294	28	suggesting	suggest	VERB
aji-17	294	29	some	some	DET
aji-17	294	30	sort	sort	NOUN
aji-17	294	31	of	of	ADP
aji-17	294	32	"	"	PUNCT
aji-17	294	33	tissue	tissue	NOUN
aji-17	294	34	tropism	tropism	NOUN
aji-17	294	35	"	"	PUNCT
aji-17	294	36	.	.	PUNCT
aji-17	295	1	additionally	additionally	ADV
aji-17	295	2	,	,	PUNCT
aji-17	295	3	the	the	DET
aji-17	295	4	novel	novel	ADJ
aji-17	295	5	corona	corona	NOUN
aji-17	295	6	virus	virus	NOUN
aji-17	295	7	is	be	AUX
aji-17	295	8	shown	show	VERB
aji-17	295	9	not	not	PART
aji-17	295	10	to	to	PART
aji-17	295	11	be	be	AUX
aji-17	295	12	disseminated	disseminate	VERB
aji-17	295	13	beyond	beyond	ADP
aji-17	295	14	the	the	DET
aji-17	295	15	respiratory	respiratory	ADJ
aji-17	295	16	tract	tract	NOUN
aji-17	295	17	.	.	PUNCT
aji-17	296	1	the	the	DET
aji-17	296	2	recent	recent	ADJ
aji-17	296	3	reports	report	NOUN
aji-17	296	4	of	of	ADP
aji-17	296	5	involvement	involvement	NOUN
aji-17	296	6	of	of	ADP
aji-17	296	7	cardiovascular	cardiovascular	ADJ
aji-17	296	8	system	system	NOUN
aji-17	296	9	(	(	PUNCT
aji-17	296	10	myocarditis	myocarditis	NOUN
aji-17	296	11	)	)	PUNCT
aji-17	296	12	and	and	CCONJ
aji-17	296	13	a	a	DET
aji-17	296	14	couple	couple	NOUN
aji-17	296	15	of	of	ADP
aji-17	296	16	cases	case	NOUN
aji-17	296	17	of	of	ADP
aji-17	296	18	involvement	involvement	NOUN
aji-17	296	19	of	of	ADP
aji-17	296	20	the	the	DET
aji-17	296	21	brain	brain	NOUN
aji-17	296	22	,	,	PUNCT
aji-17	296	23	have	have	VERB
aji-17	296	24	no	no	DET
aji-17	296	25	proof	proof	NOUN
aji-17	296	26	of	of	ADP
aji-17	296	27	direct	direct	ADJ
aji-17	296	28	involvement	involvement	NOUN
aji-17	296	29	of	of	ADP
aji-17	296	30	the	the	DET
aji-17	296	31	cov	cov	NOUN
aji-17	296	32	,	,	PUNCT
aji-17	296	33	beyond	beyond	ADP
aji-17	296	34	reasonable	reasonable	ADJ
aji-17	296	35	doubt	doubt	NOUN
aji-17	296	36	.	.	PUNCT
aji-17	297	1	it	it	PRON
aji-17	297	2	could	could	AUX
aji-17	297	3	’ve	’ve	VERB
aji-17	297	4	be	be	AUX
aji-17	297	5	due	due	ADJ
aji-17	297	6	to	to	ADP
aji-17	297	7	fallout	fallout	NOUN
aji-17	297	8	of	of	ADP
aji-17	297	9	the	the	DET
aji-17	297	10	immune	immune	ADJ
aji-17	297	11	reactio	reactio	NOUN
aji-17	297	12	mounted	mount	VERB
aji-17	297	13	against	against	ADP
aji-17	297	14	the	the	DET
aji-17	297	15	virus	virus	NOUN
aji-17	297	16	.	.	PUNCT
aji-17	298	1	consequently	consequently	ADV
aji-17	298	2	prasad	prasad	PROPN
aji-17	298	3	;	;	PUNCT
aji-17	298	4	aji	aji	NOUN
aji-17	298	5	,	,	PUNCT
aji-17	298	6	3(1	3(1	NUM
aji-17	298	7	):	):	PUNCT
aji-17	298	8	61	61	NUM
aji-17	298	9	-	-	SYM
aji-17	298	10	70	70	NUM
aji-17	298	11	,	,	PUNCT
aji-17	298	12	2020	2020	NUM
aji-17	298	13	;	;	PUNCT
aji-17	298	14	article	article	NOUN
aji-17	298	15	no.aji.55881	no.aji.55881	ADP
aji-17	298	16	68	68	NUM
aji-17	298	17	the	the	DET
aji-17	298	18	cause	cause	NOUN
aji-17	298	19	of	of	ADP
aji-17	298	20	high	high	ADJ
aji-17	298	21	mortality	mortality	NOUN
aji-17	298	22	associated	associate	VERB
aji-17	298	23	with	with	ADP
aji-17	298	24	covid	covid	PROPN
aji-17	298	25	19	19	NUM
aji-17	298	26	,	,	PUNCT
aji-17	298	27	is	be	AUX
aji-17	298	28	restricted	restrict	VERB
aji-17	298	29	to	to	ADP
aji-17	298	30	a	a	DET
aji-17	298	31	deadly	deadly	ADJ
aji-17	298	32	type	type	NOUN
aji-17	298	33	of	of	ADP
aji-17	298	34	pneumonia	pneumonia	NOUN
aji-17	298	35	.	.	PUNCT
aji-17	299	1	if	if	SCONJ
aji-17	299	2	the	the	DET
aji-17	299	3	infection	infection	NOUN
aji-17	299	4	could	could	AUX
aji-17	299	5	be	be	AUX
aji-17	299	6	arrested	arrest	VERB
aji-17	299	7	at	at	ADP
aji-17	299	8	portal	portal	NOUN
aji-17	299	9	of	of	ADP
aji-17	299	10	entry	entry	NOUN
aji-17	299	11	,	,	PUNCT
aji-17	299	12	i.e.	i.e.	X
aji-17	299	13	the	the	DET
aji-17	299	14	nasal	nasal	ADJ
aji-17	299	15	epithelial	epithelial	ADJ
aji-17	299	16	level	level	NOUN
aji-17	299	17	,	,	PUNCT
aji-17	299	18	the	the	DET
aji-17	299	19	disastrous	disastrous	ADJ
aji-17	299	20	consequences	consequence	NOUN
aji-17	299	21	of	of	ADP
aji-17	299	22	spread	spread	NOUN
aji-17	299	23	to	to	ADP
aji-17	299	24	lower	low	ADJ
aji-17	299	25	respiratory	respiratory	ADJ
aji-17	299	26	tract	tract	NOUN
aji-17	299	27	;	;	PUNCT
aji-17	299	28	ĺmay	ĺmay	AUX
aji-17	299	29	be	be	AUX
aji-17	299	30	averted	avert	VERB
aji-17	299	31	.	.	PUNCT
aji-17	300	1	this	this	PRON
aji-17	300	2	makes	make	VERB
aji-17	300	3	a	a	DET
aji-17	300	4	strong	strong	ADJ
aji-17	300	5	case	case	NOUN
aji-17	300	6	for	for	ADP
aji-17	300	7	creating	create	VERB
aji-17	300	8	local	local	ADJ
aji-17	300	9	immunity	immunity	NOUN
aji-17	300	10	at	at	ADP
aji-17	300	11	the	the	DET
aji-17	300	12	level	level	NOUN
aji-17	300	13	of	of	ADP
aji-17	300	14	the	the	DET
aji-17	300	15	nasal	nasal	ADJ
aji-17	300	16	epithelium	epithelium	NOUN
aji-17	300	17	itself	itself	PRON
aji-17	300	18	.	.	PUNCT
aji-17	301	1	local	local	ADJ
aji-17	301	2	mucosal	mucosal	NOUN
aji-17	301	3	infections	infection	NOUN
aji-17	301	4	of	of	ADP
aji-17	301	5	the	the	DET
aji-17	301	6	respiratory	respiratory	ADJ
aji-17	301	7	or	or	CCONJ
aji-17	301	8	gastro	gastro	ADJ
aji-17	301	9	-	-	PUNCT
aji-17	301	10	intestinal	intestinal	ADJ
aji-17	301	11	tract	tract	NOUN
aji-17	301	12	may	may	AUX
aji-17	301	13	elicit	elicit	VERB
aji-17	301	14	local	local	ADJ
aji-17	301	15	cell	cell	NOUN
aji-17	301	16	-	-	PUNCT
aji-17	301	17	mediateld	mediateld	NOUN
aji-17	301	18	and	and	CCONJ
aji-17	301	19	humoral	humoral	ADJ
aji-17	301	20	(	(	PUNCT
aji-17	301	21	iga	iga	PROPN
aji-17	301	22	)	)	PUNCT
aji-17	301	23	immune	immune	ADJ
aji-17	301	24	responses	response	NOUN
aji-17	301	25	,	,	PUNCT
aji-17	301	26	but	but	CCONJ
aji-17	301	27	not	not	PART
aji-17	301	28	necessarily	necessarily	ADV
aji-17	301	29	systemic	systemic	ADJ
aji-17	301	30	immunity	immunity	NOUN
aji-17	301	31	.	.	PUNCT
aji-17	302	1	conversely	conversely	ADV
aji-17	302	2	,	,	PUNCT
aji-17	302	3	systemic	systemic	ADJ
aji-17	302	4	immunity	immunity	NOUN
aji-17	302	5	does	do	AUX
aji-17	302	6	not	not	PART
aji-17	302	7	always	always	ADV
aji-17	302	8	lead	lead	VERB
aji-17	302	9	to	to	ADP
aji-17	302	10	local	local	ADJ
aji-17	302	11	mucosal	mucosal	NOUN
aji-17	302	12	immunity	immunity	NOUN
aji-17	302	13	.	.	PUNCT
aji-17	303	1	localized	localize	VERB
aji-17	303	2	infections	infection	NOUN
aji-17	303	3	of	of	ADP
aji-17	303	4	mucosal	mucosal	NOUN
aji-17	303	5	surfaces	surface	NOUN
aji-17	303	6	,	,	PUNCT
aji-17	303	7	and	and	CCONJ
aji-17	303	8	the	the	DET
aji-17	303	9	protection	protection	NOUN
aji-17	303	10	derived	derive	VERB
aji-17	303	11	,	,	PUNCT
aji-17	303	12	does	do	AUX
aji-17	303	13	not	not	PART
aji-17	303	14	correlate	correlate	VERB
aji-17	303	15	with	with	ADP
aji-17	303	16	the	the	DET
aji-17	303	17	presence	presence	NOUN
aji-17	303	18	of	of	ADP
aji-17	303	19	serum	serum	NOUN
aji-17	303	20	antibody	antibody	NOUN
aji-17	303	21	,	,	PUNCT
aji-17	303	22	but	but	CCONJ
aji-17	303	23	it	it	PRON
aji-17	303	24	does	do	AUX
aji-17	303	25	correlate	correlate	VERB
aji-17	303	26	with	with	ADP
aji-17	303	27	the	the	DET
aji-17	303	28	presence	presence	NOUN
aji-17	303	29	of	of	ADP
aji-17	303	30	local	local	ADJ
aji-17	303	31	iga	iga	PROPN
aji-17	303	32	antibody	antibody	NOUN
aji-17	303	33	,	,	PUNCT
aji-17	303	34	as	as	SCONJ
aji-17	303	35	has	have	AUX
aji-17	303	36	been	be	AUX
aji-17	303	37	shown	show	VERB
aji-17	303	38	in	in	ADP
aji-17	303	39	human	human	ADJ
aji-17	303	40	studies	study	NOUN
aji-17	303	41	of	of	ADP
aji-17	303	42	viruses	virus	NOUN
aji-17	303	43	restricted	restrict	VERB
aji-17	303	44	to	to	ADP
aji-17	303	45	the	the	DET
aji-17	303	46	respiratory	respiratory	ADJ
aji-17	303	47	tract	tract	NOUN
aji-17	303	48	(	(	PUNCT
aji-17	303	49	e.g.	e.g.	ADV
aji-17	303	50	,	,	PUNCT
aji-17	303	51	respiratory	respiratory	ADJ
aji-17	303	52	syncytial	syncytial	ADJ
aji-17	303	53	virus	virus	NOUN
aji-17	303	54	and	and	CCONJ
aji-17	303	55	influenza	influenza	NOUN
aji-17	303	56	virus	virus	NOUN
aji-17	303	57	)	)	PUNCT
aji-17	303	58	or	or	CCONJ
aji-17	303	59	to	to	ADP
aji-17	303	60	the	the	DET
aji-17	303	61	gastrointestinal	gastrointestinal	ADJ
aji-17	303	62	tract	tract	NOUN
aji-17	303	63	(	(	PUNCT
aji-17	303	64	e.g.	e.g.	ADV
aji-17	303	65	,	,	PUNCT
aji-17	303	66	enteroviruses	enterovirus	NOUN
aji-17	303	67	)	)	PUNCT
aji-17	303	68	.	.	PUNCT
aji-17	304	1	the	the	DET
aji-17	304	2	route	route	NOUN
aji-17	304	3	of	of	ADP
aji-17	304	4	administering	administer	VERB
aji-17	304	5	the	the	DET
aji-17	304	6	vaccine	vaccine	NOUN
aji-17	304	7	is	be	AUX
aji-17	304	8	the	the	DET
aji-17	304	9	major	major	ADJ
aji-17	304	10	determinant	determinant	NOUN
aji-17	304	11	of	of	ADP
aji-17	304	12	the	the	DET
aji-17	304	13	issue	issue	NOUN
aji-17	304	14	immunity	immunity	NOUN
aji-17	304	15	.	.	PUNCT
aji-17	305	1	the	the	DET
aji-17	305	2	past	past	ADJ
aji-17	305	3	experience	experience	NOUN
aji-17	305	4	of	of	ADP
aji-17	305	5	intranasal	intranasal	ADJ
aji-17	305	6	vaccine	vaccine	NOUN
aji-17	305	7	as	as	SCONJ
aji-17	305	8	is	be	AUX
aji-17	305	9	approved	approve	VERB
aji-17	305	10	for	for	ADP
aji-17	305	11	influenza	influenza	NOUN
aji-17	305	12	may	may	AUX
aji-17	305	13	be	be	AUX
aji-17	305	14	taken	take	VERB
aji-17	305	15	as	as	ADP
aji-17	305	16	an	an	DET
aji-17	305	17	example	example	NOUN
aji-17	305	18	,	,	PUNCT
aji-17	305	19	in	in	ADP
aji-17	305	20	the	the	DET
aji-17	305	21	case	case	NOUN
aji-17	305	22	of	of	ADP
aji-17	305	23	covid	covid	PROPN
aji-17	305	24	19	19	NUM
aji-17	305	25	.	.	PUNCT
aji-17	306	1	it	it	PRON
aji-17	306	2	is	be	AUX
aji-17	306	3	also	also	ADV
aji-17	306	4	shown	show	VERB
aji-17	306	5	that	that	SCONJ
aji-17	306	6	prior	prior	ADJ
aji-17	306	7	systemic	systemic	ADJ
aji-17	306	8	vaccination	vaccination	NOUN
aji-17	306	9	may	may	AUX
aji-17	306	10	interfere	interfere	VERB
aji-17	306	11	with	with	ADP
aji-17	306	12	the	the	DET
aji-17	306	13	recall	recall	NOUN
aji-17	306	14	memory	memory	NOUN
aji-17	306	15	exercised	exercise	VERB
aji-17	306	16	by	by	ADP
aji-17	306	17	the	the	DET
aji-17	306	18	nasal	nasal	PROPN
aji-17	306	19	mucosa	mucosa	PROPN
aji-17	306	20	,	,	PUNCT
aji-17	306	21	should	should	AUX
aji-17	306	22	the	the	DET
aji-17	306	23	pathogen	pathogen	NOUN
aji-17	306	24	cause	cause	VERB
aji-17	306	25	reinfection	reinfection	NOUN
aji-17	306	26	the	the	DET
aji-17	306	27	same	same	ADJ
aji-17	306	28	person	person	NOUN
aji-17	306	29	.	.	PUNCT
aji-17	307	1	there	there	PRON
aji-17	307	2	is	be	VERB
aji-17	307	3	no	no	DET
aji-17	307	4	permanent	permanent	ADJ
aji-17	307	5	infection	infection	NOUN
aji-17	307	6	-	-	PUNCT
aji-17	307	7	induced	induce	VERB
aji-17	307	8	immunity	immunity	NOUN
aji-17	307	9	conferred	confer	VERB
aji-17	307	10	by	by	ADP
aji-17	307	11	the	the	DET
aji-17	307	12	covid	covid	PROPN
aji-17	307	13	19	19	NUM
aji-17	307	14	.	.	PUNCT
aji-17	308	1	this	this	DET
aji-17	308	2	factor	factor	NOUN
aji-17	308	3	also	also	ADV
aji-17	308	4	supports	support	VERB
aji-17	308	5	the	the	DET
aji-17	308	6	suggestion	suggestion	NOUN
aji-17	308	7	of	of	ADP
aji-17	308	8	raising	raise	VERB
aji-17	308	9	local	local	ADJ
aji-17	308	10	immunity	immunity	NOUN
aji-17	308	11	of	of	ADP
aji-17	308	12	nasal	nasal	ADJ
aji-17	308	13	epithelium	epithelium	NOUN
aji-17	308	14	by	by	ADP
aji-17	308	15	administering	administer	VERB
aji-17	308	16	the	the	DET
aji-17	308	17	vaccine	vaccine	NOUN
aji-17	308	18	intranasally	intranasally	ADV
aji-17	308	19	.	.	PUNCT
aji-17	309	1	it	it	PRON
aji-17	309	2	is	be	AUX
aji-17	309	3	logical	logical	ADJ
aji-17	309	4	that	that	SCONJ
aji-17	309	5	raising	raise	VERB
aji-17	309	6	local	local	ADJ
aji-17	309	7	immunity	immunity	NOUN
aji-17	309	8	in	in	ADP
aji-17	309	9	nasal	nasal	ADJ
aji-17	309	10	epithelium	epithelium	NOUN
aji-17	309	11	may	may	AUX
aji-17	309	12	give	give	VERB
aji-17	309	13	a	a	DET
aji-17	309	14	multi	multi	ADJ
aji-17	309	15	pronged	pronged	ADJ
aji-17	309	16	protection	protection	NOUN
aji-17	309	17	from	from	ADP
aji-17	309	18	the	the	DET
aji-17	309	19	covid	covid	PROPN
aji-17	309	20	19	19	NUM
aji-17	309	21	.	.	PUNCT
aji-17	309	22	against	against	ADP
aji-17	309	23	entry	entry	NOUN
aji-17	309	24	multiplication	multiplication	NOUN
aji-17	309	25	.	.	PUNCT
aji-17	310	1	as	as	ADV
aji-17	310	2	well	well	ADV
aji-17	310	3	excretion	excretion	NOUN
aji-17	310	4	in	in	ADP
aji-17	310	5	nasal	nasal	ADJ
aji-17	310	6	sections	section	NOUN
aji-17	310	7	.	.	PUNCT
aji-17	311	1	the	the	DET
aji-17	311	2	last	last	ADJ
aji-17	311	3	one	one	NOUN
aji-17	311	4	is	be	AUX
aji-17	311	5	very	very	ADV
aji-17	311	6	important	important	ADJ
aji-17	311	7	from	from	ADP
aji-17	311	8	public	public	ADJ
aji-17	311	9	health	health	NOUN
aji-17	311	10	point	point	NOUN
aji-17	311	11	of	of	ADP
aji-17	311	12	view	view	NOUN
aji-17	311	13	,	,	PUNCT
aji-17	311	14	in	in	ADP
aji-17	311	15	preventing	prevent	VERB
aji-17	311	16	the	the	DET
aji-17	311	17	spread	spread	NOUN
aji-17	311	18	of	of	ADP
aji-17	311	19	the	the	DET
aji-17	311	20	infection	infection	NOUN
aji-17	311	21	to	to	ADP
aji-17	311	22	others	other	NOUN
aji-17	311	23	.	.	PUNCT
aji-17	312	1	local	local	ADJ
aji-17	312	2	immunity	immunity	NOUN
aji-17	312	3	is	be	AUX
aji-17	312	4	found	find	VERB
aji-17	312	5	to	to	PART
aji-17	312	6	be	be	AUX
aji-17	312	7	effective	effective	ADJ
aji-17	312	8	at	at	ADP
aji-17	312	9	least	least	ADJ
aji-17	312	10	in	in	ADP
aji-17	312	11	two	two	NUM
aji-17	312	12	diseases	disease	NOUN
aji-17	312	13	.	.	PUNCT
aji-17	313	1	to	to	PART
aji-17	313	2	elaborate	elaborate	VERB
aji-17	313	3	this	this	DET
aji-17	313	4	point	point	NOUN
aji-17	313	5	,	,	PUNCT
aji-17	313	6	the	the	DET
aji-17	313	7	polio	polio	NOUN
aji-17	313	8	virus	virus	NOUN
aji-17	313	9	,	,	PUNCT
aji-17	313	10	whose	whose	DET
aji-17	313	11	portal	portal	NOUN
aji-17	313	12	of	of	ADP
aji-17	313	13	entry	entry	NOUN
aji-17	313	14	of	of	ADP
aji-17	313	15	the	the	DET
aji-17	313	16	infection	infection	NOUN
aji-17	313	17	is	be	AUX
aji-17	313	18	the	the	DET
aji-17	313	19	gastrointestinal	gastrointestinal	ADJ
aji-17	313	20	tract	tract	NOUN
aji-17	313	21	,	,	PUNCT
aji-17	313	22	oral	oral	ADJ
aji-17	313	23	polio	polio	NOUN
aji-17	313	24	vaccine	vaccine	NOUN
aji-17	313	25	is	be	AUX
aji-17	313	26	the	the	DET
aji-17	313	27	time	time	NOUN
aji-17	313	28	tested	test	VERB
aji-17	313	29	vaccine	vaccine	NOUN
aji-17	313	30	that	that	PRON
aji-17	313	31	conferred	confer	VERB
aji-17	313	32	immunity	immunity	NOUN
aji-17	313	33	to	to	PART
aji-17	313	34	polio	polio	VERB
aji-17	313	35	virus	virus	NOUN
aji-17	313	36	.	.	PUNCT
aji-17	314	1	it	it	PRON
aji-17	314	2	is	be	AUX
aji-17	314	3	shown	show	VERB
aji-17	314	4	to	to	PART
aji-17	314	5	be	be	AUX
aji-17	314	6	effective	effective	ADJ
aji-17	314	7	by	by	ADP
aji-17	314	8	raising	raise	VERB
aji-17	314	9	mucosa	mucosa	NOUN
aji-17	314	10	immunity	immunity	NOUN
aji-17	314	11	both	both	CCONJ
aji-17	314	12	at	at	ADP
aji-17	314	13	pharyngeal	pharyngeal	ADJ
aji-17	314	14	and	and	CCONJ
aji-17	314	15	intestinal	intestinal	ADJ
aji-17	314	16	levelled	level	VERB
aji-17	314	17	–	–	PUNCT
aji-17	314	18	ipv	ipv	PROPN
aji-17	314	19	(	(	PUNCT
aji-17	314	20	inactivated	inactivated	ADJ
aji-17	314	21	polio	polio	NOUN
aji-17	314	22	vaccine	vaccine	NOUN
aji-17	314	23	)	)	PUNCT
aji-17	314	24	was	be	AUX
aji-17	314	25	less	less	ADV
aji-17	314	26	effective	effective	ADJ
aji-17	314	27	than	than	ADP
aji-17	314	28	opv	opv	NOUN
aji-17	314	29	in	in	ADP
aji-17	314	30	preventing	prevent	VERB
aji-17	314	31	and	and	CCONJ
aji-17	314	32	limiting	limit	VERB
aji-17	314	33	intestinal	intestinal	ADJ
aji-17	314	34	infection	infection	NOUN
aji-17	314	35	,	,	PUNCT
aji-17	314	36	even	even	ADV
aji-17	314	37	though	though	SCONJ
aji-17	314	38	it	it	PRON
aji-17	314	39	induced	induce	VERB
aji-17	314	40	higher	high	ADJ
aji-17	314	41	post	post	NOUN
aji-17	314	42	vaccination	vaccination	NOUN
aji-17	314	43	serum	serum	NOUN
aji-17	314	44	antibody	antibody	NOUN
aji-17	314	45	levels	level	NOUN
aji-17	314	46	.	.	PUNCT
aji-17	315	1	while	while	SCONJ
aji-17	315	2	opv	opv	PROPN
aji-17	315	3	(	(	PUNCT
aji-17	315	4	oral	oral	ADJ
aji-17	315	5	polio	polio	NOUN
aji-17	315	6	vaccine	vaccine	NOUN
aji-17	315	7	)	)	PUNCT
aji-17	315	8	checks	check	VERB
aji-17	315	9	the	the	DET
aji-17	315	10	excretion	excretion	NOUN
aji-17	315	11	of	of	ADP
aji-17	315	12	polio	polio	NOUN
aji-17	315	13	virus	virus	NOUN
aji-17	315	14	through	through	ADP
aji-17	315	15	faeces	faece	NOUN
aji-17	315	16	(	(	PUNCT
aji-17	315	17	there	there	ADV
aji-17	315	18	by	by	ADP
aji-17	315	19	preventing	prevent	VERB
aji-17	315	20	the	the	DET
aji-17	315	21	spread	spread	NOUN
aji-17	315	22	of	of	ADP
aji-17	315	23	infection	infection	NOUN
aji-17	315	24	to	to	ADP
aji-17	315	25	others	other	NOUN
aji-17	315	26	,	,	PUNCT
aji-17	315	27	[	[	X
aji-17	315	28	36	36	NUM
aji-17	315	29	]	]	PUNCT
aji-17	315	30	the	the	DET
aji-17	315	31	continued	continue	VERB
aji-17	315	32	excretion	excretion	NOUN
aji-17	315	33	of	of	ADP
aji-17	315	34	the	the	DET
aji-17	315	35	polio	polio	NOUN
aji-17	315	36	virus	virus	NOUN
aji-17	315	37	in	in	ADP
aji-17	315	38	case	case	NOUN
aji-17	315	39	of	of	ADP
aji-17	315	40	immunisation	immunisation	NOUN
aji-17	315	41	by	by	ADP
aji-17	315	42	the	the	DET
aji-17	315	43	inactivated	inactivated	ADJ
aji-17	315	44	vaccine	vaccine	NOUN
aji-17	315	45	administered	administer	VERB
aji-17	315	46	by	by	ADP
aji-17	315	47	parenteral	parenteral	ADJ
aji-17	315	48	route	route	NOUN
aji-17	315	49	,	,	PUNCT
aji-17	315	50	poses	pose	VERB
aji-17	315	51	risk	risk	NOUN
aji-17	315	52	of	of	ADP
aji-17	315	53	continued	continue	VERB
aji-17	315	54	deco	deco	NOUN
aji-17	315	55	-	-	PUNCT
aji-17	315	56	oral	oral	ADJ
aji-17	315	57	transmission	transmission	NOUN
aji-17	315	58	,	,	PUNCT
aji-17	315	59	though	though	SCONJ
aji-17	315	60	it	it	PRON
aji-17	315	61	offered	offer	VERB
aji-17	315	62	immunity	immunity	NOUN
aji-17	315	63	at	at	ADP
aji-17	315	64	the	the	DET
aji-17	315	65	personal	personal	ADJ
aji-17	315	66	level	level	NOUN
aji-17	315	67	.	.	PUNCT
aji-17	316	1	secondly	secondly	ADV
aji-17	316	2	,	,	PUNCT
aji-17	316	3	the	the	DET
aji-17	316	4	influenza	influenza	NOUN
aji-17	316	5	vaccine	vaccine	NOUN
aji-17	316	6	administered	administer	VERB
aji-17	316	7	intranasally	intranasally	ADV
aji-17	316	8	as	as	SCONJ
aji-17	316	9	a	a	DET
aji-17	316	10	spray	spray	NOUN
aji-17	316	11	type	type	NOUN
aji-17	316	12	vaccine	vaccine	NOUN
aji-17	316	13	has	have	AUX
aji-17	316	14	been	be	AUX
aji-17	316	15	accepted	accept	VERB
aji-17	316	16	efficacy	efficacy	NOUN
aji-17	316	17	-	-	PUNCT
aji-17	316	18	wise	wise	ADJ
aji-17	316	19	by	by	ADP
aji-17	316	20	the	the	DET
aji-17	316	21	cdc	cdc	PROPN
aji-17	316	22	.	.	PROPN
aji-17	317	1	3	3	X
aji-17	317	2	.	.	X
aji-17	317	3	conclusion	conclusion	NOUN
aji-17	317	4	the	the	DET
aji-17	317	5	covid	covid	PROPN
aji-17	317	6	19	19	NUM
aji-17	317	7	,	,	PUNCT
aji-17	317	8	as	as	SCONJ
aji-17	317	9	seen	see	VERB
aji-17	317	10	from	from	ADP
aji-17	317	11	the	the	DET
aji-17	317	12	tropism	tropism	NOUN
aji-17	317	13	to	to	ADP
aji-17	317	14	airway	airway	NOUN
aji-17	317	15	(	(	PUNCT
aji-17	317	16	nasal	nasal	NOUN
aji-17	317	17	)	)	PUNCT
aji-17	317	18	epithelium	epithelium	NOUN
aji-17	317	19	through	through	ADP
aji-17	317	20	which	which	PRON
aji-17	317	21	it	it	PRON
aji-17	317	22	gains	gain	VERB
aji-17	317	23	entry	entry	NOUN
aji-17	317	24	,	,	PUNCT
aji-17	317	25	multiplies	multiplie	NOUN
aji-17	317	26	and	and	CCONJ
aji-17	317	27	even	even	ADV
aji-17	317	28	shed	shed	VERB
aji-17	317	29	in	in	ADP
aji-17	317	30	the	the	DET
aji-17	317	31	nasal	nasal	NOUN
aji-17	317	32	secretions	secretion	NOUN
aji-17	317	33	,	,	PUNCT
aji-17	317	34	indicates	indicate	VERB
aji-17	317	35	that	that	SCONJ
aji-17	317	36	,	,	PUNCT
aji-17	317	37	efforts	effort	NOUN
aji-17	317	38	to	to	PART
aji-17	317	39	raise	raise	VERB
aji-17	317	40	the	the	DET
aji-17	317	41	local	local	ADJ
aji-17	317	42	immunity	immunity	NOUN
aji-17	317	43	of	of	ADP
aji-17	317	44	the	the	DET
aji-17	317	45	respiratory	respiratory	ADJ
aji-17	317	46	epithelium	epithelium	NOUN
aji-17	317	47	,	,	PUNCT
aji-17	317	48	especially	especially	ADV
aji-17	317	49	at	at	ADP
aji-17	317	50	the	the	DET
aji-17	317	51	very	very	ADJ
aji-17	317	52	portal	portal	NOUN
aji-17	317	53	of	of	ADP
aji-17	317	54	its	its	PRON
aji-17	317	55	entry	entry	NOUN
aji-17	317	56	,	,	PUNCT
aji-17	317	57	may	may	AUX
aji-17	317	58	be	be	AUX
aji-17	317	59	fruitful	fruitful	ADJ
aji-17	317	60	in	in	ADP
aji-17	317	61	‘	'	PUNCT
aji-17	317	62	nipping	nip	VERB
aji-17	317	63	the	the	DET
aji-17	317	64	infection	infection	NOUN
aji-17	317	65	in	in	ADP
aji-17	317	66	the	the	DET
aji-17	317	67	bud	bud	NOUN
aji-17	317	68	’	'	PUNCT
aji-17	317	69	.	.	PUNCT
aji-17	318	1	accordingly	accordingly	ADV
aji-17	318	2	in	in	ADP
aji-17	318	3	the	the	DET
aji-17	318	4	case	case	NOUN
aji-17	318	5	of	of	ADP
aji-17	318	6	covid	covid	PROPN
aji-17	318	7	19	19	NUM
aji-17	318	8	,	,	PUNCT
aji-17	318	9	vaccine	vaccine	NOUN
aji-17	318	10	developed	develop	VERB
aji-17	318	11	might	might	AUX
aji-17	318	12	be	be	AUX
aji-17	318	13	effective	effective	ADJ
aji-17	318	14	,	,	PUNCT
aji-17	318	15	if	if	SCONJ
aji-17	318	16	administered	administer	VERB
aji-17	318	17	intranasally	intranasally	ADV
aji-17	318	18	,	,	PUNCT
aji-17	318	19	rather	rather	ADV
aji-17	318	20	than	than	ADP
aji-17	318	21	other	other	ADJ
aji-17	318	22	routes	route	NOUN
aji-17	318	23	of	of	ADP
aji-17	318	24	vaccine	vaccine	NOUN
aji-17	318	25	administration	administration	NOUN
aji-17	318	26	,	,	PUNCT
aji-17	318	27	it	it	PRON
aji-17	318	28	is	be	AUX
aji-17	318	29	felt	feel	VERB
aji-17	318	30	.	.	PUNCT
aji-17	319	1	consent	consent	NOUN
aji-17	319	2	and	and	CCONJ
aji-17	319	3	ethical	ethical	ADJ
aji-17	319	4	approval	approval	NOUN
aji-17	319	5	it	it	PRON
aji-17	319	6	is	be	AUX
aji-17	319	7	not	not	PART
aji-17	319	8	applicable	applicable	ADJ
aji-17	319	9	.	.	PUNCT
aji-17	320	1	competing	compete	VERB
aji-17	320	2	interests	interest	NOUN
aji-17	320	3	author	author	NOUN
aji-17	320	4	has	have	AUX
aji-17	320	5	declared	declare	VERB
aji-17	320	6	that	that	SCONJ
aji-17	320	7	no	no	DET
aji-17	320	8	competing	compete	VERB
aji-17	320	9	interests	interest	NOUN
aji-17	320	10	exist	exist	VERB
aji-17	320	11	.	.	PUNCT
aji-17	321	1	references	reference	NOUN
aji-17	321	2	1	1	NUM
aji-17	321	3	.	.	PUNCT
aji-17	322	1	zhang	zhang	PROPN
aji-17	322	2	s	s	PROPN
aji-17	322	3	,	,	PUNCT
aji-17	322	4	na	na	ADP
aji-17	322	5	j	j	PROPN
aji-17	322	6	,	,	PUNCT
aji-17	322	7	zhou	zhou	PROPN
aji-17	322	8	w	w	PROPN
aji-17	322	9	,	,	PUNCT
aji-17	322	10	liu	liu	PROPN
aji-17	322	11	b	b	PROPN
aji-17	322	12	,	,	PUNCT
aji-17	322	13	yang	yang	PROPN
aji-17	322	14	w	w	PROPN
aji-17	322	15	,	,	PUNCT
aji-17	322	16	zhou	zhou	PROPN
aji-17	322	17	p	p	X
aji-17	322	18	,	,	PUNCT
aji-17	322	19	et	et	PROPN
aji-17	322	20	al	al	PROPN
aji-17	322	21	.	.	PUNCT
aji-17	323	1	a	a	DET
aji-17	323	2	familial	familial	ADJ
aji-17	323	3	cluster	cluster	NOUN
aji-17	323	4	of	of	ADP
aji-17	323	5	covid19	covid19	NOUN
aji-17	323	6	indicating	indicate	VERB
aji-17	323	7	virus	virus	NOUN
aji-17	323	8	can	can	AUX
aji-17	323	9	be	be	AUX
aji-17	323	10	transmitted	transmit	VERB
aji-17	323	11	by	by	ADP
aji-17	323	12	asymptomatic	asymptomatic	ADJ
aji-17	323	13	carriers	carrier	NOUN
aji-17	323	14	.	.	PUNCT
aji-17	324	1	[	[	X
aji-17	324	2	submitted	submit	VERB
aji-17	324	3	]	]	PUNCT
aji-17	324	4	.	.	PUNCT
aji-17	325	1	bull	bull	PROPN
aji-17	325	2	world	world	PROPN
aji-17	325	3	health	health	NOUN
aji-17	325	4	organ	organ	NOUN
aji-17	325	5	.	.	PUNCT
aji-17	326	1	e	e	X
aji-17	326	2	-	-	NOUN
aji-17	326	3	pub	pub	NOUN
aji-17	326	4	;	;	PUNCT
aji-17	326	5	2020	2020	NUM
aji-17	326	6	.	.	X
aji-17	327	1	2	2	X
aji-17	327	2	.	.	X
aji-17	327	3	yan	yan	PROPN
aji-17	327	4	bai	bai	PROPN
aji-17	327	5	,	,	PUNCT
aji-17	327	6	lingsheng	lingsheng	PROPN
aji-17	327	7	yao	yao	PROPN
aji-17	327	8	,	,	PUNCT
aji-17	327	9	tao	tao	PROPN
aji-17	327	10	wei	wei	PROPN
aji-17	327	11	,	,	PUNCT
aji-17	327	12	et	et	PROPN
aji-17	327	13	al	al	PROPN
aji-17	327	14	.	.	PROPN
aji-17	327	15	presumed	presume	VERB
aji-17	327	16	asymptomatic	asymptomatic	ADJ
aji-17	327	17	carrier	carrier	NOUN
aji-17	327	18	transmission	transmission	NOUN
aji-17	327	19	of	of	ADP
aji-17	327	20	covid-19	covid-19	PROPN
aji-17	327	21	.	.	PUNCT
aji-17	327	22	jama	jama	PROPN
aji-17	327	23	;	;	PUNCT
aji-17	327	24	2020	2020	NUM
aji-17	327	25	.	.	PUNCT
aji-17	328	1	3	3	X
aji-17	328	2	.	.	X
aji-17	328	3	camilla	camilla	PROPN
aji-17	328	4	rothe	rothe	PROPN
aji-17	328	5	,	,	PUNCT
aji-17	328	6	mirjam	mirjam	PROPN
aji-17	328	7	schunk	schunk	PROPN
aji-17	328	8	,	,	PUNCT
aji-17	328	9	peter	peter	PROPN
aji-17	328	10	sothmann	sothmann	PROPN
aji-17	328	11	,	,	PUNCT
aji-17	328	12	et	et	PROPN
aji-17	328	13	al	al	PROPN
aji-17	328	14	.	.	PUNCT
aji-17	328	15	transmission	transmission	NOUN
aji-17	328	16	of	of	ADP
aji-17	328	17	2019ncov	2019ncov	NUM
aji-17	328	18	infection	infection	NOUN
aji-17	328	19	from	from	ADP
aji-17	328	20	an	an	DET
aji-17	328	21	asymptomatic	asymptomatic	ADJ
aji-17	328	22	contact	contact	NOUN
aji-17	328	23	in	in	ADP
aji-17	328	24	germany	germany	PROPN
aji-17	328	25	,	,	PUNCT
aji-17	328	26	nejm	nejm	PROPN
aji-17	328	27	;	;	PUNCT
aji-17	328	28	2019	2019	NUM
aji-17	328	29	.	.	PUNCT
aji-17	329	1	doi	doi	NOUN
aji-17	329	2	:	:	PUNCT
aji-17	329	3	10.1056	10.1056	NUM
aji-17	329	4	/	/	SYM
aji-17	329	5	nejmc2001468	nejmc2001468	PROPN
aji-17	329	6	4	4	NUM
aji-17	329	7	.	.	PUNCT
aji-17	330	1	study	study	NOUN
aji-17	330	2	claiming	claim	VERB
aji-17	330	3	new	new	ADJ
aji-17	330	4	coronavirus	coronavirus	NOUN
aji-17	330	5	can	can	AUX
aji-17	330	6	be	be	AUX
aji-17	330	7	transmitted	transmit	VERB
aji-17	330	8	by	by	ADP
aji-17	330	9	people	people	NOUN
aji-17	330	10	without	without	ADP
aji-17	330	11	symptoms	symptom	NOUN
aji-17	330	12	was	be	AUX
aji-17	330	13	flawed	flawed	ADJ
aji-17	330	14	.	.	PUNCT
aji-17	331	1	local	local	ADJ
aji-17	331	2	immunity	immunity	NOUN
aji-17	331	3	in	in	ADP
aji-17	331	4	infectious	infectious	ADJ
aji-17	331	5	diseases	disease	NOUN
aji-17	331	6	.	.	PUNCT
aji-17	332	1	nature	nature	NOUN
aji-17	332	2	.	.	PUNCT
aji-17	333	1	2020;113:242–243	2020;113:242–243	NOUN
aji-17	333	2	.	.	PUNCT
aji-17	334	1	available	available	ADJ
aji-17	334	2	:	:	PUNCT
aji-17	334	3	sciencemag.org	sciencemag.org	X
aji-17	334	4	/	/	SYM
aji-17	334	5	news/2020	news/2020	NOUN
aji-17	334	6	5	5	NUM
aji-17	334	7	.	.	PUNCT
aji-17	335	1	aford	aford	PROPN
aji-17	335	2	rh	rh	PROPN
aji-17	335	3	,	,	PUNCT
aji-17	335	4	rossen	rossen	PROPN
aji-17	335	5	rd	rd	PROPN
aji-17	335	6	,	,	PUNCT
aji-17	335	7	butler	butler	PROPN
aji-17	335	8	wt	wt	PROPN
aji-17	335	9	,	,	PUNCT
aji-17	335	10	kasel	kasel	PROPN
aji-17	335	11	ja	ja	PROPN
aji-17	335	12	.	.	PUNCT
aji-17	335	13	neutralizing	neutralizing	PROPN
aji-17	335	14	and	and	CCONJ
aji-17	335	15	hemagglutination	hemagglutination	NOUN
aji-17	335	16	i	i	PRON
aji-17	335	17	nhibiting	nhibite	VERB
aji-17	335	18	activity	activity	NOUN
aji-17	335	19	of	of	ADP
aji-17	335	20	nasal	nasal	ADJ
aji-17	335	21	secretions	secretion	NOUN
aji-17	335	22	following	follow	VERB
aji-17	335	23	experimental	experimental	ADJ
aji-17	335	24	human	human	ADJ
aji-17	335	25	infection	infection	NOUN
aji-17	335	26	with	with	ADP
aji-17	335	27	a2	a2	PROPN
aji-17	335	28	influenza	influenza	PROPN
aji-17	335	29	virus	virus	PROPN
aji-17	335	30	.	.	PUNCT
aji-17	336	1	j.	j.	PROPN
aji-17	336	2	mmunol	mmunol	PROPN
aji-17	336	3	.	.	PUNCT
aji-17	337	1	1967;98:724	1967;98:724	NUM
aji-17	337	2	-	-	SYM
aji-17	337	3	731	731	NUM
aji-17	337	4	.	.	PUNCT
aji-17	338	1	prasad	prasad	PROPN
aji-17	338	2	;	;	PUNCT
aji-17	338	3	aji	aji	NOUN
aji-17	338	4	,	,	PUNCT
aji-17	338	5	3(1	3(1	NUM
aji-17	338	6	):	):	PUNCT
aji-17	338	7	61	61	NUM
aji-17	338	8	-	-	SYM
aji-17	338	9	70	70	NUM
aji-17	338	10	,	,	PUNCT
aji-17	338	11	2020	2020	NUM
aji-17	338	12	;	;	PUNCT
aji-17	338	13	article	article	NOUN
aji-17	338	14	no.aji.55881	no.aji.55881	ADP
aji-17	338	15	69	69	NUM
aji-17	338	16	6	6	NUM
aji-17	338	17	.	.	PUNCT
aji-17	339	1	welliver	welliver	PROPN
aji-17	339	2	rc	rc	PROPN
aji-17	339	3	,	,	PUNCT
aji-17	339	4	et	et	PROPN
aji-17	339	5	al	al	PROPN
aji-17	339	6	.	.	PUNCT
aji-17	339	7	importance	importance	NOUN
aji-17	339	8	of	of	ADP
aji-17	339	9	local	local	ADJ
aji-17	339	10	immunity	immunity	NOUN
aji-17	339	11	in	in	ADP
aji-17	339	12	enteric	enteric	ADJ
aji-17	339	13	infection	infection	NOUN
aji-17	339	14	.	.	PUNCT
aji-17	340	1	review	review	NOUN
aji-17	340	2	article	article	NOUN
aji-17	340	3	.	.	PUNCT
aji-17	341	1	j	j	PROPN
aji-17	341	2	am	be	AUX
aji-17	341	3	vet	vet	NOUN
aji-17	341	4	.	.	PUNCT
aji-17	342	1	medassoc	medassoc	PROPN
aji-17	342	2	;	;	PUNCT
aji-17	342	3	1978	1978	NUM
aji-17	342	4	.	.	PUNCT
aji-17	343	1	7	7	X
aji-17	343	2	.	.	X
aji-17	343	3	potter	potter	PROPN
aji-17	343	4	cw	cw	PROPN
aji-17	343	5	,	,	PUNCT
aji-17	343	6	oxford	oxford	PROPN
aji-17	343	7	js	js	PROPN
aji-17	343	8	,	,	PUNCT
aji-17	343	9	shore	shore	PROPN
aji-17	343	10	sl	sl	PROPN
aji-17	343	11	,	,	PUNCT
aji-17	343	12	mclaren	mclaren	PROPN
aji-17	343	13	c	c	PROPN
aji-17	343	14	,	,	PUNCT
aji-17	343	15	stuart	stuart	PROPN
aji-17	343	16	-	-	PUNCT
aji-17	343	17	harris	harris	PROPN
aji-17	343	18	ch	ch	PROPN
aji-17	343	19	.	.	PUNCT
aji-17	344	1	immunity	immunity	NOUN
aji-17	344	2	to	to	ADP
aji-17	344	3	influenza	influenza	NOUN
aji-17	344	4	in	in	ADP
aji-17	344	5	ferrets	ferret	NOUN
aji-17	344	6	.	.	PUNCT
aji-17	345	1	i.	i.	PROPN
aji-17	345	2	response	response	NOUN
aji-17	345	3	to	to	PART
aji-17	345	4	live	live	VERB
aji-17	345	5	and	and	CCONJ
aji-17	345	6	killed	kill	VERB
aji-17	345	7	virus	virus	NOUN
aji-17	345	8	.	.	PUNCT
aji-17	346	1	br	br	PROPN
aji-17	346	2	.	.	PUNCT
aji-17	347	1	j.	j.	PROPN
aji-17	347	2	exp	exp	PROPN
aji-17	347	3	.	.	PUNCT
aji-17	347	4	pathol	pathol	NOUN
aji-17	347	5	.	.	PUNCT
aji-17	348	1	1972;53:153	1972;53:153	NUM
aji-17	348	2	-	-	SYM
aji-17	348	3	167	167	NUM
aji-17	348	4	.	.	PUNCT
aji-17	349	1	8	8	NUM
aji-17	349	2	.	.	PUNCT
aji-17	350	1	henry	henry	PROPN
aji-17	350	2	barber	barber	PROPN
aji-17	350	3	w	w	PROPN
aji-17	350	4	,	,	PUNCT
aji-17	350	5	parker	parker	PROPN
aji-17	350	6	a	a	PRON
aji-17	350	7	,	,	PUNCT
aji-17	350	8	small	small	PROPN
aji-17	350	9	jr	jr	PROPN
aji-17	350	10	.	.	PROPN
aji-17	350	11	local	local	ADJ
aji-17	350	12	and	and	CCONJ
aji-17	350	13	systemic	systemic	ADJ
aji-17	350	14	immunity	immunity	NOUN
aji-17	350	15	to	to	ADP
aji-17	350	16	influenza	influenza	NOUN
aji-17	350	17	infections	infection	NOUN
aji-17	350	18	in	in	ADP
aji-17	350	19	ferret	ferret	PROPN
aji-17	350	20	.	.	PUNCT
aji-17	351	1	infection	infection	NOUN
aji-17	351	2	and	and	CCONJ
aji-17	351	3	immunity	immunity	NOUN
aji-17	351	4	.	.	PUNCT
aji-17	352	1	1978;221	1978;221	PROPN
aji-17	352	2	-	-	PUNCT
aji-17	352	3	2283	2283	NUM
aji-17	352	4	.	.	PUNCT
aji-17	353	1	9	9	X
aji-17	353	2	.	.	X
aji-17	353	3	aford	aford	PROPN
aji-17	353	4	rh	rh	PROPN
aji-17	353	5	,	,	PUNCT
aji-17	353	6	rossen	rossen	PROPN
aji-17	353	7	rd	rd	PROPN
aji-17	353	8	,	,	PUNCT
aji-17	353	9	butler	butler	PROPN
aji-17	353	10	wt	wt	PROPN
aji-17	353	11	,	,	PUNCT
aji-17	353	12	kasel	kasel	PROPN
aji-17	353	13	ja	ja	PROPN
aji-17	353	14	.	.	PUNCT
aji-17	353	15	neutralizing	neutralizing	PROPN
aji-17	353	16	and	and	CCONJ
aji-17	353	17	hemagglutination	hemagglutination	NOUN
aji-17	353	18	inhibiting	inhibit	VERB
aji-17	353	19	activity	activity	NOUN
aji-17	353	20	of	of	ADP
aji-17	353	21	nasal	nasal	ADJ
aji-17	353	22	secretions	secretion	NOUN
aji-17	353	23	following	follow	VERB
aji-17	353	24	experimental	experimental	ADJ
aji-17	353	25	human	human	ADJ
aji-17	353	26	infection	infection	NOUN
aji-17	353	27	with	with	ADP
aji-17	353	28	a2	a2	PROPN
aji-17	353	29	influenza	influenza	PROPN
aji-17	353	30	virus	virus	PROPN
aji-17	353	31	.	.	PUNCT
aji-17	354	1	j.	j.	PROPN
aji-17	354	2	immunol	immunol	PROPN
aji-17	354	3	.	.	PUNCT
aji-17	355	1	1967;98:724	1967;98:724	NUM
aji-17	355	2	-	-	SYM
aji-17	355	3	731	731	NUM
aji-17	355	4	.	.	PUNCT
aji-17	356	1	10	10	NUM
aji-17	356	2	.	.	PUNCT
aji-17	357	1	rossen	rossen	PROPN
aji-17	357	2	rd	rd	PROPN
aji-17	357	3	,	,	PUNCT
aji-17	357	4	douglas	douglas	PROPN
aji-17	357	5	rg	rg	PROPN
aji-17	357	6	,	,	PUNCT
aji-17	357	7	cate	cate	PROPN
aji-17	357	8	tr	tr	VERB
aji-17	357	9	,	,	PUNCT
aji-17	357	10	couch	couch	NOUN
aji-17	357	11	rb	rb	NOUN
aji-17	357	12	,	,	PUNCT
aji-17	357	13	butler	butler	NOUN
aji-17	357	14	wt	wt	PROPN
aji-17	357	15	.	.	PUNCT
aji-17	358	1	the	the	DET
aji-17	358	2	sedimentation	sedimentation	NOUN
aji-17	358	3	behaviour	behaviour	NOUN
aji-17	358	4	of	of	ADP
aji-17	358	5	rhino	rhino	PROPN
aji-17	358	6	virus	virus	NOUN
aji-17	358	7	neutralizing	neutralize	VERB
aji-17	358	8	activity	activity	NOUN
aji-17	358	9	in	in	ADP
aji-17	358	10	nasal	nasal	ADJ
aji-17	358	11	secretions	secretion	NOUN
aji-17	358	12	and	and	CCONJ
aji-17	358	13	serum	serum	NOUN
aji-17	358	14	following	follow	VERB
aji-17	358	15	the	the	DET
aji-17	358	16	rhinovirus	rhinovirus	NOUN
aji-17	358	17	common	common	ADJ
aji-17	358	18	cold	cold	NOUN
aji-17	358	19	.	.	PUNCT
aji-17	359	1	j.	j.	PROPN
aji-17	359	2	immunol	immunol	PROPN
aji-17	359	3	.	.	PUNCT
aji-17	360	1	1966;97:532	1966;97:532	NOUN
aji-17	360	2	-	-	SYM
aji-17	360	3	538	538	NUM
aji-17	360	4	.	.	PUNCT
aji-17	361	1	11	11	NUM
aji-17	361	2	.	.	PUNCT
aji-17	362	1	smith	smith	PROPN
aji-17	362	2	cb	cb	PROPN
aji-17	362	3	,	,	PUNCT
aji-17	362	4	purcell	purcell	PROPN
aji-17	362	5	rh	rh	PROPN
aji-17	362	6	,	,	PUNCT
aji-17	362	7	bellanti	bellanti	PROPN
aji-17	362	8	ja	ja	PROPN
aji-17	362	9	,	,	PUNCT
aji-17	362	10	chanock	chanock	PROPN
aji-17	362	11	rm	rm	PROPN
aji-17	362	12	.	.	PUNCT
aji-17	362	13	protective	protective	ADJ
aji-17	362	14	antibody	antibody	NOUN
aji-17	362	15	to	to	PART
aji-17	362	16	para	para	VERB
aji-17	362	17	influenza	influenza	NOUN
aji-17	362	18	type	type	NOUN
aji-17	362	19	1	1	NUM
aji-17	362	20	virus	virus	NOUN
aji-17	362	21	.	.	PUNCT
aji-17	363	1	n.	n.	PROPN
aji-17	363	2	engl	engl	PROPN
aji-17	363	3	.	.	PUNCT
aji-17	364	1	j.	j.	PROPN
aji-17	364	2	med	med	PROPN
aji-17	364	3	.	.	PUNCT
aji-17	365	1	1966;275:1145	1966;275:1145	NUM
aji-17	365	2	-	-	PUNCT
aji-17	365	3	1152	1152	NUM
aji-17	365	4	.	.	PUNCT
aji-17	366	1	12	12	NUM
aji-17	366	2	.	.	PUNCT
aji-17	367	1	liem	liem	PROPN
aji-17	367	2	ks	ks	PROPN
aji-17	367	3	,	,	PUNCT
aji-17	367	4	jacobs	jacobs	PROPN
aji-17	367	5	j	j	PROPN
aji-17	367	6	,	,	PUNCT
aji-17	367	7	marcus	marcus	PROPN
aji-17	367	8	ea	ea	PROPN
aji-17	367	9	,	,	PUNCT
aji-17	367	10	van	van	PROPN
aji-17	367	11	strik	strik	PROPN
aji-17	367	12	r.	r.	PROPN
aji-17	367	13	the	the	DET
aji-17	367	14	protective	protective	ADJ
aji-17	367	15	effect	effect	NOUN
aji-17	367	16	of	of	ADP
aji-17	367	17	intranasal	intranasal	NOUN
aji-17	367	18	immu	immu	NOUN
aji-17	367	19	;	;	PUNCT
aji-17	367	20	1973	1973	NUM
aji-17	367	21	.	.	PUNCT
aji-17	368	1	13	13	NUM
aji-17	368	2	.	.	PUNCT
aji-17	369	1	waldman	waldman	PROPN
aji-17	369	2	rh	rh	PROPN
aji-17	369	3	,	,	PUNCT
aji-17	369	4	coggins	coggin	VERB
aji-17	369	5	wj	wj	PROPN
aji-17	369	6	.	.	PUNCT
aji-17	370	1	influenza	influenza	ADJ
aji-17	370	2	immunization	immunization	NOUN
aji-17	370	3	:	:	PUNCT
aji-17	370	4	field	field	NOUN
aji-17	370	5	trial	trial	NOUN
aji-17	370	6	on	on	ADP
aji-17	370	7	a	a	DET
aji-17	370	8	university	university	NOUN
aji-17	370	9	campus	campus	NOUN
aji-17	370	10	.	.	PUNCT
aji-17	371	1	j.	j.	PROPN
aji-17	371	2	infect	infect	PROPN
aji-17	371	3	.	.	PUNCT
aji-17	372	1	dis	dis	PROPN
aji-17	372	2	.	.	PUNCT
aji-17	373	1	1972;126:242	1972;126:242	NUM
aji-17	373	2	-	-	SYM
aji-17	373	3	248	248	NUM
aji-17	373	4	.	.	PUNCT
aji-17	374	1	14	14	NUM
aji-17	374	2	.	.	PUNCT
aji-17	375	1	waldman	waldman	PROPN
aji-17	375	2	rh	rh	PROPN
aji-17	375	3	,	,	PUNCT
aji-17	375	4	mann	mann	PROPN
aji-17	375	5	jj	jj	PROPN
aji-17	375	6	,	,	PUNCT
aji-17	375	7	small	small	PROPN
aji-17	375	8	pa	pa	PROPN
aji-17	375	9	,	,	PUNCT
aji-17	375	10	jr	jr	PROPN
aji-17	375	11	.	.	PROPN
aji-17	375	12	immunization	immunization	NOUN
aji-17	375	13	against	against	ADP
aji-17	375	14	influenza	influenza	NOUN
aji-17	375	15	:	:	PUNCT
aji-17	375	16	prevention	prevention	NOUN
aji-17	375	17	ofillness	ofillness	NOUN
aji-17	375	18	in	in	ADP
aji-17	375	19	man	man	NOUN
aji-17	375	20	by	by	ADP
aji-17	375	21	aerosolized	aerosolize	VERB
aji-17	375	22	inactivated	inactivated	ADJ
aji-17	375	23	vaccine	vaccine	NOUN
aji-17	375	24	.	.	PUNCT
aji-17	376	1	j.	j.	PROPN
aji-17	376	2	am	am	PROPN
aji-17	376	3	.	.	PUNCT
aji-17	377	1	med	med	PROPN
aji-17	377	2	.	.	PUNCT
aji-17	377	3	assoc	assoc	PROPN
aji-17	377	4	.	.	PUNCT
aji-17	378	1	1969;207:520	1969;207:520	NUM
aji-17	378	2	-	-	SYM
aji-17	378	3	524	524	NUM
aji-17	378	4	.	.	PUNCT
aji-17	379	1	15	15	NUM
aji-17	379	2	.	.	PUNCT
aji-17	380	1	barber	barber	PROPN
aji-17	380	2	wh	wh	PROPN
aji-17	380	3	,	,	PUNCT
aji-17	380	4	small	small	PROPN
aji-17	380	5	pa	pa	PROPN
aji-17	380	6	,	,	PUNCT
aji-17	380	7	jr	jr	PROPN
aji-17	380	8	.	.	PUNCT
aji-17	381	1	construction	construction	NOUN
aji-17	381	2	of	of	ADP
aji-17	381	3	an	an	DET
aji-17	381	4	improved	improved	ADJ
aji-17	381	5	tracheal	tracheal	NOUN
aji-17	381	6	pouch	pouch	NOUN
aji-17	381	7	in	in	ADP
aji-17	381	8	the	the	DET
aji-17	381	9	ferret	ferret	NOUN
aji-17	381	10	.	.	PUNCT
aji-17	382	1	am	be	AUX
aji-17	382	2	.	.	PUNCT
aji-17	383	1	rev	rev	AUX
aji-17	383	2	.	.	PUNCT
aji-17	383	3	respir	respir	PROPN
aji-17	383	4	.	.	PUNCT
aji-17	384	1	dis	dis	PROPN
aji-17	384	2	.	.	PUNCT
aji-17	385	1	1976;115:165	1976;115:165	NUM
aji-17	385	2	-	-	SYM
aji-17	385	3	169	169	NUM
aji-17	385	4	.	.	PUNCT
aji-17	386	1	16	16	NUM
aji-17	386	2	.	.	PUNCT
aji-17	387	1	edmondson	edmondson	PROPN
aji-17	387	2	wp	wp	PROPN
aji-17	387	3	,	,	PUNCT
aji-17	387	4	jr	jr	PROPN
aji-17	387	5	.	.	PUNCT
aji-17	388	1	rothenberg	rothenberg	PROPN
aji-17	388	2	r	r	PROPN
aji-17	388	3	,	,	PUNCT
aji-17	388	4	white	white	PROPN
aji-17	388	5	pw	pw	PROPN
aji-17	388	6	,	,	PUNCT
aji-17	388	7	gwaltney	gwaltney	PROPN
aji-17	388	8	jm	jm	PROPN
aji-17	388	9	,	,	PUNCT
aji-17	388	10	jr	jr	PROPN
aji-17	388	11	.	.	PUNCT
aji-17	389	1	a	a	DET
aji-17	389	2	comparison	comparison	NOUN
aji-17	389	3	of	of	ADP
aji-17	389	4	sub	sub	ADJ
aji-17	389	5	-	-	ADJ
aji-17	389	6	cutaneous	cutaneous	ADJ
aji-17	389	7	,	,	PUNCT
aji-17	389	8	nasal	nasal	NOUN
aji-17	389	9	and	and	CCONJ
aji-17	389	10	combined	combined	ADJ
aji-17	389	11	influenza	influenza	NOUN
aji-17	389	12	vaccination	vaccination	NOUN
aji-17	389	13	;	;	PUNCT
aji-17	389	14	1971	1971	NUM
aji-17	389	15	.	.	PUNCT
aji-17	390	1	17	17	NUM
aji-17	390	2	.	.	PUNCT
aji-17	390	3	downie	downie	PROPN
aji-17	390	4	jc	jc	PROPN
aji-17	390	5	,	,	PUNCT
aji-17	390	6	stuart	stuart	PROPN
aji-17	390	7	-	-	PUNCT
aji-17	390	8	harris	harris	PROPN
aji-17	390	9	ch	ch	PROPN
aji-17	390	10	.	.	PUNCT
aji-17	391	1	theproduction	theproduction	NOUN
aji-17	391	2	of	of	ADP
aji-17	391	3	neutralizing	neutralize	VERB
aji-17	391	4	activity	activity	NOUN
aji-17	391	5	in	in	ADP
aji-17	391	6	serum	serum	NOUN
aji-17	391	7	and	and	CCONJ
aji-17	391	8	nasalsecretion	nasalsecretion	NOUN
aji-17	391	9	following	follow	VERB
aji-17	391	10	immunization	immunization	NOUN
aji-17	391	11	with	with	ADP
aji-17	391	12	influenza	influenza	PROPN
aji-17	391	13	b.	b.	PROPN
aji-17	391	14	vi	vi	PROPN
aji-17	391	15	-	-	PUNCT
aji-17	391	16	rus	rus	NOUN
aji-17	391	17	.	.	PUNCT
aji-17	392	1	j.	j.	PROPN
aji-17	392	2	hyg	hyg	PROPN
aji-17	392	3	.	.	PUNCT
aji-17	392	4	(	(	PUNCT
aji-17	392	5	cambridge	cambridge	PROPN
aji-17	392	6	)	)	PUNCT
aji-17	392	7	.	.	PUNCT
aji-17	393	1	1970;68	1970;68	X
aji-17	393	2	:	:	PUNCT
aji-17	393	3	233	233	NUM
aji-17	393	4	-	-	SYM
aji-17	393	5	244	244	NUM
aji-17	393	6	.	.	PUNCT
aji-17	394	1	18	18	NUM
aji-17	394	2	.	.	PUNCT
aji-17	395	1	small	small	ADJ
aji-17	395	2	pa	pa	PROPN
aji-17	395	3	jr	jr	PROPN
aji-17	395	4	.	.	PROPN
aji-17	395	5	,	,	PUNCT
aji-17	395	6	waldman	waldman	PROPN
aji-17	395	7	rh	rh	PROPN
aji-17	395	8	,	,	PUNCT
aji-17	395	9	bruno	bruno	PROPN
aji-17	395	10	jc	jc	PROPN
aji-17	395	11	,	,	PUNCT
aji-17	395	12	g.	g.	PROPN
aji-17	395	13	gifford	gifford	PROPN
aji-17	395	14	e.	e.	PROPN
aji-17	395	15	influenza	influenza	PROPN
aji-17	395	16	infection	infection	NOUN
aji-17	395	17	in	in	ADP
aji-17	395	18	ferrets	ferret	NOUN
aji-17	395	19	:	:	PUNCT
aji-17	395	20	role	role	NOUN
aji-17	395	21	of	of	ADP
aji-17	395	22	serum	serum	NOUN
aji-17	395	23	antibody	antibody	NOUN
aji-17	395	24	in	in	ADP
aji-17	395	25	protection	protection	NOUN
aji-17	395	26	and	and	CCONJ
aji-17	395	27	recovery	recovery	NOUN
aji-17	395	28	.	.	PUNCT
aji-17	396	1	infect	infect	VERB
aji-17	396	2	.	.	PUNCT
aji-17	397	1	im	im	PROPN
aji-17	397	2	-	-	PUNCT
aji-17	397	3	mun	mun	PROPN
aji-17	397	4	.	.	PROPN
aji-17	397	5	1976;13:417424	1976;13:417424	NUM
aji-17	397	6	.	.	NOUN
aji-17	397	7	19	19	NUM
aji-17	397	8	.	.	PUNCT
aji-17	397	9	stuart	stuart	PROPN
aji-17	397	10	-	-	PUNCT
aji-17	397	11	harris	harris	PROPN
aji-17	397	12	c.	c.	PROPN
aji-17	397	13	influenza	influenza	PROPN
aji-17	397	14	-	-	PUNCT
aji-17	397	15	the	the	DET
aji-17	397	16	problems	problem	NOUN
aji-17	397	17	and	and	CCONJ
aji-17	397	18	the	the	DET
aji-17	397	19	,	,	PUNCT
aji-17	397	20	future	future	NOUN
aji-17	397	21	.	.	PUNCT
aji-17	398	1	med	med	PROPN
aji-17	398	2	.	.	PUNCT
aji-17	399	1	j.	j.	PROPN
aji-17	399	2	small	small	PROPN
aji-17	399	3	pa	pa	PROPN
aji-17	399	4	,	,	PUNCT
aji-17	399	5	jr	jr	PROPN
aji-17	399	6	.	.	PUNCT
aji-17	399	7	waldman	waldman	PROPN
aji-17	399	8	rh	rh	PROPN
aji-17	399	9	,	,	PUNCT
aji-17	399	10	bruno	bruno	PROPN
aji-17	399	11	jc	jc	PROPN
aji-17	399	12	,	,	PUNCT
aji-17	399	13	gifford	gifford	PROPN
aji-17	399	14	ge	ge	PROPN
aji-17	399	15	.	.	PUNCT
aji-17	400	1	influenza	influenza	ADJ
aji-17	400	2	infection	infection	NOUN
aji-17	400	3	in	in	ADP
aji-17	400	4	ferrets	ferret	NOUN
aji-17	400	5	:	:	PUNCT
aji-17	400	6	role	role	NOUN
aji-17	400	7	of	of	ADP
aji-17	400	8	serum	serum	NOUN
aji-17	400	9	antibody	antibody	NOUN
aji-17	400	10	in	in	ADP
aji-17	400	11	protection	protection	NOUN
aji-17	400	12	and	and	CCONJ
aji-17	400	13	recovery	recovery	NOUN
aji-17	400	14	.	.	PUNCT
aji-17	401	1	infect	infect	VERB
aji-17	401	2	.	.	PUNCT
aji-17	402	1	im	im	PROPN
aji-17	402	2	-	-	PUNCT
aji-17	402	3	mun	mun	NOUN
aji-17	402	4	.	.	PUNCT
aji-17	403	1	1973;13:417	1973;13:417	PROPN
aji-17	403	2	-	-	PUNCT
aji-17	403	3	424	424	NUM
aji-17	403	4	.	.	NOUN
aji-17	403	5	20	20	NUM
aji-17	403	6	.	.	PUNCT
aji-17	404	1	morris	morris	PROPN
aji-17	404	2	ja	ja	PROPN
aji-17	404	3	,	,	PUNCT
aji-17	404	4	kosel	kosel	PROPN
aji-17	404	5	ja	ja	PROPN
aji-17	404	6	,	,	PUNCT
aji-17	404	7	saclam	saclam	PROPN
aji-17	404	8	m	m	PROPN
aji-17	404	9	,	,	PUNCT
aji-17	404	10	knight	knight	NOUN
aji-17	404	11	v	v	ADP
aji-17	404	12	,	,	PUNCT
aji-17	404	13	loda	loda	PROPN
aji-17	404	14	fa	fa	PROPN
aji-17	404	15	.	.	PUNCT
aji-17	404	16	immunity	immunity	NOUN
aji-17	404	17	to	to	ADP
aji-17	404	18	influenza	influenza	NOUN
aji-17	404	19	as	as	ADP
aji-17	404	20	related	relate	VERB
aji-17	404	21	to	to	ADP
aji-17	404	22	antibody	antibody	NOUN
aji-17	404	23	levels	level	NOUN
aji-17	404	24	.	.	PUNCT
aji-17	405	1	n.	n.	PROPN
aji-17	405	2	engl	engl	PROPN
aji-17	405	3	.	.	PUNCT
aji-17	406	1	j.	j.	PROPN
aji-17	406	2	med	med	PROPN
aji-17	406	3	.	.	PUNCT
aji-17	407	1	1966;274:527	1966;274:527	NUM
aji-17	407	2	-	-	SYM
aji-17	407	3	535	535	NUM
aji-17	407	4	.	.	PUNCT
aji-17	408	1	21	21	NUM
aji-17	408	2	.	.	PUNCT
aji-17	409	1	kaji	kaji	PROPN
aji-17	409	2	j	j	PROPN
aji-17	409	3	,	,	PUNCT
aji-17	409	4	oseasohn	oseasohn	ADJ
aji-17	409	5	r	r	PROPN
aji-17	409	6	,	,	PUNCT
aji-17	409	7	jordan	jordan	PROPN
aji-17	409	8	ws	ws	PROPN
aji-17	409	9	,	,	PUNCT
aji-17	409	10	dingle	dingle	PROPN
aji-17	409	11	jh	jh	PROPN
aji-17	409	12	.	.	PUNCT
aji-17	410	1	isolation	isolation	NOUN
aji-17	410	2	of	of	ADP
aji-17	410	3	asian	asian	ADJ
aji-17	410	4	virus	virus	NOUN
aji-17	410	5	from	from	ADP
aji-17	410	6	eztrapulmonary	eztrapulmonary	PROPN
aji-17	410	7	tis	tis	PROPN
aji-17	410	8	-	-	PUNCT
aji-17	410	9	sues	sue	NOUN
aji-17	410	10	in	in	ADP
aji-17	410	11	fatal	fatal	ADJ
aji-17	410	12	human	human	ADJ
aji-17	410	13	influenza	influenza	NOUN
aji-17	410	14	.	.	PUNCT
aji-17	411	1	proc	proc	NOUN
aji-17	411	2	.	.	PUNCT
aji-17	412	1	soc	soc	PROPN
aji-17	412	2	.	.	PUNCT
aji-17	413	1	ezp	ezp	PROPN
aji-17	413	2	.	.	PUNCT
aji-17	414	1	biol	biol	PROPN
aji-17	414	2	.	.	PUNCT
aji-17	415	1	med	med	PROPN
aji-17	415	2	.	.	PUNCT
aji-17	416	1	1959;100:272	1959;100:272	NUM
aji-17	416	2	-	-	SYM
aji-17	416	3	275	275	NUM
aji-17	416	4	.	.	PUNCT
aji-17	417	1	22	22	NUM
aji-17	417	2	.	.	PUNCT
aji-17	418	1	kilbourne	kilbourne	PROPN
aji-17	418	2	ed	ed	NOUN
aji-17	418	3	,	,	PUNCT
aji-17	418	4	butler	butler	PROPN
aji-17	418	5	wt	wt	PROPN
aji-17	418	6	,	,	PUNCT
aji-17	418	7	rossen	rossen	PROPN
aji-17	418	8	rd	rd	PROPN
aji-17	418	9	.	.	PROPN
aji-17	419	1	vibrio	vibrio	PROPN
aji-17	419	2	ref	ref	PROPN
aji-17	419	3	.	.	PUNCT
aji-17	420	1	23	23	NUM
aji-17	420	2	.	.	X
aji-17	420	3	bloom	bloom	PROPN
aji-17	420	4	pd	pd	PROPN
aji-17	420	5	,	,	PUNCT
aji-17	420	6	et	et	PROPN
aji-17	420	7	al	al	PROPN
aji-17	420	8	.	.	PUNCT
aji-17	420	9	mucosal	mucosal	ADJ
aji-17	420	10	immune	immune	ADJ
aji-17	420	11	responses	response	NOUN
aji-17	420	12	to	to	ADP
aji-17	420	13	intestinal	intestinal	ADJ
aji-17	420	14	bacterial	bacterial	ADJ
aji-17	420	15	pathogens	pathogen	NOUN
aji-17	420	16	.	.	PUNCT
aji-17	421	1	semin	semin	PROPN
aji-17	421	2	gastrointest	gastrointest	PROPN
aji-17	421	3	dis	dis	PROPN
aji-17	421	4	;	;	PUNCT
aji-17	421	5	1996	1996	NUM
aji-17	421	6	.	.	PUNCT
aji-17	422	1	24	24	NUM
aji-17	422	2	.	.	PUNCT
aji-17	422	3	boullier	boullier	PROPN
aji-17	422	4	s	s	PROPN
aji-17	422	5	,	,	PUNCT
aji-17	422	6	et	et	PROPN
aji-17	422	7	al	al	PROPN
aji-17	422	8	.	.	PROPN
aji-17	422	9	secretory	secretory	PROPN
aji-17	422	10	iga	iga	PROPN
aji-17	422	11	-	-	PUNCT
aji-17	422	12	mediated	mediate	VERB
aji-17	422	13	neutralization	neutralization	NOUN
aji-17	422	14	of	of	ADP
aji-17	422	15	shigella	shigella	PROPN
aji-17	422	16	flexneri	flexneri	PROPN
aji-17	422	17	prevents	prevent	VERB
aji-17	422	18	intestinal	intestinal	ADJ
aji-17	422	19	tissue	tissue	NOUN
aji-17	422	20	destruction	destruction	NOUN
aji-17	422	21	by	by	ADP
aji-17	422	22	downregulating	downregulate	VERB
aji-17	422	23	inflammatory	inflammatory	ADJ
aji-17	422	24	circuits	circuit	NOUN
aji-17	422	25	.	.	PUNCT
aji-17	423	1	j	j	PROPN
aji-17	423	2	immunol	immunol	NOUN
aji-17	423	3	;	;	PUNCT
aji-17	423	4	2009	2009	NUM
aji-17	423	5	.	.	PUNCT
aji-17	424	1	25	25	NUM
aji-17	424	2	.	.	PUNCT
aji-17	425	1	lisa	lisa	PROPN
aji-17	425	2	m.	m.	PROPN
aji-17	425	3	hodge	hodge	PROPN
aji-17	425	4	,	,	PUNCT
aji-17	425	5	jerry	jerry	PROPN
aji-17	425	6	w.	w.	PROPN
aji-17	425	7	simecka	simecka	PROPN
aji-17	425	8	role	role	NOUN
aji-17	425	9	of	of	ADP
aji-17	425	10	upper	upper	ADJ
aji-17	425	11	and	and	CCONJ
aji-17	425	12	lower	low	ADJ
aji-17	425	13	respiratory	respiratory	ADJ
aji-17	425	14	tract	tract	NOUN
aji-17	425	15	immunity	immunity	NOUN
aji-17	425	16	in	in	ADP
aji-17	425	17	resistance	resistance	NOUN
aji-17	425	18	to	to	PART
aji-17	425	19	mycoplasma	mycoplasma	VERB
aji-17	425	20	respiratory	respiratory	ADJ
aji-17	425	21	disease	disease	NOUN
aji-17	425	22	.	.	PUNCT
aji-17	426	1	the	the	DET
aji-17	426	2	journal	journal	NOUN
aji-17	426	3	of	of	ADP
aji-17	426	4	infectious	infectious	ADJ
aji-17	426	5	diseases	disease	NOUN
aji-17	426	6	.	.	PUNCT
aji-17	427	1	2002;186	2002;186	NUM
aji-17	427	2	(	(	PUNCT
aji-17	427	3	2)290–294	2)290–294	NUM
aji-17	427	4	.	.	NOUN
aji-17	428	1	26	26	NUM
aji-17	428	2	.	.	PUNCT
aji-17	429	1	robert	robert	PROPN
aji-17	429	2	herich	herich	PROPN
aji-17	429	3	.	.	PUNCT
aji-17	430	1	is	be	AUX
aji-17	430	2	the	the	DET
aji-17	430	3	role	role	NOUN
aji-17	430	4	of	of	ADP
aji-17	430	5	iga	iga	PROPN
aji-17	430	6	in	in	ADP
aji-17	430	7	local	local	ADJ
aji-17	430	8	immunity	immunity	NOUN
aji-17	430	9	completely	completely	ADV
aji-17	430	10	known	know	VERB
aji-17	430	11	?	?	PUNCT
aji-17	430	12	,	,	PUNCT
aji-17	430	13	food	food	NOUN
aji-17	430	14	and	and	CCONJ
aji-17	430	15	agricultural	agricultural	ADJ
aji-17	430	16	immunology	immunology	NOUN
aji-17	430	17	.	.	PUNCT
aji-17	431	1	2017;28(2):223237	2017;28(2):223237	NUM
aji-17	431	2	.	.	PUNCT
aji-17	432	1	doi	doi	NOUN
aji-17	432	2	:	:	PUNCT
aji-17	432	3	10.1080/09540105.2016.1258547	10.1080/09540105.2016.1258547	NUM
aji-17	432	4	27	27	NUM
aji-17	432	5	.	.	PUNCT
aji-17	433	1	belyakov	belyakov	PROPN
aji-17	433	2	i	i	PROPN
aji-17	433	3	m	m	PROPN
aji-17	433	4	,	,	PUNCT
aji-17	433	5	hel	hel	PROPN
aji-17	433	6	z	z	PROPN
aji-17	433	7	,	,	PUNCT
aji-17	433	8	kelsall	kelsall	PROPN
aji-17	433	9	b	b	PROPN
aji-17	433	10	,	,	PUNCT
aji-17	433	11	kuznetsov	kuznetsov	PROPN
aji-17	433	12	va	va	PROPN
aji-17	433	13	,	,	PUNCT
aji-17	433	14	ahlers	ahlers	PROPN
aji-17	433	15	jd	jd	PROPN
aji-17	433	16	,	,	PUNCT
aji-17	433	17	nacsa	nacsa	ADJ
aji-17	433	18	j	j	PROPN
aji-17	433	19	,	,	PUNCT
aji-17	433	20	watkins	watkins	PROPN
aji-17	433	21	di	di	PROPN
aji-17	433	22	,	,	PUNCT
aji-17	433	23	allen	allen	PROPN
aji-17	433	24	tm	tm	PROPN
aji-17	433	25	,	,	PUNCT
aji-17	433	26	sette	sette	PROPN
aji-17	433	27	a	a	PROPN
aji-17	433	28	,	,	PUNCT
aji-17	433	29	altman	altman	PROPN
aji-17	433	30	j	j	PROPN
aji-17	433	31	,	,	PUNCT
aji-17	433	32	et	et	PROPN
aji-17	433	33	al	al	PROPN
aji-17	433	34	.	.	PUNCT
aji-17	433	35	mucosal	mucosal	PROPN
aji-17	433	36	aids	aid	NOUN
aji-17	433	37	vaccine	vaccine	NOUN
aji-17	433	38	reduces	reduce	VERB
aji-17	433	39	disease	disease	NOUN
aji-17	433	40	and	and	CCONJ
aji-17	433	41	viral	viral	ADJ
aji-17	433	42	load	load	NOUN
aji-17	433	43	in	in	ADP
aji-17	433	44	gut	gut	NOUN
aji-17	433	45	reservoir	reservoir	NOUN
aji-17	433	46	and	and	CCONJ
aji-17	433	47	blood	blood	NOUN
aji-17	433	48	after	after	ADP
aji-17	433	49	mucosal	mucosal	ADJ
aji-17	433	50	infection	infection	NOUN
aji-17	433	51	of	of	ADP
aji-17	433	52	macaques	macaque	NOUN
aji-17	433	53	.	.	PUNCT
aji-17	434	1	nat	nat	PROPN
aji-17	434	2	.	.	PUNCT
aji-17	434	3	med	med	PROPN
aji-17	434	4	.	.	PUNCT
aji-17	435	1	2001;7:1320–1326	2001;7:1320–1326	NUM
aji-17	435	2	.	.	X
aji-17	436	1	28	28	NUM
aji-17	436	2	.	.	PUNCT
aji-17	437	1	ichinohe	ichinohe	PROPN
aji-17	437	2	t	t	PROPN
aji-17	437	3	,	,	PUNCT
aji-17	437	4	lee	lee	PROPN
aji-17	437	5	hk	hk	PROPN
aji-17	437	6	,	,	PUNCT
aji-17	437	7	ogura	ogura	PROPN
aji-17	437	8	y	y	PROPN
aji-17	437	9	,	,	PUNCT
aji-17	437	10	flavell	flavell	ADJ
aji-17	437	11	r	r	NOUN
aji-17	437	12	,	,	PUNCT
aji-17	437	13	iwasaki	iwasaki	PROPN
aji-17	437	14	a.	a.	NOUN
aji-17	437	15	inflammasome	inflammasome	PROPN
aji-17	437	16	recognition	recognition	NOUN
aji-17	437	17	of	of	ADP
aji-17	437	18	influenza	influenza	NOUN
aji-17	437	19	virus	virus	NOUN
aji-17	437	20	is	be	AUX
aji-17	437	21	essential	essential	ADJ
aji-17	437	22	for	for	ADP
aji-17	437	23	adaptive	adaptive	ADJ
aji-17	437	24	immune	immune	ADJ
aji-17	437	25	responses	response	NOUN
aji-17	437	26	.	.	PUNCT
aji-17	438	1	j.	j.	PROPN
aji-17	438	2	exp	exp	PROPN
aji-17	438	3	.	.	PROPN
aji-17	438	4	med	med	PROPN
aji-17	438	5	.	.	PUNCT
aji-17	439	1	2009;206:79–87	2009;206:79–87	NUM
aji-17	439	2	.	.	PUNCT
aji-17	440	1	29	29	NUM
aji-17	440	2	.	.	PUNCT
aji-17	441	1	kantele	kantele	PROPN
aji-17	441	2	a	a	PROPN
aji-17	441	3	,	,	PUNCT
aji-17	441	4	ha¨kkinen	ha¨kkinen	PROPN
aji-17	441	5	m	m	PROPN
aji-17	441	6	,	,	PUNCT
aji-17	441	7	moldoveanu	moldoveanu	PROPN
aji-17	441	8	z	z	PROPN
aji-17	441	9	,	,	PUNCT
aji-17	441	10	lu	lu	PROPN
aji-17	441	11	a	a	NOUN
aji-17	441	12	,	,	PUNCT
aji-17	441	13	savilahti	savilahti	NOUN
aji-17	441	14	e	e	PROPN
aji-17	441	15	,	,	PUNCT
aji-17	441	16	alvarez	alvarez	PROPN
aji-17	441	17	rd	rd	PROPN
aji-17	441	18	,	,	PUNCT
aji-17	441	19	michalek	michalek	NOUN
aji-17	441	20	s	s	PART
aji-17	441	21	,	,	PUNCT
aji-17	441	22	mestecky	mestecky	PROPN
aji-17	441	23	j.	j.	PROPN
aji-17	441	24	differences	difference	NOUN
aji-17	441	25	in	in	ADP
aji-17	441	26	immune	immune	ADJ
aji-17	441	27	responses	response	NOUN
aji-17	441	28	induced	induce	VERB
aji-17	441	29	by	by	ADP
aji-17	441	30	oral	oral	ADJ
aji-17	441	31	and	and	CCONJ
aji-17	441	32	rectal	rectal	ADJ
aji-17	441	33	immunizations	immunization	NOUN
aji-17	441	34	with	with	ADP
aji-17	441	35	salmonella	salmonella	NOUN
aji-17	441	36	typhi	typhi	VERB
aji-17	441	37	ty21a	ty21a	ADV
aji-17	441	38	:	:	PUNCT
aji-17	441	39	evidence	evidence	NOUN
aji-17	441	40	for	for	ADP
aji-17	441	41	compartmental	compartmental	NOUN
aji-17	441	42	-	-	PUNCT
aji-17	441	43	ization	ization	NOUN
aji-17	441	44	within	within	ADP
aji-17	441	45	the	the	DET
aji-17	441	46	common	common	ADJ
aji-17	441	47	mucosal	mucosal	ADJ
aji-17	441	48	immune	immune	ADJ
aji-17	441	49	system	system	NOUN
aji-17	441	50	in	in	ADP
aji-17	441	51	humans	human	NOUN
aji-17	441	52	.	.	PUNCT
aji-17	442	1	infect	infect	VERB
aji-17	442	2	.	.	PUNCT
aji-17	443	1	immun	immun	PROPN
aji-17	443	2	.	.	PUNCT
aji-17	444	1	1998;66:5630–5635	1998;66:5630–5635	NUM
aji-17	444	2	.	.	NOUN
aji-17	444	3	30	30	NUM
aji-17	444	4	.	.	PUNCT
aji-17	445	1	bienenstock	bienenstock	PROPN
aji-17	445	2	j	j	PROPN
aji-17	445	3	,	,	PUNCT
aji-17	445	4	befus	befus	PROPN
aji-17	445	5	ad	ad	NOUN
aji-17	445	6	,	,	PUNCT
aji-17	445	7	mcdermott	mcdermott	PROPN
aji-17	445	8	m	m	PROPN
aji-17	445	9	,	,	PUNCT
aji-17	445	10	mirski	mirski	NOUN
aji-17	445	11	s	s	PROPN
aji-17	445	12	,	,	PUNCT
aji-17	445	13	rosenthal	rosenthal	PROPN
aji-17	445	14	k	k	PROPN
aji-17	445	15	,	,	PUNCT
aji-17	445	16	tagliabue	tagliabue	PROPN
aji-17	445	17	a.	a.	NOUN
aji-17	445	18	the	the	DET
aji-17	445	19	mucosal	mucosal	ADJ
aji-17	445	20	immunological	immunological	ADJ
aji-17	445	21	network	network	NOUN
aji-17	445	22	:	:	PUNCT
aji-17	445	23	prasad	prasad	PROPN
aji-17	445	24	;	;	PUNCT
aji-17	445	25	aji	aji	NOUN
aji-17	445	26	,	,	PUNCT
aji-17	445	27	3(1	3(1	NUM
aji-17	445	28	):	):	PUNCT
aji-17	445	29	61	61	NUM
aji-17	445	30	-	-	SYM
aji-17	445	31	70	70	NUM
aji-17	445	32	,	,	PUNCT
aji-17	445	33	2020	2020	NUM
aji-17	445	34	;	;	PUNCT
aji-17	445	35	article	article	NOUN
aji-17	445	36	no.aji.55881	no.aji.55881	ADP
aji-17	445	37	70	70	NUM
aji-17	445	38	compartmentalization	compartmentalization	NOUN
aji-17	445	39	of	of	ADP
aji-17	445	40	lymphocytes	lymphocyte	NOUN
aji-17	445	41	,	,	PUNCT
aji-17	445	42	natural	natural	ADJ
aji-17	445	43	killer	killer	NOUN
aji-17	445	44	cells	cell	NOUN
aji-17	445	45	and	and	CCONJ
aji-17	445	46	mast	mast	NOUN
aji-17	445	47	cells	cell	NOUN
aji-17	445	48	.	.	PUNCT
aji-17	446	1	ann	ann	PROPN
aji-17	446	2	.	.	PROPN
aji-17	446	3	ny	ny	PROPN
aji-17	446	4	acad	acad	PROPN
aji-17	446	5	.	.	PUNCT
aji-17	447	1	sci	sci	PROPN
aji-17	447	2	.	.	PROPN
aji-17	447	3	1983;409:164–170	1983;409:164–170	NUM
aji-17	447	4	.	.	PUNCT
aji-17	448	1	31	31	NUM
aji-17	448	2	.	.	PUNCT
aji-17	449	1	wang	wang	PROPN
aji-17	449	2	j	j	PROPN
aji-17	449	3	,	,	PUNCT
aji-17	449	4	thorson	thorson	PROPN
aji-17	449	5	l	l	PROPN
aji-17	449	6	,	,	PUNCT
aji-17	449	7	stokes	stokes	PROPN
aji-17	449	8	rw	rw	PROPN
aji-17	449	9	,	,	PUNCT
aji-17	449	10	santosuosso	santosuosso	PROPN
aji-17	449	11	m	m	PROPN
aji-17	449	12	,	,	PUNCT
aji-17	449	13	huygen	huygen	PROPN
aji-17	449	14	k	k	X
aji-17	449	15	,	,	PUNCT
aji-17	449	16	zganiacz	zganiacz	VERB
aji-17	449	17	a	a	DET
aji-17	449	18	,	,	PUNCT
aji-17	449	19	hitt	hitt	X
aji-17	449	20	m	m	PROPN
aji-17	449	21	,	,	PUNCT
aji-17	449	22	xing	xing	PROPN
aji-17	449	23	z.	z.	PROPN
aji-17	449	24	single	single	ADJ
aji-17	449	25	mucosal	mucosal	NOUN
aji-17	449	26	,	,	PUNCT
aji-17	449	27	but	but	CCONJ
aji-17	449	28	not	not	PART
aji-17	449	29	parenteral	parenteral	ADJ
aji-17	449	30	,	,	PUNCT
aji-17	449	31	immunization	immunization	NOUN
aji-17	449	32	with	with	ADP
aji-17	449	33	recombinant	recombinant	ADJ
aji-17	449	34	adenoviral	adenoviral	ADJ
aji-17	449	35	-	-	PUNCT
aji-17	449	36	based	base	VERB
aji-17	449	37	vaccine	vaccine	NOUN
aji-17	449	38	provides	provide	VERB
aji-17	449	39	potent	potent	ADJ
aji-17	449	40	protection	protection	NOUN
aji-17	449	41	from	from	ADP
aji-17	449	42	pulmonary	pulmonary	ADJ
aji-17	449	43	tuberculosis	tuberculosis	NOUN
aji-17	449	44	.	.	PUNCT
aji-17	450	1	j.	j.	PROPN
aji-17	450	2	immunol	immunol	PROPN
aji-17	450	3	.	.	PUNCT
aji-17	451	1	2004;173:6357–6365	2004;173:6357–6365	NOUN
aji-17	451	2	.	.	PUNCT
aji-17	452	1	32	32	NUM
aji-17	452	2	.	.	PUNCT
aji-17	453	1	neutra	neutra	PROPN
aji-17	453	2	mr	mr	PROPN
aji-17	453	3	,	,	PUNCT
aji-17	453	4	kozlowski	kozlowski	PROPN
aji-17	453	5	pa	pa	PROPN
aji-17	453	6	.	.	PROPN
aji-17	453	7	m30	m30	PROPN
aji-17	453	8	.	.	PUNCT
aji-17	454	1	neutra	neutra	PROPN
aji-17	454	2	mr	mr	PROPN
aji-17	454	3	,	,	PUNCT
aji-17	454	4	kozlowski	kozlowski	PROPN
aji-17	454	5	pa	pa	PROPN
aji-17	454	6	.	.	PROPN
aji-17	454	7	mucosal	mucosal	NOUN
aji-17	454	8	vaccines	vaccine	NOUN
aji-17	454	9	:	:	PUNCT
aji-17	454	10	the	the	DET
aji-17	454	11	promise	promise	NOUN
aji-17	454	12	and	and	CCONJ
aji-17	454	13	thechallenge	thechallenge	NOUN
aji-17	454	14	.	.	PUNCT
aji-17	455	1	nat	nat	PROPN
aji-17	455	2	.	.	PUNCT
aji-17	456	1	rev	rev	PROPN
aji-17	456	2	.	.	PROPN
aji-17	456	3	immunol	immunol	NOUN
aji-17	456	4	.	.	PUNCT
aji-17	457	1	2006;6:148–158	2006;6:148–158	X
aji-17	457	2	.	.	PUNCT
aji-17	458	1	33	33	NUM
aji-17	458	2	.	.	PUNCT
aji-17	459	1	gallichan	gallichan	PROPN
aji-17	459	2	ws	ws	PROPN
aji-17	459	3	,	,	PUNCT
aji-17	459	4	rosenthal	rosenthal	PROPN
aji-17	459	5	kl	kl	PROPN
aji-17	459	6	.	.	PUNCT
aji-17	459	7	long	long	ADV
aji-17	459	8	-	-	PUNCT
aji-17	459	9	lived	live	VERB
aji-17	459	10	cytotoxic	cytotoxic	ADJ
aji-17	459	11	t	t	NOUN
aji-17	459	12	lymphocytememory	lymphocytememory	NOUN
aji-17	459	13	in	in	ADP
aji-17	459	14	mucosal	mucosal	ADJ
aji-17	459	15	tissues	tissue	NOUN
aji-17	459	16	after	after	ADP
aji-17	459	17	mucosal	mucosal	NOUN
aji-17	459	18	but	but	CCONJ
aji-17	459	19	not	not	PART
aji-17	459	20	systemic	systemic	ADJ
aji-17	459	21	immunization	immunization	NOUN
aji-17	459	22	.	.	PUNCT
aji-17	460	1	j.	j.	PROPN
aji-17	460	2	exp	exp	PROPN
aji-17	460	3	.	.	PROPN
aji-17	460	4	med	med	PROPN
aji-17	460	5	.	.	PUNCT
aji-17	461	1	1996;184:1879	1996;184:1879	NUM
aji-17	461	2	–	–	PUNCT
aji-17	461	3	1890	1890	NUM
aji-17	461	4	.	.	PUNCT
aji-17	462	1	34	34	NUM
aji-17	462	2	.	.	PUNCT
aji-17	463	1	revaz	revaz	PROPN
aji-17	463	2	v	v	PROPN
aji-17	463	3	,	,	PUNCT
aji-17	463	4	benyacoub	benyacoub	PROPN
aji-17	463	5	j	j	PROPN
aji-17	463	6	,	,	PUNCT
aji-17	463	7	kast	kast	PROPN
aji-17	463	8	wm	wm	PROPN
aji-17	463	9	,	,	PUNCT
aji-17	463	10	schiller	schiller	PROPN
aji-17	463	11	jt	jt	PROPN
aji-17	463	12	,	,	PUNCT
aji-17	463	13	de	de	X
aji-17	463	14	grandi	grandi	X
aji-17	463	15	p	p	X
aji-17	463	16	,	,	PUNCT
aji-17	463	17	nardelli	nardelli	NOUN
aji-17	463	18	-	-	PUNCT
aji-17	463	19	haefliger	haefliger	NOUN
aji-17	463	20	d.	d.	PROPN
aji-17	463	21	mucosal	mucosal	NOUN
aji-17	463	22	vaccination	vaccination	NOUN
aji-17	463	23	with	with	ADP
aji-17	463	24	a	a	DET
aji-17	463	25	recombinant	recombinant	ADJ
aji-17	463	26	salmonella	salmonella	NOUN
aji-17	463	27	ty	ty	NOUN
aji-17	463	28	-	-	PUNCT
aji-17	463	29	phimurium	phimurium	NOUN
aji-17	463	30	expressing	express	VERB
aji-17	463	31	human	human	ADJ
aji-17	463	32	papillomavirus	papillomavirus	NOUN
aji-17	463	33	type	type	NOUN
aji-17	463	34	16	16	NUM
aji-17	463	35	(	(	PUNCT
aji-17	463	36	hpv16	hpv16	NOUN
aji-17	463	37	)	)	PUNCT
aji-17	463	38	l1	l1	PROPN
aji-17	463	39	virus	virus	NOUN
aji-17	463	40	-	-	PUNCT
aji-17	463	41	like	like	ADJ
aji-17	463	42	particles	particle	NOUN
aji-17	463	43	(	(	PUNCT
aji-17	463	44	vlps	vlps	NOUN
aji-17	463	45	)	)	PUNCT
aji-17	463	46	or	or	CCONJ
aji-17	463	47	hpv16	hpv16	NOUN
aji-17	463	48	vlps	vlps	NOUN
aji-17	463	49	purified	purify	VERB
aji-17	463	50	from	from	ADP
aji-17	463	51	insect	insect	NOUN
aji-17	463	52	cells	cell	NOUN
aji-17	463	53	inhibits	inhibit	VERB
aji-17	463	54	the	the	DET
aji-17	463	55	growth	growth	NOUN
aji-17	463	56	of	of	ADP
aji-17	463	57	hpv16	hpv16	NOUN
aji-17	463	58	-	-	PUNCT
aji-17	463	59	expressing	express	VERB
aji-17	463	60	tumor	tumor	NOUN
aji-17	463	61	cells	cell	NOUN
aji-17	463	62	in	in	ADP
aji-17	463	63	mice	mouse	NOUN
aji-17	463	64	.	.	PUNCT
aji-17	464	1	virology	virology	NOUN
aji-17	464	2	.	.	PUNCT
aji-17	465	1	2001;279	2001;279	NUM
aji-17	465	2	:	:	PUNCT
aji-17	466	1	354–360	354–360	NUM
aji-17	466	2	.	.	NOUN
aji-17	466	3	35	35	NUM
aji-17	466	4	.	.	PUNCT
aji-17	467	1	kozlowski	kozlowski	PROPN
aji-17	467	2	pa	pa	PROPN
aji-17	467	3	,	,	PUNCT
aji-17	467	4	cu	cu	PROPN
aji-17	467	5	-	-	PUNCT
aji-17	467	6	uvin	uvin	PROPN
aji-17	467	7	s	s	PROPN
aji-17	467	8	,	,	PUNCT
aji-17	467	9	neutra	neutra	PROPN
aji-17	467	10	mr	mr	PROPN
aji-17	467	11	,	,	PUNCT
aji-17	467	12	t.	t.	PROPN
aji-17	467	13	flanigan	flanigan	PROPN
aji-17	467	14	p.	p.	PROPN
aji-17	467	15	comparisonof	comparisonof	VERB
aji-17	467	16	the	the	DET
aji-17	467	17	oral	oral	ADJ
aji-17	467	18	,	,	PUNCT
aji-17	467	19	rectal	rectal	ADJ
aji-17	467	20	and	and	CCONJ
aji-17	467	21	vaginal	vaginal	ADJ
aji-17	467	22	immunization	immunization	NOUN
aji-17	467	23	routes	route	NOUN
aji-17	467	24	for	for	ADP
aji-17	467	25	induction	induction	NOUN
aji-17	467	26	of	of	ADP
aji-17	467	27	antibodies	antibody	NOUN
aji-17	467	28	inrectal	inrectal	ADJ
aji-17	467	29	and	and	CCONJ
aji-17	467	30	genital	genital	ADJ
aji-17	467	31	tract	tract	NOUN
aji-17	467	32	secretions	secretion	NOUN
aji-17	467	33	of	of	ADP
aji-17	467	34	women	woman	NOUN
aji-17	467	35	.	.	PUNCT
aji-17	468	1	infect	infect	VERB
aji-17	468	2	.	.	PUNCT
aji-17	469	1	immun	immun	PROPN
aji-17	469	2	.	.	PUNCT
aji-17	470	1	1997;65:1387–1394	1997;65:1387–1394	NUM
aji-17	470	2	.	.	PROPN
aji-17	471	1	36	36	NUM
aji-17	471	2	.	.	PUNCT
aji-17	472	1	majid	majid	PROPN
aji-17	472	2	laassri	laassri	PROPN
aji-17	472	3	,	,	PUNCT
aji-17	472	4	kathleen	kathleen	PROPN
aji-17	472	5	lottenbach	lottenbach	PROPN
aji-17	472	6	,	,	PUNCT
aji-17	472	7	robert	robert	PROPN
aji-17	472	8	belshe	belshe	PROPN
aji-17	472	9	,	,	PUNCT
aji-17	472	10	mark	mark	PROPN
aji-17	472	11	wolff	wolff	PROPN
aji-17	472	12	,	,	PUNCT
aji-17	472	13	margaret	margaret	PROPN
aji-17	472	14	rennels	rennels	PROPN
aji-17	472	15	,	,	PUNCT
aji-17	472	16	stanley	stanley	PROPN
aji-17	472	17	plotkin	plotkin	PROPN
aji-17	472	18	,	,	PUNCT
aji-17	472	19	konstantin	konstantin	PROPN
aji-17	472	20	chumakov	chumakov	PROPN
aji-17	472	21	.	.	PUNCT
aji-17	473	1	effect	effect	NOUN
aji-17	473	2	of	of	ADP
aji-17	473	3	different	different	ADJ
aji-17	473	4	vaccination	vaccination	NOUN
aji-17	473	5	schedules	schedule	NOUN
aji-17	473	6	on	on	ADP
aji-17	473	7	excretion	excretion	NOUN
aji-17	473	8	of	of	ADP
aji-17	473	9	oral	oral	ADJ
aji-17	473	10	poliovirus	poliovirus	NOUN
aji-17	473	11	vaccine	vaccine	NOUN
aji-17	473	12	strains	strain	VERB
aji-17	473	13	.	.	PUNCT
aji-17	474	1	the	the	DET
aji-17	474	2	journal	journal	NOUN
aji-17	474	3	of	of	ADP
aji-17	474	4	infectious	infectious	ADJ
aji-17	474	5	diseases	disease	NOUN
aji-17	474	6	.	.	PUNCT
aji-17	475	1	2005;192(12):2092–2098	2005;192(12):2092–2098	NUM
aji-17	475	2	.	.	PUNCT
aji-17	476	1	_	_	PUNCT
aji-17	477	1	_	_	PUNCT
aji-17	478	1	_	_	PUNCT
aji-17	479	1	_	_	PUNCT
aji-17	480	1	_	_	PUNCT
aji-17	481	1	_	_	PUNCT
aji-17	482	1	_	_	PUNCT
aji-17	483	1	_	_	PUNCT
aji-17	484	1	_	_	PUNCT
aji-17	485	1	_	_	PUNCT
aji-17	486	1	_	_	PUNCT
aji-17	487	1	_	_	PUNCT
aji-17	488	1	_	_	PUNCT
aji-17	489	1	_	_	PUNCT
aji-17	490	1	_	_	PUNCT
aji-17	491	1	_	_	PUNCT
aji-17	492	1	_	_	PUNCT
aji-17	493	1	_	_	PUNCT
aji-17	494	1	_	_	PUNCT
aji-17	495	1	_	_	PUNCT
aji-17	496	1	_	_	PUNCT
aji-17	497	1	_	_	PUNCT
aji-17	498	1	_	_	PUNCT
aji-17	499	1	_	_	PUNCT
aji-17	500	1	_	_	PUNCT
aji-17	501	1	_	_	PUNCT
aji-17	502	1	_	_	PUNCT
aji-17	503	1	_	_	PUNCT
aji-17	504	1	_	_	PUNCT
aji-17	505	1	_	_	PUNCT
aji-17	506	1	_	_	PUNCT
aji-17	507	1	_	_	PUNCT
aji-17	508	1	_	_	PUNCT
aji-17	509	1	_	_	PUNCT
aji-17	510	1	_	_	PUNCT
aji-17	511	1	_	_	PUNCT
aji-17	512	1	_	_	PUNCT
aji-17	513	1	_	_	PUNCT
aji-17	514	1	_	_	PUNCT
aji-17	515	1	_	_	PUNCT
aji-17	516	1	_	_	PUNCT
aji-17	517	1	_	_	PUNCT
aji-17	518	1	_	_	PUNCT
aji-17	519	1	_	_	PUNCT
aji-17	520	1	_	_	PUNCT
aji-17	521	1	_	_	PUNCT
aji-17	522	1	_	_	PUNCT
aji-17	523	1	_	_	PUNCT
aji-17	524	1	_	_	PUNCT
aji-17	525	1	_	_	PUNCT
aji-17	526	1	_	_	PUNCT
aji-17	527	1	_	_	PUNCT
aji-17	528	1	_	_	PUNCT
aji-17	529	1	_	_	PUNCT
aji-17	530	1	_	_	PUNCT
aji-17	531	1	_	_	PUNCT
aji-17	532	1	_	_	PUNCT
aji-17	533	1	_	_	PUNCT
aji-17	534	1	_	_	PUNCT
aji-17	535	1	_	_	PUNCT
aji-17	536	1	_	_	PUNCT
aji-17	537	1	_	_	PUNCT
aji-17	538	1	_	_	PUNCT
aji-17	539	1	_	_	PUNCT
aji-17	540	1	_	_	PUNCT
aji-17	541	1	_	_	PUNCT
aji-17	542	1	_	_	PUNCT
aji-17	543	1	_	_	PUNCT
aji-17	544	1	_	_	PUNCT
aji-17	545	1	_	_	PUNCT
aji-17	546	1	_	_	PUNCT
aji-17	547	1	_	_	PUNCT
aji-17	548	1	_	_	PUNCT
aji-17	549	1	_	_	PUNCT
aji-17	550	1	_	_	PUNCT
aji-17	551	1	_	_	PUNCT
aji-17	552	1	_	_	PUNCT
aji-17	553	1	_	_	PUNCT
aji-17	554	1	_	_	PUNCT
aji-17	555	1	_	_	PUNCT
aji-17	556	1	_	_	PUNCT
aji-17	557	1	©	©	PROPN
aji-17	557	2	2020	2020	NUM
aji-17	557	3	prasad	prasad	NOUN
aji-17	557	4	;	;	PUNCT
aji-17	557	5	this	this	PRON
aji-17	557	6	is	be	AUX
aji-17	557	7	an	an	DET
aji-17	557	8	open	open	ADJ
aji-17	557	9	access	access	NOUN
aji-17	557	10	article	article	NOUN
aji-17	557	11	distributed	distribute	VERB
aji-17	557	12	under	under	ADP
aji-17	557	13	the	the	DET
aji-17	557	14	terms	term	NOUN
aji-17	557	15	of	of	ADP
aji-17	557	16	the	the	DET
aji-17	557	17	creative	creative	ADJ
aji-17	557	18	commons	common	NOUN
aji-17	557	19	attribution	attribution	NOUN
aji-17	557	20	license	license	NOUN
aji-17	557	21	(	(	PUNCT
aji-17	557	22	http://creativecommons.org/licenses/by/4.0	http://creativecommons.org/licenses/by/4.0	NOUN
aji-17	557	23	)	)	PUNCT
aji-17	557	24	,	,	PUNCT
aji-17	557	25	which	which	PRON
aji-17	557	26	permits	permit	VERB
aji-17	557	27	unrestricted	unrestricted	ADJ
aji-17	557	28	use	use	NOUN
aji-17	557	29	,	,	PUNCT
aji-17	557	30	distribution	distribution	NOUN
aji-17	557	31	,	,	PUNCT
aji-17	557	32	and	and	CCONJ
aji-17	557	33	reproduction	reproduction	NOUN
aji-17	557	34	in	in	ADP
aji-17	557	35	any	any	DET
aji-17	557	36	medium	medium	NOUN
aji-17	557	37	,	,	PUNCT
aji-17	557	38	provided	provide	VERB
aji-17	557	39	the	the	DET
aji-17	557	40	original	original	ADJ
aji-17	557	41	work	work	NOUN
aji-17	557	42	is	be	AUX
aji-17	557	43	properly	properly	ADV
aji-17	557	44	cited	cite	VERB
aji-17	557	45	.	.	PUNCT
aji-17	558	1	peer	peer	NOUN
aji-17	558	2	-	-	PUNCT
aji-17	558	3	review	review	NOUN
aji-17	558	4	history	history	NOUN
aji-17	558	5	:	:	PUNCT
aji-17	558	6	the	the	DET
aji-17	558	7	peer	peer	NOUN
aji-17	558	8	review	review	NOUN
aji-17	558	9	history	history	NOUN
aji-17	558	10	for	for	ADP
aji-17	558	11	this	this	DET
aji-17	558	12	paper	paper	NOUN
aji-17	558	13	can	can	AUX
aji-17	558	14	be	be	AUX
aji-17	558	15	accessed	access	VERB
aji-17	558	16	here	here	ADV
aji-17	558	17	:	:	PUNCT
aji-17	558	18	http://www.sdiarticle4.com/review-history/55881	http://www.sdiarticle4.com/review-history/55881	DET
aji-17	558	19	http://creativecommons.org/licenses/by/4.0	http://creativecommons.org/licenses/by/4.0	NOUN